LF1|LF2|Synonym
cartilage-derived morphogenetic protein-1|Cartilage-derived morphogenetic protein-1|Y
quantitative real time polymerase chain reaction assay|quantitative reverse transcription polymerase chain reaction assay|N
phorbol myristic acetate|phorbol myristate acetate|Y
anterior temporal lobectomy|anterior temporal lobe|N
laparoscopic hysterectomy|laparoscopic hepatectomy|N
Platelet-derived growth factor bb|platelet derived growth factor BB|Y
American Society of Anaesthesiology status 1|American Society of Anaesthesiologists status 1|Y
palmo-plantar pustular psoriasis|palmoplantar pustulosis|Y
mammalian gonadotropin releasing hormone|mammalian gonadotropin-releasing hormone|Y
type 1 cannabinoid receptor|cannabinoid 1 receptor|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiology status 1|Y
paradoxical vocal cord movement|paradoxical vocal cord motion|Y
ventral posteromedial thalamic nucleus|ventral posteromedial nucleus|Y
alpha-ketoisocaproate|ketoisocaproate|Y
glutamate receptor 2|glutamate receptor subunit 2|N
thrombin-antithrombin complex|thrombin antithrombin III complex|Y
Erythroid Kruppel-like factor|erythroid Kruppel-like factor|Y
glycolate oxidase|glucose oxidase|N
class II transactivator|class II transcriptional activator|Y
in vivo expression technology|vivo expression technology|Y
5-phosphoribosyl 1-pyrophosphate|phosphoribosylpyrophosphate|Y
artemisinin based combination therapy|artemisinin combination therapy|Y
membrane-associated guanylate kinase|Membrane-associated guanylate kinase|Y
thoracic duct fistula|thoracic duct flow|N
Health Insurance Portability and Accountability Act|Health Insurance Portability and Accountability Act of 1996|Y
magnetic-activated cell separation|magnetic-activated cell sorter|Y
human adenovirus 15|human adenovirus type 15|Y
mucopolysaccharidosis type 1|mucopolysaccharidosis 1|Y
lysine acetylsalicylic acid|lysine acetylsalicylate|N
electronystagmogram|electronystagmograph|Y
transforming growth factor β receptor I|transforming growth factor-beta receptor type I|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiology physical status 1|Y
diffuse intravascular coagulation|disseminated intravascular coagulation|Y
L-type amino acid transporter 1|large amino acid transporter 1|Y
adenylate cyclase 9|adenylyl cyclase 9|Y
vasoactive intestinal polypeptide receptor antagonist|vasoactive intestinal peptide receptor antagonist|Y
ankle brachial index|ankle brachial pressure index|Y
hypo-osmotic swelling test|hypoosmotic swelling test|Y
placenta conditioned medium|platelet conditioned medium|N
alpha-atrial natriuretic polypeptide|alpha atrial natriuretic peptide|Y
zonula occludens 1|zonula occludens 1 protein|Y
ovine corticotropin releasing factor|ovine corticotropin-releasing factor|Y
inhibition constant|inhibitory constant|Y
field emission scanning electron microscope|field emission scanning electron microscopy|Y
chick embryo cell|chicken embryo cell|Y
human adenovirus serotype F|human adenovirus type F|Y
test stimulation|tetanic stimulation|N
ubiquinone 10|ubiquinone|Y
antero-posterior|anterior posterior|Y
ribosomal S6 kinase|ribosomal S-6 kinase|Y
inhibitor constant value|inhibition constant value|Y
interleukin 4 receptor alpha|interleukin-4 receptor α chain|Y
pig cytomegalovirus|porcine cytomegalovirus|Y
prion protein|prion protein gene|N
California|Californian|N
parainfluenza virus type 3|parainfluenza 3 virus|Y
squamous epithelial cell|surface epithelial cell|N
human adenovirus 24|human adenovirus serotype 24|Y
primary visual cortex|primary visual area|Y
fluorescence lifetime imaging microscopy|fluorescence lifetime imaging|Y
vasoactive intestinal peptide immunoreactive nerve|vasoactive intestinal polypeptide immunoreactive nerve|Y
type 1 cannabinoid receptor|cannabinoid receptor|Y
thrombelastogram|thromboelastography|Y
platelet-derived growth factor BB|platelet-derived growth factor-BB|Y
interleukin 5 receptor α-subunit|interleukin-5 receptor α|Y
low density lipoprotein receptor related protein|lipoprotein receptor related protein|Y
raphe nucleus|red nucleus|N
hereditary non-polyposis colon cancer syndrome|hereditary nonpolyposis colon cancer|Y
light-harvesting chlorophyll a/b-binding protein I|light-harvesting chlorophyll a/b protein-I|Y
Modified Gingival Index|modified gingival index|Y
myosin heavy chain kinase A|myosin II heavy chain kinase A|Y
beta-APP cleaving enzyme|beta site APP cleaving enzyme|Y
indocyanine green|indo-cyanine green|Y
dextran induced anaphylactic reaction|dextran-induced anaphylactoid reaction|Y
DNA polymerase eta|DNA polymerase-η|Y
interleukine-2 receptor α|interleukine-2 receptor α-chain|Y
vesicular stomatitis virus glycoprotein G|vesicular stomatitis virus G protein|Y
continuous hemodiafiltration|continuous hæmodiafiltration|Y
American Society of Anesthesiology grade 3|American Society of Anaesthesiology class III|Y
evaporative light scattering detector|evaporative light scattering detection|Y
sub-mucosal|submucosa|Y
optic spinal multiple sclerosis|opticospinal multiple sclerosis|Y
continuous intravenous infusion|continuous intravenous|Y
serum- and glucocorticoid-regulated kinase|serum and glucocorticoid-inducible kinase 1|Y
remnant-like particle-cholesterol|remnant-like particle cholesterol|Y
glucocorticoid induced leucine zipper|glucocorticoid-induced leucine zipper|Y
Epstein-Barr viral capsid antigen|Epstein-Barr virus capsid antigen|Y
corneal epithelium|columnar epithelium|N
human adenovirus 52|human adenovirus serotype 52|Y
IL-6 receptor alpha chain|IL-6 receptor alpha|Y
cytochrom c oxidase|cytochrome oxidase|Y
ventilatory threshold|ventilation threshold|Y
parachloromercuribenzoate|p-chloromercuric benzoate|Y
Geriatric Depression Scale|geriatric depression score|N
midlatency auditory evoked response|middle latency auditory evoked response|Y
x-ray repair cross complementing 1|x-ray repair cross-complementing group 1|Y
cysteinyl leucotriene receptor 2|cysteinyl leukotriene 2 receptor|Y
nonsense mediated mRNA decay|nonsense-mediated decay|Y
Phoca sibirica|Pusa sibirica|Y
multiple locus VNTR analysis|multi-locus VNTR analysis|Y
macrophage migration index|macrophage migration inhibition|N
anterior septal artery|anterior spinal artery|N
intramuscular|intramuscularly|Y
National Institute of Neurological Disorders and Stroke|National Institute of Neurological Disorders and Stroke rt-PA Stroke Study|N
catabolite gene activator protein|catabolite activator protein|Y
exercise-induced bronchospasm|exercise induced bronchospasm|Y
postmortem computed tomography|post-mortem computed tomography|Y
Mycobacterium avium subspecies hominissuis|Mycobacterium avium hominissuis|Y
human adenovirus serotype 25|human adenovirus type 25|Y
enamel matrix protein derivative|enamel matrix derivative|Y
multidrug resistance 1|multidrug resistance gene 1|Y
artificial springwater|artificial seawater|N
erythropoietin|erythropoiesis|N
standardised proportional mortality ratio|standardised proportionate mortality ratio|Y
transthoracic echocardiographic|trans-thoracic echocardiogram|Y
fumarylacetoacetic acid|fumarylacetoacetate|N
surface electromyographic|surface electromyogram|Y
human adenovirus serotype 12|human adenovirus 12|Y
heat stable enterotoxin a|Heat-stable enterotoxins|N
ER alpha knockout|ERalpha knockout mouse|Y
American Society of Anesthesiologists physical status 5|American Society of Anesthesiology physical status 5|Y
epidermal growth factor receptor|epidermal growth factor receptor gene|N
transcatheter arterial chemoembolisation|transcatheter arterial chemo-embolization|Y
vesicular stomatitis virus glycoprotein|vesicular stomatitis virus glycoprotein G|Y
inter-auricular septal defect|interatrial septal defect|Y
attenuated total reflection Fourier transform infrared|attenuated total reflection Fourier-transform infrared spectroscopy|Y
creatinine clearance rate|creatinine clearance|Y
calcium adenosinetriphosphatase|adenosinetriphosphatase|N
plasminogen activation|plasminogenactivator|Y
reperfused myocardial infarction|recurrent myocardial infarction|N
limb girdle muscular dystrophy 2J|limb girdle muscular dystrophy type 2J|Y
cerebrovascular resistance|cerebrovascular reserve|N
Equid herpesvirus 4|equine herpesvirus 4|Y
methylmalonyl coenzyme a mutase|methylmalonyl-coenzyme A mutase|Y
phagocyte oxidase|phagocyte NADPH oxidase|Y
electroconvulsive therapy|electroconvulsive shock therapy|Y
Charcot-Marie-Tooth disease type 1|Charcot-Marie-Tooth neuropathy type 1|Y
peak airway pressure|airway pressure|N
duodenal obstruction|chronic duodenal obstruction|N
polycyclic aromatic hydrocarbon|polynuclear aromatic hydrocarbon|Y
heteronuclear multiple bond coherence|heteronuclear multiple bond correlation|Y
Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome|Y
extended field radiation therapy|extended field radiotherapy|Y
Novel erythropoiesis stimulating protein|novel erythropoiesis-stimulating protein|Y
deMan Rogosa Sharpe broth|Man Rogosa Sharpe broth|Y
computer assisted telephone interview|computer assisted telephone interviewing|Y
resistant|resistance|Y
right portal vein|rat portal vein|N
cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia 2|Y
amplified ribosomal DNA restriction analysis|amplified rDNA restriction analysis|Y
fragile X-associated tremor-ataxia syndrome|Fragile X-associated tremor/ataxia syndrome|Y
inverted terminal repeats|inverted terminal repetition|Y
A disintegrin and metalloprotease 11|a disintegrin and metalloproteinase-11|Y
levo-dopa|levodopa|Y
American Society of Anaesthesiology class I|American Society of Anesthesiology physical status 1|Y
octyltrimethoxysilane|octadecyltrimethoxysilane|N
diethylenetriaminepenta-acetate|diethylenetriaminepentacetic acid|N
separate|separately|Y
intragastric pressure|intra-gastric pressure|Y
vulvar intraepithelial neoplasia grade 3|vulvar intraepithelial neoplasia 3|Y
crossreacting determinant|cross-reacting determinant|Y
transforming growth factor-β receptor type II|type II transforming growth factor-β receptor|Y
a disintegrin and metalloproteinase 21|a disintegrin and metalloprotease-21|Y
metabotropic glutamate receptor 1|metabotropic glutamate 1 receptor|Y
A disintegrin and metalloproteinase 9|A disintegrin and metalloprotease-9|Y
resin-modified glass ionomer cement|resin modified glass ionomer cement|Y
instructor|instruction|N
visible/near-infrared reflectance spectroscopy|visible and near infrared reflectance spectroscopy|Y
human adenovirus serotype 13|human adenovirus 13|Y
Guanylate cyclase-activating protein 1|guanylyl cyclase activating protein 1|Y
American Society of Anesthesiology status 1|American Society of Anesthesiology Grade 1|Y
uridine diphosphate glucuronosyltransferase|uridine diphospho-glucuronosyl transferase|Y
atrophic chronic gastritis|active chronic gastritis|N
adenovirus serotype 2|adenovirus type 2|Y
tryptone soy broth|tryptone soia broth|Y
Herlitz junctional epidermolysis bullosa|junctional epidermolysis bullosa|Y
hexamethylphosphoramide|hexamethyl-phosphoric triamide|Y
cannabinoid receptor type 2|cannabinoid receptor 2|Y
intra-nasally|intranasal|Y
intraduodenally|mg/kg intraduodenally|Y
p70 ribosomal S6 kinase|70 kDa ribosomal S6 kinase|Y
dengue type 4 virus|dengue 4 virus|Y
post-pneumonectomy|postpneumonectomy|Y
lactotransferrin|lactoferrin|Y
human adenovirus 18|human adenovirus serotype 18|Y
follicular fluid meiosis-activating sterol|follicular-fluid meiosis activating sterol|N
cycle ergometer|cycle ergometry|Y
American Society of Anaesthesiology Class 1|American Society of Anesthesiologists Class I|Y
hormone responsive element|hypoxia responsive element|N
American Society of Anaesthesiologists Status 2|American Society of Anaesthesiology status II|Y
volume computed tomography dose index|volume computed tomographic dose index|Y
oro-facio-digital syndrome type III|oral facial digital syndrome type III|Y
early asthmatic response|early asthmatic reaction|Y
complexed prostate specific antigen|complexed prostate-specific antigen|Y
acute myeloid leukemia cell line|acute myelogenous leukemia cell line|Y
otorhinolaryngology|otolaryngology|N
thermo-luminescence dosimeter|thermo-luminescence dosimetry|Y
transient receptor potential vanilloid receptor 1|transient receptor potential vanilloid 1 receptor|Y
telegraphy|telegraph|Y
receptor protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase-zeta|Y
Mental Health Inventory-5|Mental Health Index-5|Y
American Society of Anesthesiology Grade III|American Society of Anesthesiologists Class III|N
glycerophosphoryl-diglucosyl-diacyl-glycerol|glycerophosphoryldiglucosyldiacylglycerol|Y
orthotopic liver transplant|orthotopic liver transplantation|Y
jurum doctor|juris doctor|Y
transforming growth factor beta receptor type 1|transforming growth factor-β receptor 1|Y
live-attenuated influenza virus|live attenuated influenza vaccine|N
physical activity ratio|physical activity recall|N
high resolution melt|high resolution manometry|N
a disintegrin and metalloproteinase-8|A disintegrin and metalloprotease-8|Y
transforming growth factor beta receptor type 2|transforming growth factor beta type II receptor|Y
ventilation|ventilatory|Y
oral facial digital syndrome type VII|orofaciodigital syndrome type VII|Y
soluble tumor necrosis factor receptor 1|soluble tumor necrosis factor receptor type I|Y
angiotensin receptor 1|angiotensin receptor subtype 1|Y
hypervariable region 1|hypervariable region|N
overall survival time|overall survival rate|N
angiotensinconverting enzyme inhibitor|angiotensin-converting-enzyme inhibition|N
store-operated calcium|store-operated channel|N
Wilms tumor 1|Wilms tumor gene 1|Y
Treponema pallidum hemagglutination assay|Treponema pallidum hemagglutination test|Y
even-skipped|even-skipped gene|N
acute lymphocytic leucemia|acute lymphoid leukemia|Y
rat thyroid cell line|Fisher rat thyroid cell line 5|Y
rotating frame nuclear Overhauser effect spectroscopy|rotating frame Overhauser effect spectroscopy|Y
granulocyte-macrophage colony-stimulating factor receptor|granulocyte-macrophage colony stimulating factor receptor|Y
intrauterine growth restricted|intra-uterine growth retardation|Y
epizootic hæmatopoietic necrosis virus|epizootic hematopoietic necrosis virus|Y
huntingtin associated protein-1|huntingtin-associated protein|Y
human lymphocyte antigen|human leucocyte antigen|Y
recombinant murine interferon alpha|recombinant murine alpha interferon|Y
leucemic stem cell|leukemia stem cell|Y
Chromatium tepidum|Chlorobium tepidum|N
3D quantitative structure activity relationship study|3D quantitative structure-affinity relationship study|Y
transient receptor potential vanilloid receptor type 1|transient receptor potential vanilloid 1|Y
volume computed tomography dose index|computed tomography dose index volume|Y
chemokine receptor 1|C-C chemokine receptor-1|Y
normalized noise energy|normalised noise energy|Y
platelet derived growth factor A|platelet-derived growth factor A chain|Y
reverse passive hemagglutination assay|passive hemagglutination assay|N
interleukine 2 receptor α chain|interleukine-2 receptor-α|N
systemic arterial blood pressure|systemic arterial pressure|Y
transmembrane tumor necrosis factor α|murine tumor necrosis factor α|N
American Society of Anaesthesiologists class II|American Society of Anaesthesiology status II|Y
insulin-like growth factor II messenger RNA binding protein 2|insulin-like growth factor II mRNA-binding protein 2|Y
DNAX activation protein 10|DNAX activating protein 10|Y
diacylglycerol acyltransferase|diacylglycerol transferase|Y
post transplantation lymphoproliferative disorders|post-transplant lympho-proliferative disease|Y
12 item General Health Questionnaire|General Health Questionnaire 12|Y
stromal cell derived factor 1|stromal derived factor 1|Y
x-ray repair cross-complementing protein 1|x-ray repair cross complementing group 1|Y
high resolution transmission electron microscopic|high resolution transmission electron microscopy|Y
GTP binding protein betagamma subunit|G protein betagamma subunit|Y
American Society of Hematology|American Society for Hematology|Y
biological warfare|bacteriological warfare|N
Clinical Global Impressions Improvement Scale|Clinical Global Impression of Improvement|Y
American Society of Anaesthesiologists status 3|American Society of Anesthesiology Grade 3|Y
sulfamethoxazole-trimethoprim|sulphamethoxazole-trimethoprim|Y
60 item General Health Questionnaire|General Health Questionnaire 60|Y
methylmercuric chloride|methylmercury chloride|Y
platelet-derived growth factor beta receptor|platelet-derived growth factor-beta receptor|Y
American Society of Anaesthesiologists score|American Society of Anaesthesiology score|Y
tryptone soy broth|tryptic soy broth|Y
childhood rheumatic disease|chronic rheumatic disease|N
botulinum neurotoxin serotype E|botulinum neurotoxin E|Y
growth factor receptor binding protein 2|growth factor receptor bound protein 2|Y
TNF receptor-associated factor 6|TNF receptor associated factor 6|Y
drug resistant|drug resistance|Y
flame atomic absorption spectrometer|flame atomic absorption spectroscopy|Y
mink cell focus inducing virus|mink cell focus forming virus|Y
rumen epithelial cell|renal epithelial cell|N
human adenovirus 26|human adenovirus serotype 26|Y
uroporphyrinogen synthase|uroporphyrinogen III synthase|N
randomly amplified polymorphic DNA-polymerase chain reaction|random amplified polymorphic DNA polymerase chain reaction|Y
protruded intervertebral disk|prolapsed intervertebral disk|Y
Thiry-Vella fistulas|Thiry-Vella fistula|Y
vegetative filter strip|vegetated filter strip|Y
ρ-guanine nucleotide dissociation inhibitor-1|Rho-guanine dinucleotide phosphate dissociation inhibitor 1|Y
breast-conserving therapy|breast conservation therapy|Y
human adenovirus type 27|human adenovirus serotype 27|Y
human adenovirus 42|human adenovirus type 42|Y
poly(tetrafluoroethylene)|polytetrafluroethylene|Y
tuberous sclerosis|tuberous sclerosis complex|Y
small ubiquitin-like modifier E3 ligase|small ubiquitin-related modifier E3 ligase|Y
mean fluorescent intensity|median fluorescence intensity|N
minimum inhibition concentration|minimal inhibitory concentration|Y
plasmin inhibitor complex|α2 plasmin inhibitor/plasmin complex|Y
phosphocreatine|phosphocitrate|N
orchiectomy|orchiectomise|Y
tocopherol|α tocopherol|N
catastrophic antiphospholipid syndrome|catastrophic antiphospholipid antibody syndrome|Y
heavy chain joining segment|heavy chain joining region|N
human adenovirus serotype 49|human adenovirus type 49|Y
nodularin|nodulation|N
X-linked dystonia-parkinsonism syndrome|X linked dystonia parkinsonism|Y
topical negative pressure therapy|topical negative pressure|Y
Hodgkin/Reed-Sternberg cell|Hodgkin and Reed-Sternberg cell|Y
metabotropic glutamate 7 receptor|metabotropic glutamate receptor subtype 7|Y
zonula occludens 1 protein|zonula occludens protein 1|Y
microtubule-associated protein-5|microtubule-associated protein 5|Y
guanylyl cyclase-activating protein|guanylate-cyclase-activating protein|Y
cytochrome c oxidase 1|cytochrome c oxidase subunit 1|Y
telegram|telegraph|Y
Charcot-Marie-Tooth type 2A|Charcot-Marie-Tooth neuropathy type 2A|Y
hydroxyindole-O-methyltransferase|hydroxyindole o methyltransferase|Y
Kirsten rat sarcoma viral oncogene homolog|Kirsten rat sarcoma virus oncogene|N
voiding cystourethrogram|voiding cysto-urethrography|Y
luteinized unruptured follicle|luteinised unruptured follicle|Y
posttraumatic stress symptomatology|post-traumatic stress symptom|Y
C-type atrial natriuretic peptide|C terminal atrial natriuretic peptide|Y
anti-interleukin-4 receptor alpha antibody|anti-IL-4 receptor alpha antibody|Y
antihepatitis B core antigen|antihepatitis B core antibody|N
oral anti-coagulant|oral anti-coagulation|Y
metacarpophalangeal|metatarsophalangeal|N
Charcot-Marie-Tooth type 2|Charcot-Marie-Tooth disease type 2|Y
trabecular separation|trabecular spacing|N
volume computed tomography dose index|volume-weighted computed tomographic dose index|Y
intravenous immunoglobulin G|intravenous immunoglobulin|Y
Roux-en-Y gastric bypass|Rouxen-Y gastric bypass|Y
glosso-pharyngeal neuralgia|glossopharyngeal nerve|N
calf diarrhea virus|Nebraska calf diarrhea virus|N
indirect immunofluorescent antibody test|indirect immunofluorescence antibody test|Y
oligodeoxynucleotide|oligodeoxyribonucleotide|N
hepatic veno-occlusive disease|hepatic veno occlusive disease|Y
67-gallium scintigraphy|gallium 67 scintigraphy|Y
Psychomotor Development Index|Psychomotor Developmental Index|Y
pubo-vaginal sling|pubovaginal sling|Y
macro-molecular creatine kinase type-1|macromolecular creatine kinase type 1|Y
apolipoprotein B|apoprotein B|Y
post-transplantation lymphoproliferative disease|post-transplant lympho-proliferative disease|Y
arteriovenous anastomosis|arteriovenous anastomotic|Y
dopamine 2 receptor|dopamine type 2 receptor|Y
head and neck squamous cell cancer|head and neck squamous cell carcinomas|Y
99mTc macroaggregated albumin|technetium 99m macroaggregated albumin|Y
nocturnal gastric acid breakthrough|nocturnal acid breakthrough|Y
interleukine-18 receptor α subunit|interleukine-18 receptor-α|Y
cyclicAMP response element binding protein|c-AMP response element binding protein|Y
adenosine deaminase|adenosine deaminase gene|N
receptor-linked protein-tyrosine-phosphatase alpha|receptor protein tyrosine phosphatase alpha|Y
broadband ultrasound attenuation|broadband ultrasonic attenuation|Y
otolith-ocular response|otolith-ocular reflex|Y
American Society of Anesthesiologists Status 2|American Society of Anaesthesiology status II|Y
virion host shutoff|virion host shutoff protein|Y
ocular coherence tomography|optical coherence tomograph|N
Vero toxin-producing Escherichia coli|verocytotoxin-producing Escherichia coli|Y
angiogenin|angiotensin|N
clinical medical library|clinical medical librarian|N
transendothelial electrical resistance|transepithelial electrical resistance|Y
toxic unit|toxicity unit|Y
double knockout|double knockout mouse|Y
synaptosome-associated protein 25|synaptosomal associated protein 25 kDa|Y
ethylenediamine 2,4-dinitrophenyl|ethylenediaminedinitrophenyl|Y
American Society of Anaesthesiologists status 5|American Society of Anaesthesiologists Grade V|Y
aminomethylcoumarin acetate|aminomethylcoumarin acetic acid|N
dopamine D2 receptor|Dopamine D(2) receptor|Y
insulin-like growth factor-II messenger RNA binding protein-3|insulin-like growth factor-II mRNA binding protein-3|Y
aminolevulinic acid dehydratase|delta aminolevulinic acid dehydratase|Y
specific oxygen utilisation rate|specific oxygen uptake rate|Y
parainfluenza 3 virus|parainfluenza type 3 virus|Y
pulvinar-lateral posterior complex|pulvinar-lateralis posterior complex|Y
computerized tomography angiogram|computed tomography angiography|Y
American Society of Anesthesiologists class 2|American Society of Anesthesiology Class 2|Y
limb girdle muscular dystrophy 2C|limb girdle muscular dystrophy type 2C|Y
m-chlorophenylbiguanide|meta-chlorophenylbiguanide|Y
tocopheryl polyethylene glycol succinate|d-alpha-tocopheryl polyethylene glycol 1000 succinate|Y
latissimus dorsi|longissimus dorsi|N
abdominal aortic aneurism|abdominal aortic aneurysmectomy|N
ferredoxin:NADP(H) reductase|ferredoxin-NADP+ oxidoreductase|Y
human immunodeficiency virus-1 trans-activator protein|human immunodeficiency virus type 1 transactivator protein|Y
heparin binding egf like growth factor|heparin binding EGF-like growth factor|Y
retinoid X receptor alpha|rexinoid receptor alpha|Y
recombinant murine interferon-α|recombinant murine alpha interferon|Y
receptor protein tyrosine phosphatase-δ|receptor-like protein-tyrosine phosphatase-δ|Y
immuno-fluorometric assay|immunofluorometric assay|Y
neurofilament light chain|neurofilament light subunit|Y
advanced chronic renal failure|chronic renal failure|N
fibromuscular dysplasia|fibro-muscular dysplasia|Y
postmeiotic segregation 2|postmeiotic segregation increased 2|Y
cannabinoid receptor 1|type 1 cannabinoid receptor|Y
laser Doppler flux|laser Doppler fluxmetry|Y
peroxidase antiperoxidase method|peroxidase-antiperoxidase complex|N
muscle type creatine kinase|muscle creatin kinase|Y
N terminal probrain natriuretic peptide|N-terminal pro-brain-type natriuretic peptide|Y
prostaglandin G/H synthase-2|prostaglandin G/H synthase-II|Y
peracetic acid|phenoxyacetic acid|N
5-methyltetrahydrofolate|methyltetrahydrofolate|Y
volume computed tomography dose index|volume weighted computed tomography dose index|Y
matrix metalloproteinase 2|matrix metalloprotease 2|Y
metabotropic glutamate 2 receptor|metabotropic glutamate receptor subtype 2|Y
cardio-respiratory fitness|cardio-respiratory function|N
guanylate binding protein|glutamate binding protein|N
three dimensional quantitative structure affinity relationship|three-dimensional quantitative structure-activity relationship|Y
insulin-like growth factor receptor type I|insulinlike growth factor 1 receptor|Y
ventricular tachycardia|venricular tachycardia|Y
acute respiratory insufficiency|acute respiratory infection|N
modified vaccinia virus Ankara|modified vaccinia Ankara|Y
pectate lyase|pectate lyase gene|N
equid herpesvirus type 4|equine herpesvirus type 4|Y
nucleic acid amplification technique|nucleic acid amplification test|Y
dilauroylphosphatidylethanolamine|dilinoleoylphosphatidylethanolamine|N
laparoscopic uterine nerve ablation|laparoscopic uterosacral nerve ablation|Y
human adenovirus type 16|human adenovirus 16|Y
IFN stimulated gene|IFN-stimulated gene|Y
glucose dehydrogenase|glutamate dehydrogenase|N
transient receptor potential vanilloid type 1|transient receptor potential vanilloid type 1 receptor|Y
multidrug resistance related protein 1|multi-drug resistance protein 1|Y
Bombyx mori nucleopolyhedrovirus|Bombyx mori nucleopolyhedrosis virus|Y
natural head posture|natural head position|Y
Hamilton Depression Rating Scale|Hamilton Depression Scale|Y
Dina japonica|Draba japonica|N
extracellular regulated kinase|extracellular-signal regulated kinase|Y
sequence specific primer|sequence specific priming|Y
endonuclease 1|AP endonuclease 1|N
Griffonia simplicifolia I|Griffonia simplicifolia lectin I|Y
3D quantitative structure-affinity relationship study|three-dimensional quantitative structure-affinity relationship study|Y
apolipoprotein E epsilon4|apolipoprotein E4|Y
Epstein-Barr virus nuclear antigen|Epstein-Barr virus determined nuclear antigen|Y
baroreflex sensitivity|baroreceptor reflex sensitivity|Y
neuroepithelial|neuroepithelioma|N
American Spinal Injury Association Impairment Scale grade A|American Spinal Injury Association grade A|Y
2,3,4,7,8-pentachlorodibenzofuran|pentachlorodibenzofuran|Y
endocrine gland-derived vascular endothelial growth factor|Endocrine gland-derived vascular endothelial growth factor|Y
computer tomographic scan|computerized tomography scan|Y
Medication Adherence Rating Scale|Medication Adherence Report Scale|Y
T effector memory cell|effector memory T cell|Y
Na+/H+ exchanger 3|Na+/H+ exchanger isoform 3|Y
Niemann-Pick type C-1|Niemann-Pick type C1|Y
LIM domain containing 1|LIM domains containing 1|Y
General Health Questionnaire|12 item General Health Questionnaire|N
behavioral|behavior|Y
interleukine-15 receptor alpha|interleukin-15 receptor alpha chain|Y
Hodgkin and Reed-Sternberg cell|Hodgkin-Reed/Sternberg cell|Y
respiratory inductive plethysmograph|respiratory inductance plethysmograph|Y
endothelial constitutive nitric oxide synthase|endothelial nitric oxide synthase|Y
minor traumatic brain injury|mild traumatic brain injury|Y
second look laparotomy|second look laparoscopy|N
molybdopterin cofactor|molybdenum cofactor|N
upper motor neuron syndrome|upper motoneuron syndrome|Y
General Health Questionnaire 30|30 item General Health Questionnaire|Y
fibroblast growth factor 1|acidic fibroblast growth factor|Y
quantitative electro-encephalogram|quantitative electroencephalography|Y
transient receptor potential vanilloid receptor 4|transient receptor potential vanilloid type 4|Y
uncoupling protein 1|uncoupling protein-1|Y
post-transplant|posttransplant|Y
analytical processing|on-line analytical processing|N
Yes-associated protein|yes-associated protein|Y
interleukin 12 receptor β2|interleukin 12 receptor β2 chain|Y
maximal midexpiratory flow|maximum midexpiratory flow|Y
three dimensional computed tomographic angiography|three-dimensional computed tomography-angiography|Y
gamma aminobutyric acidA|gammaaminobutyric acid|N
visceral epithelial cell|vaginal epithelial cell|N
cannabinoid|cannabinoid 1|N
T-helper type 1/T-helper type 2 balance|T-helper 1/T-helper 2 balance|Y
glyceraldehyde 3 phosphate dehydrogenase|glyceraldehydephosphate dehydrogenase|Y
intravenous immunoglobulin G|intravenous gammaglobulin|Y
murine embryonic fibroblast|mouse embryonic fibroblast|Y
intercalated disc|intercalated duct|N
human immunodeficiency virus 1|human immunodeficiency type 1 virus|Y
recombinant deoxyribonucleic acid|ribosomal deoxyribonucleic acid|N
human herpes virus type 8|human herpesvirus 8|Y
bovine prolactin|big prolactin|N
intraarticular pressure|intraarterial pressure|N
glutamine oxaloacetic transaminase|glutamate oxalacetate transaminase|Y
somatostatin immunoreactivity|somatostatin immunoreactive|Y
multiple endocrine neoplasia 1|multiple endocrine neoplasia type 1|Y
galactosidase|galactose|N
infantile sialic acid storage disease|infantile free sialic acid storage disease|Y
paraaminobenzoic acid|p-aminobenzoic acid|Y
Dopplerultrasound|power Doppler ultrasound|N
middle temporal area|middle temporal visual area|Y
Equid herpesvirus 2|equid herpesvirus type 2|Y
triphenylphosphite|triphenylphosphine|N
Northwest|north-west|Y
50% tissue-culture infective dose|50% tissue culture infectious dose|Y
oculopneumoplethysmography|oculoplethysmography|N
carboxy-terminal Src kinase|C-terminal Src kinase|Y
neuromuscular block|neuromuscular blocker|N
nitroglycerin-mediated dilatation|nitroglycerin-mediated vasodilation|Y
p-chloromercuriphenylsulfonate|p-chloromercuriphenyl sulfonate|Y
total rosette-forming cell|total rosette forming cells|Y
melanocortin receptor 1|melanocortin 1 receptor|Y
glutamic acid decarboxylase 67|glutamate decarboxylase 67|Y
indirect immunofluorescence antibody test|immunofluorescence antibody test|N
quantitative electro-encephalogram|quantitative electroencephalographic|Y
autopositive end-expiratory pressure|automatic positive end-expiratory pressure|Y
computer-assisted semen analysis|computer-aided semen analysis|Y
metabolic|metalic|N
transient receptor potential vanilloid receptor type 2|transient receptor potential vanilloid 2|Y
American Society of Anesthesiologists Grade 2|American Society of Anaesthesiologists physical status 2|Y
standard sodium citrate|standard saline citrate|Y
precursor B acute lymphoblastic leukemia|precursor B cell acute lymphoblastic leukemia|Y
glucocerebrosidase|galactocerebroside|N
American Society of Anaesthesiologists grade 3|American Society of Anesthesiology Class 3|Y
secreted amyloid precursor protein-α|soluble amyloid precursor protein-α|Y
nuclear inclusion protein|nuclear inclusion b|N
fluorine 18 fluorodeoxyglucose|fluorine-18 labelled fluoro-deoxy-glucose|Y
tomato spotted wilt virus|tomato spotted wilt Tospovirus|Y
stroke length|stride length|N
General Health Questionnaire 30|General Health Questionnaire|N
incentive spirometer|incentive spirometry|Y
insulinoma 1|insulin 1|N
retrorubral field|retro-rubral field|Y
Charcot-Marie-Tooth syndrome type X|Charcot-Marie-Tooth type X|Y
transient receptor potential vanilloid receptor 1|transient receptor potential vanilloid receptor subtype 1|Y
phosphoethanolamine|phosphatidylethanolamine|N
70 kDa ribosomal protein S6 kinase|70 kDa ribosomal S6 kinase|Y
ubiquitin carboxy-terminal hydrolase L-1|ubiquitin carboxyl-terminal hydrolase-L1|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiology class 2|Y
oral poliovirus vaccine|oral poliomyelitis vaccine|Y
systemic scleroderma|systemic sclerodermia|Y
human dermal fibroblast|human diploid fibroblast|N
axilla|axillary|Y
orotidine-5'-monophosphate pyrophosphorylase|orotidine monophosphate pyrophosphorylase|Y
activating transcription factor-2|Activating transcription factor 2|Y
emergency medical doctor|emergency medical dispatcher|N
mitogen activated protein kinase phosphatase-1|mitogen-activated protein kinase phosphatase 1|Y
type 2 diabetic|type 2 diabetes|N
activity-regulated cytoskeleton associated protein|activity-regulated cytoskeletal-associated protein|Y
transmembrane tumor necrosis factor alpha|murine tumor necrosis factor alpha|N
ammonia monooxygenase subunit A|ammonia monooxygenase alpha subunit|Y
formylmethionylleucylphenylalanine|formylmethionine leucyl phenylalanine|Y
American Society of Anaesthesiology grade II|American Society of Anesthesiologists Grade 2|Y
relative medullary thickness|relative medial thickness|N
American Society of Anaesthesiologists physical status V|American Society of Anesthesiologists Grade V|Y
inner medullary|intramedullary|N
Anatomic Therapeutic Chemical Classification|Anatomical Therapeutic Chemical Classification System|Y
extracorporeal circuit|extracorporeal circulation|Y
temporary|temporal|N
corrected QT interval|corrected QT intervals|Y
surface enhanced resonance Raman spectroscopy|surface enhanced resonance Raman scattering|Y
electro-chemiluminescence|electrogenerated chemiluminescence|Y
multi-drug resistant|multiple drug resistant|Y
human adenovirus type 33|human adenovirus serotype 33|Y
metastatic castration resistant prostate cancer|metastatic castrate resistant prostate cancer|Y
Scottish intercollegiate guidelines network|Scottish Intercollegiate Guidelines Network|Y
metabolic rate|metabolic ratio|N
AD Assessment Scale Cognitive Subscale|Alzheimer Disease Assessment Scale Cognitive Subscale|Y
hydroxypropylcyclodextrin|2-hydroxypropyl-beta-cyclodextrin|Y
steroid resistant nephrotic syndrome|steroid responsive nephrotic syndrome|N
phospho-inositide|phosphoinositol|N
glial maturation factor|glia maturation factor|Y
rostro-ventro-lateral medulla|rostro-ventrolateral medulla|Y
intermediate and medial part of the hyperstriatum ventrale|intermediate medial hyperstriatum ventrale|Y
hepatoporto-enterostomy|hepatic porto-enterostomy|Y
body injury|bone injury|N
Exhaled nitric oxide|exhaled nitric oxide|Y
Medical Doctor|Medicinae Doctor|Y
murine tumor necrosis factor|mouse tumor necrosis factor|Y
adipose tissue derived stromal cell|adipose-derived stromal cell|Y
normal standard dose|nominal standard dose|N
Ashkenazi Jew|Ashkenazi Jewish|Y
American Society of Anesthesiology class V|American Society of Anesthesiology physical status 5|Y
do not intubate|do not intubate order|Y
chronic active Epstein-Barr virus infection|chronic active Epstein-Barr virus|Y
NaCl cotransporter|Na-Cl cotransporter|Y
polysomnogram|polysomnography|Y
ligand to metal charge transfer|ligand-to-metal charge-transfer|Y
human adenovirus type 23|human adenovirus serotype 23|Y
prednisolon|prednisone|N
randomly amplified polymorphic DNA primer|random-amplified polymorphic DNA primer|Y
x-ray repair cross-complementation group 1|x-ray repair cross-complementing protein 1|Y
ultra conserved region|upstream conserved region|N
rotavirus-infected|rabies virus-infected|N
late gadolinium enhanced magnetic resonance imaging|late gadolinium enhancement magnetic resonance imaging|Y
receptor-linked protein-tyrosine-phosphatase alpha|receptor-like protein-tyrosine phosphatase-α|Y
green fluorescence protein|green fluorescent protein|Y
receptor protein tyrosine phosphatase ζ|receptor-like protein tyrosine phosphatase zeta|Y
peptide binding assay|protein binding assay|N
Mental Component Score|Mental Component Summary|Y
multidrug resistance related protein 1|multidrug resistance protein 1|Y
regional cerebral blood flow|relative cerebral blood flow|N
total internal reflection fluorescence microscopy|total internal reflection fluorescent microscopy|Y
family practice|family practitioner|N
muscarinic cholinergic receptors|muscarinic acetylcholine receptor|Y
transient receptor potential vanilloid type 1|transient receptor potential vanilloid receptor type 1|Y
computed tomographic colonography|computed tomographic cisternography|N
tert-butyl-catechol|tertiary butylcatechol|Y
insulinlike growth factor receptor 2|insulin-like growth factor receptor type II|Y
sustained ventricular tachycardia|supraventricular tachycardia|N
benign paroxysmal positioning nystagmus|benign paroxysmal positional nystagmus|Y
inhibin A|inhibin α|Y
estrogen receptor-α knockout|oestrogen receptor-α knockout mouse|Y
simultaneous multichannel autoanalyzer|sequential multichannel autoanalyzer|N
lead zirconium titanate|lead zirconate titanate|Y
Ralph H. Johnson Veterans Affairs Medical Center|Ralph H Johnson Veterans' Administration Medical Center|Y
intravenous immune globulin|intravenous immunoglobulin|Y
variable corneal compensation|variable corneal compensator|Y
proteinase activated receptor-1|Protease-activated receptor 1|Y
anodic aluminium oxide|anodic aluminum oxide|Y
central pattern generator|computer pattern generator|N
multiple endocrine neoplasia type 2A syndrome|multiple endocrine neoplasia 2A syndrome|Y
extracellular signal related kinase|extracellular-signal regulated kinase|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloprotease-1 antibody|Y
vancomycin sensitive Enterococcus|vancomycin susceptible Enterococcus|Y
fifth transmembrane domain|transmembrane domain 5|Y
pair distribution function|probability distribution function|N
dichloroethene|dichloroethylene|Y
serum agglutination test|slide agglutination test|Y
cephalic|cephalin|N
laparoscopic-assisted vaginal hysterectomy|laparoscopically-assisted vaginal hysterectomy|Y
electric acupuncture|electroacupuncture|Y
interleukine-11 receptor α|interleukin-11 receptor α subunit|Y
sleep/wakefulness cycle|sleep-wakefulness cycle|Y
plasma renin activity|plasmatic renin activity|Y
non-accidental head injury|nonaccidental head injury|Y
relapsing-remitting experimental autoimmune encephalomyelitis|relapsing-remitting experimental allergic encephalomyelitis|Y
American Society of Anaesthesiologists physical status IV|American Society of Anesthesiologists status IV|Y
hydroxy-proline|hydroxyproline|Y
L-ascorbic acid|levo-ascorbic acid|Y
A disintegrin and metalloprotease-29|a disintegrin and metalloproteinase-29|Y
audio-computer assisted self-interview|audio-computer-assisted self-interviewing|Y
volumetric computed tomography|volume computed tomography|Y
gonadectomise|gonadectomy|Y
phorbol dibutylate|phorbol dibutyrate|Y
left leg|left lung|N
peak expiratory flow rate|peak expiratory flow|Y
human immunodeficiency type 1 virus|human immunodeficiency virus type 1|Y
acute myelo-monoblastic leukaemia|acute myelomonocytic leucemia|Y
Attention Network Task|Attention Network Test|Y
micelle electrokinetic capillary chromatography|micellar electrokinetic capillary chromatography|Y
Equid herpesvirus 3|equine herpesvirus 3|Y
synaptosomal-associated protein-25|synaptosomal associated protein-25 kDa|Y
gradient recalled echo sequence|gradient echo sequence|Y
nuclear acid amplification test|nucleic acid amplification test|Y
visual working memory|verbal working memory|N
human adenovirus serotype 40|human adenovirus 40|Y
cardiac computed tomography angiography|cardiac computed tomographic angiography|Y
borderline lepromatous|borderline lepromatous leprosy|Y
velocity-encoded cine magnetic resonance imaging|velocity encoded cine magnetic resonance|Y
insulin-like growth factor receptor-1|insulinlike growth factor 1 receptor|Y
Vertical banded gastroplasty|vertical banded gastroplasty|Y
gastric inhibitory peptide|gastric inhibitory polypeptide|Y
antiendothelial cell antibody|antiendothelial cell auto-antibody|Y
internal transcribed spacer|intergenic transcribed spacer|Y
rotavirus-specific|rabies virus-specific|N
left lower lobe|left lower leg|N
American Society of Anaesthesiology status 3|American Society of Anaesthesiologists physical status III|Y
laser scanning cytometry|laser scanning cytometer|Y
pro-collagen III peptide|procollagen III peptide|Y
University of Washington Quality of Life Questionnaire|University of Washington Quality-of-Life Scale|Y
polycystic ovarian morphology|polycystic ovary morphology|Y
hamster embryo fibroblast|human embryo fibroblast|N
American Society of Anaesthesiology Class 2|American Society of Anaesthesiologists Class 2|Y
pancreaticoduodenectomy|pancreato-duodenectomy|Y
left ventricular ejection fraction|left ventricle ejection fraction|Y
m-phenylenediamine|metaphenylenediamine|Y
adjunctive therapy|adjuvant therapy|Y
relative dose intensity|received dose intensity|N
growth hormone release inhibiting hormone|growth hormone-release inhibiting hormone|Y
dihydro-testosterone|[3H]dihydrotestosterone|Y
endoscopic retrograde cholangiopancreatography|endoscopic retrograde choledochopancreatography|N
combination anti-retroviral treatment|combination antiretroviral therapy|Y
oral contraceptive|oral contraception|N
American Society of Anesthesiologists Status II|American Society of Anesthesiologists Grade 2|Y
Heidelberg retina tomograph|Heidelberg retinal tomography|Y
human immunodeficiency virus type 1|human immunodeficiency type 1 virus|Y
intraoperative radiation therapy|intra-operative radiotherapy|Y
X-ray computed tomogram|X-ray-computed tomography|Y
American Society of Anesthesiology physical status III|American Society of Anaesthesiologists class III|Y
human adenovirus serotype 30|human adenovirus 30|Y
myeloid differentiation protein 2|myeloid differentiation 2|Y
divalent metal transporter 1|divalent metal ion transporter 1|Y
open reading frame|short open reading frame|N
interleukin-13 receptor alpha 1-subunit|interleukine-13 receptor alpha-1 chain|Y
finite element method|finite element model|Y
simian sarcoma associated virus|simian sarcoma-associated virus|Y
adenosylmethionine|S adenosylmethionine|Y
bioartificial liver support system|biological life support system|N
antibiotic susceptibility testing|antimicrobial susceptibility test|Y
metatarsophalangeal joint|metatarsal phalangeal joint|Y
Fatigue Assessment Questionnaire|Functional Assessment Questionnaire|N
antigalactosyl antibody|anti-galactose antibody|Y
calf vascular resistance|cutaneous vascular resistance|N
colorectal neoplasm|colo-rectal neoplasia|Y
transient receptor potential vanilloid receptor type 1|transient receptor potential vanilloid 1 receptor|Y
phosphate buffered saline solution|phosphate buffer saline|Y
matrix-assisted laser-desorption ionization|matrix assisted laser desorption ionization|Y
seminal fluid|spinal fluid|N
glutamic acid|glutaric acid|N
seroagglutination test|slide agglutination test|Y
50% tissue culture infectious dose|tissue culture infective dose 50%|Y
anaphylatoxin inhibitor|anaphylatoxin inactivator|Y
normal comparison subject|normal control subject|Y
variable antigen type|variant antigen type|Y
tissue transglutaminase|type 2 transglutaminase|N
bladder neck stenosis|bladder neck suspension|N
synaptosome-associated protein 25|synaptosomal associated protein 25|N
portal venous phase|portal venous pressure|N
A disintegrin and metalloproteinase 5|A disintegrin and metalloprotease 5|Y
pedunculo-pontine nucleus|pedunculo-pontine tegmental nucleus|Y
soft gel capsule|soft gelatin capsule|Y
Medical Dictionary for Regulatory Activities|medical dictionary for regulatory activities|Y
computed tomographic guidance|computed tomography guidance|Y
paroxysmal supraventricular tachyarrhythmia|paroxysmal supraventricular tachycardia|Y
metabotropic glutamate receptor 7|metabotropic glutamate 7 receptor|Y
antioxidant activity|antioxidative activity|Y
acyl CoA binding protein|acyl coenzyme A binding protein|Y
geriatric nurse practitioner|gerontologic nurse practitioner|Y
Rho-guanine nucleotide dissociation inhibitor-1|guanine nucleotide dissociation inhibitor 1|Y
rifampicin resistant|rifampicin resistance|Y
enhanced green fluorescence protein gene|enhanced green fluorescent protein gene|Y
glycyrrhizic acid|glycyrrhetic acid|Y
α-glycerophosphate dehydrogenase|alpha glycerophosphate dehydrogenase|Y
myocardial contraction force|myocardial contractile force|Y
monoamine oxidase A|monoamino oxidase A|Y
high mobility group box protein 1|High mobility group box chromosomal protein 1|Y
computed tomographic angiogram|computed tomography angiography|Y
non-ST-segment elevation myocardial infarction|nonST elevation myocardial infarction|Y
laser Doppler perfusion imaging|laser Doppler perfusion imager|N
manual lymph drainage|manual lymphatic drainage|Y
immediate early protein 1|immediate early 1|Y
dideoxycytidine triphosphate|2',3'-dideoxycytidine 5'-triphosphate|Y
upstream activator sequence 1|upstream activating sequence 1|Y
inductively coupled plasma-source mass spectrometry|inductively coupled plasma mass spectrometer|Y
promyelocytic leucemia zinc finger|promyelocytic leukemia zinc finger protein|Y
phosphoinositide dependent kinase 1|phosphoinositide-dependent protein kinase-1|Y
oral facial digital syndrome type IV|orofaciodigital syndrome type IV|Y
glutamic oxalacetic transaminase|glutamate oxalacetate transaminase|Y
mu opioid receptor|μ-opioid receptor|Y
sex hormone binding globulin|serum sex hormone binding globulin|N
myogenic regulatory factor 4|muscle regulatory factor 4|Y
Raja agassizii|Rioraja agassizii|Y
schizophrenia|schizophrenic|N
human adenovirus 44|human adenovirus serotype 44|Y
cannabinoid type 1 receptor|cannabinoid 1 receptor|Y
phosphodiesterase type 4|phosphodiesterase 4|Y
alpha naphthyl acetate esterase|alpha-naphthyl acetate esterase|Y
magnetocardiography|magnetocardiographic|Y
insulinlike growth factor receptor 1|insulin-like growth factor-I receptor|Y
human adenovirus 51|human adenovirus type 51|Y
equine leucocyte antigen|equine lymphocyte antigen|Y
lymphvascular space invasion|lymph vascular space involvement|Y
prostaglandin D2|prostaglandin D(2)|Y
transient receptor potential vanilloid type 1|transient receptor potential vanilloid receptor subtype 1|Y
lympho-granuloma venereum|lymphogranuloma venereum|Y
acquired Fanconi syndrome|adult Fanconi syndrome|N
Subacute myelo-optico-neuropathy|subacute myeloopticoneuropathy|Y
para-hydroxymercuribenzoic acid|parahydroxymercuribenzoate|N
complement component C4b binding protein|complement 4b binding protein|Y
matrix metalloproteinase 1|matrix metalloprotease 1|Y
triethylene pyrophosphate|tetraethylpyrophosphate|N
left ventricular dyssynchrony|left ventricular disfunction|N
retinoic acid|retinoid acid|Y
Anxiety Inventory|Test Anxiety Inventory|N
growth hormone deficient|growth hormone deficiency|Y
neonatal calf diarrhea virus|Nebraska calf diarrhea virus|N
hyperbaric oxygen|hyperbaric oxygenation|Y
collection efficiency|conversion efficiency|N
suppressor of cytokine signaling-1|suppressor of cytokine signaling 1|Y
death associated protein|death-associated protein|Y
human adenovirus serotype 46|human adenovirus 46|Y
ubiquitin carboxy terminal hydrolase L-1|ubiquitin carboxyl-terminal hydrolase-L1|Y
American Society of Anaesthesiology class V|American Society of Anesthesiology physical status 5|Y
inhibitor constant|inhibitory constant|Y
human adenovirus serotype 21|human adenovirus type 21|Y
intravenous drug abuser|intravenous drug abuse|N
positron emission tomographic|positron emission tomograph|Y
slow oscillator|slow oscillation|N
tissue culture infective dose|tissue culture infective dose 50%|Y
U.S. Bureau of Labor Statistics|United States Bureau of Labor Statistics|Y
electrochemical impedance spectrum|electrical impedance spectroscopy|Y
lymphoepitheliomalike carcinoma|lymphoepithelioma-like carcinoma|Y
human adenovirus type 8|human adenovirus serotype 8|Y
maximal H reflex|maximum H reflex|Y
tick-borne encephalitis|tickborne encephalitis|Y
Odontoglossum ringspot tobamovirus|Odontoglossum ringspot virus|Y
metabotropic glutamate 2 receptor|metabotropic glutamate receptor type 2|Y
c-Jun N-terminal kinase|c-Jun N-terminal kinase 1|Y
tumor growth inhibition|total growth inhibition|N
12-item Short Form Health Survey|12-item short-form health survey|Y
interleukin 8|interleukin|N
volume computed tomographic dose index|volume-weighted computed tomographic dose index|Y
organophosphate-induced delayed neuropathy|organophosphate-induced delayed neurotoxicity|Y
Niemann-Pick C1 Like 1|Niemann-Pick C1 Like-1|Y
arteriosclerosis obliterans|atherosclerosis obliterans|N
percutaneous nephrolithotripsy|percutaneous nephrolithotomy|Y
otorhinolaryngology|otorhinolaryngological|Y
4-hydroxy-3-methoxymandelic acid|hydroxymethylmandelic acid|Y
unfavorable non-Hodgkin's lymphoma|untreated non-Hodgkin lymphoma|N
magnetoencephalograph|magnetoencephalographic|Y
heparin binding protein|hepatic binding protein|N
Brackett-Oliphant medium|Brackett and Oliphant medium|Y
Chinese hamster ovarian|Chinese hamster ovary|Y
a disintegrin and metalloprotease 7|A disintegrin and metalloproteinase 7|Y
ultrasonic cardiogram|ultrasound cardiography|Y
platelet distribution weight|platelet distribution width|N
retinal guanylylcyclase|retinal guanylatecyclase|Y
Minnesota Multiphasic Personality Inventory|Minnesota Multiphasic Personality Inventory 2|N
tri-O-tolyl phosphate|triorthotolyl phosphate|Y
American Society of Anaesthesiology physical status 4|American Society of Anesthesiology class IV|Y
bone morphogenic protein 4|bone morphogenetic protein 4|Y
Berardinelli-Seip congenital lipodystrophy type 2|Berardinelli Seip congenital lipodystrophy 2|Y
T2 weighted imaging|T(2) weighted image|Y
bacteriological index|bacterial index|Y
urokinase plasminogen activator receptor|urokinase type plasminogen activator receptor|Y
American Speech and Hearing Association|American Speech-Language-Hearing Association|Y
aromatic L-amino acid decarboxylase|aromatic amino acid decarboxylase|Y
fluorescence-activated cell sorting|fluorescent-activated cell-sorting|Y
protein catabolic rate|protein catabolism rate|Y
intrathecal|intratracheal|N
American Society of Anesthesiology class V|American Society of Anesthesiologists Class 5|Y
right arm|right atrium|N
thymidylate synthase|thymidylate synthetase|Y
chronic recurrent multifocal osteomyelitis|chronic multifocal osteomyelitis|Y
organophosphorous|organophosphorus|Y
growth hormone release inhibitory hormone|growth hormone release inhibiting hormone|Y
interleukin 2 receptor alpha chain|interleukin 2 receptor alpha|Y
magnetic resonance image|magnet resonance imaging|Y
insulin-like growth factor receptor type II|insulin-like growth factor receptor 2|Y
Orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus|Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus|Y
cannabinoid receptor|cannabinoid 1 receptor|Y
chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like gene|chromodomain helicase/ATPase DNA binding protein 1-like gene|Y
pulsed-field gel electrophoretic|pulse field gel electrophoresis|Y
x-ray powder diffraction|X-ray powder diffractometry|Y
random amplification of polymorphic DNA polymerase chain reaction|randomly amplified polymorphic DNA-polymerase chain reaction|Y
T cell acute lymphoblastic leukemia|T acute lymphoblastic leukemia|Y
soluble worm antigen preparation|worm antigen preparation|Y
endovascular aortic aneurysm repair|endovascular abdominal aortic aneurysm repair|Y
multi-linear regression|multiple linear regression|Y
lactose repressor|lac repressor|Y
thoracic epidural analgesia|thoracic epidural anesthesia|Y
verocytotoxin-producing Escherichia coli|verocytotoxin-producing E coli|Y
5-aminoimidazole-4-carboxamide riboside|aminoimidazole carboxamide ribonucleotide|Y
ubiquitin fusion degradation 1 like protein|ubiquitin fusion degradation 1 like gene|N
GTPase activating protein|gtpase activating protein|Y
p-nitrophenylphosphatase|para-nitrophenyl-phosphatase|Y
inositolphosphate|inositolmonophosphate|N
sustained viral response|sustained virological response|Y
cannabinoid type 1 receptor|cannabinoid receptor 1|Y
psychical|psychological|Y
antibiotic|anti-biotic|Y
quantitative reverse transcription polymerase chain reaction|quantitative real time polymerase chain reaction|N
nuclear ribo-nucleoprotein|nuclear ribonucleoprotein|Y
Streptococcus hemolyticus|Staphylococcus haemolyticus|N
adenovirus type 5 E1B|adenovirus 5 E1B|Y
carbonic anhydrase-related polypeptide|carbonic anhydrase related protein|Y
Dulbecco's modified Eagle's medium|Dulbecco's modified Eagle medium|Y
right ventricular apex|right ventricular area|N
butylated hydroxyanisol|butylated hydroxyanisole|Y
urethral pressure profilometry|urethral pressure profile|N
light harvesting chlorophyll protein I|light-harvesting chlorophyll a/b protein-I|Y
American Society of Anaesthesiologists status 4|American Society of Anaesthesiology physical status 4|Y
longitudinal strain|longitudinal section|N
dihydroergokriptin|dihydroergotoxin|N
pulmonary inflation pressure|peak inflation pressure|N
angiotensin 1|angiotensin type 1|Y
cannabinoid 2 receptor|cannabinoid receptor type 2|Y
orthophthaldialdehyde|o-phthaldialdehyde|Y
supraspinous ligament|sacrospinous ligament|N
human adenovirus type 9|human adenovirus serotype 9|Y
steroidogenic acute regulatory protein|steroid acute regulatory protein|Y
intravenously|intravenous|Y
secreted amyloid precursor protein-α|soluble amyloid precursor protein α|Y
small-for-dates|small-for-date|Y
early growth response gene 1|early growth response protein 1|N
randomly amplified polymorphic DNA pattern|random amplified polymorphic DNA pattern|Y
serum transferrin receptor|transferrin receptor|N
methyl thiazolyl tetrazolium|methylthiazol tetrazolium|Y
recombinant murine β interferon|recombinant murine interferon beta|Y
computed tomographic angiographic|computed tomographic angiogram|Y
computer tomographic scan|computer tomography scanning|Y
bilateral breast cancer|bilateral breast carcinoma|Y
maximal heart rate|maternal heart rate|N
differential scanning calorimetric|differential scanning calorimeter|Y
acute nonlymphocytic leucemia|acute nonlymphocytic leukemia|Y
human adenovirus type 15|human adenovirus serotype 15|Y
human adenovirus 37|human adenovirus serotype 37|Y
2,3-butanedione monoxime|butanedione monoxime|Y
complement receptor 1|complement receptor type one|Y
cystic fibrosis related diabetes|cystic fibrosis related diabetes mellitus|Y
myeloid differentiation factor 2|myeloid differentiation 2|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid type 6|Y
extracellular enveloped virion|extracellular enveloped virus|Y
American Society of Anaesthesiologists physical status V|American Society of Anesthesiology physical status 5|Y
sheep red cell|sheep red blood cell|Y
tertbutylhydroperoxide|t-butyl hydroperoxide|Y
General Health Questionnaire|General Health Questionnaire 12|N
Xanthomonas campestris pv vesicatoria|Xanthomonas campestris pathovar vesicatoria|Y
chronic calcifying pancreatitis|chronic calcific pancreatitis|Y
canine rheumatoid arthritis|chronic rheumatoid arthritis|N
activator protein 2|activating protein 2|Y
internally transcribed spacer region|internal transcribed spacer region|Y
graft versus leukemia effect|graft versus lymphoma effect|N
electroretinography|electroretinogram|Y
giant serotonin containing neurone|giant serotonin-containing neuron|Y
para-nitroaniline|paranitroanisole|N
hypoxic response element|hypoxia responsive element|Y
other inflammatory diseases|ocular inflammatory disease|N
critical flicker fusion|critical flicker frequency|Y
intensity modulation radiotherapy|intensity modulation radiation therapy|Y
levonorgestrel intrauterine system|laevonorgestrel-releasing intrauterine system|Y
x-ray repair cross-complementing gene 1|x-ray cross-complementing 1|N
motor action potential|monophasic action potential|N
peripheral nerve stimulator|peripheral nerve stimulation|N
neuro-surgery|neuro-surgeon|N
insertion sequence|inversion sequence|N
ethylenediaminedisuccinic acid|ethylenediaminedisuccinate|N
Charcot-Marie-Tooth neuropathy type 2|Charcot-Marie-Tooth type 2|Y
protein 1|β protein 1|N
vasopressin V2 receptor|vasopressin type 2 receptor|Y
cornu ammonis region 2|cornu ammonis 2|Y
American Society of Anaesthesiology grade I|American Society of Anaesthesiology class 1|Y
proteo-lipid protein|proteolipid apoprotein|Y
anterodorsal thalami nucleus|anterodorsal thalami nuclei|Y
pituitary adenylate cyclase activating polypeptide type 1 receptor|pituitary adenylate cyclase activating peptide type 1 receptor|Y
motor evoked potentials|motor evoked potential|Y
porcine circovirus 2|porcine circovirus type 2|Y
hepatitis C viral|hepatitis C virus|Y
single-stranded DNA binding|single stranded DNA binding protein|N
minimally important difference|minimal important difference|Y
laparoscopic-assisted vaginal hysterectomy|Laparoscopic-assisted vaginal hysterectomy|Y
serotonin binding protein|sex steroid binding protein|N
6 min walk distance|6 minute walk distance|Y
insecticide treated bed net|insecticide treated net|Y
squamous cell carcinoma|squamous cell carcinoma antigen|N
human papillomavirus type 11|human papillomavirus 11|Y
power Doppler ultrasonography|power Doppler ultrasound|Y
American Society of Anesthesiologists Grade 2|American Society of Anaesthesiologists Class 2|Y
American College of Psychiatrists|American College of Prosthodontists|N
atomic absorption spectrophotometer|atomic absorption spectrophotometry|Y
Amblyomma tigrinum|Ambystoma tigrinum|N
latency-associated promoter|latency-associated protein|N
American Society of Anesthesiologists class II|American Society of Anaesthesiologists status II|Y
rolling mouse Nagoya|Rolling Mouse Nagoya|Y
proliferation cell nuclear antigen|proliferating-cell nuclear antigen|Y
3D quantitative structure-affinity relationship study|3D quantitative structure activity relationship study|Y
phosphorylated p38 mitogen-activated protein kinase|phospho-p38-mitogen-activated protein kinase|Y
beta adrenergic receptor kinase|β-adrenergic receptor kinase-1|Y
tobacco mosaic tobamovirus|tobacco mosaic virus|Y
anti-matrix metalloproteinase-2 antibody|anti-matrix metalloprotease-2 antibody|Y
vastus medialis obliquus|vastus medialis oblique|Y
procollagen type III|procollagen III|Y
electro-olfactography|electrooculography|N
polychlorinated dibenzo-p-dioxin|polychlorinated dibenzo-para-dioxin|Y
fatty acid synthase|fatty acid synthetase|Y
idiopathic pain syndrome|idiopathic postprandial syndrome|N
13-carbon-urea breath test|carbon 13 urea breath test|Y
acute transverse myelitis|acute transverse myelopathy|Y
antinuclear factor|anti-nuclear factor|Y
deficiency|deficient|Y
murine tumor necrosis factor|transmembrane tumor necrosis factor|N
metabotropic glutamate receptor 5|metabotropic glutamate 5 receptor|Y
transactive response DNA-binding protein 43|transactivation response DNA-binding protein 43|Y
painful diabetic neuropathy|diabetic neuropathy|N
individualised education program|individual education plan|Y
symbolic|symbiotic|N
American Society of Anesthesiology Class 2|American Society of Anaesthesiologists status II|Y
serum angiotensin-converting enzyme|Serum angiotensin-converting enzyme activity|N
non-structural protein|nonstructural protein 1|Y
angiotensin II receptor subtype 1|angiotensin receptor type 1|Y
glycopeptide-intermediate Staphylococcus aureus|glycopeptide intermediate resistant Staphylococcus aureus|Y
flexible fiberoptic endoscopy|flexible fiberoptic endoscope|Y
transmural laser revascularisation|trans-myocardial laser revascularization|Y
reduced folate carrier|reduced-folate carrier|Y
seroagglutination test|serum agglutination test|Y
formin homology 2 domain containing protein 3|formin homology 2 domain containing 3|Y
tissue culture infective dose|50% tissue-culture infective dose|Y
Core Assessment Programme for Intracerebral Transplantations|Core assessment program for intracerebral transplantations|Y
anti-IL 13 monoclonal antibody|anti-interleukin 13 monoclonal antibody|Y
cerebellar granule neuron|cerebellar granular neuron|Y
intracisternally|intracisternal|Y
interleukin-11 receptor alpha subunit|interleukin 11 receptor alpha|Y
skin protection factor|sun protection factor|Y
angiotensin II type 1 receptor blocker|angiotensin II receptor blocker|Y
thermogravimetric analyser|thermal gravimetric analysis|N
geranylgeranyl protein transferase 1|geranylgeranyl protein transferase type 1|Y
late asthmatic reaction|late asthmatic response|Y
multiplex-fluorescence in-situ hybridisation|fluorescence in situ hybridization|N
pelvic nerve stimulation|preganglionic nerve stimulation|N
anti-matrix metallopeptidase-9 antibody|anti-matrix metalloproteinase-9 antibody|Y
multidrug resistance-associated protein|multidrug resistance related protein 2|N
matrix metalloproteinase 1|matrix metallopeptidase 1|Y
p-chloromercuribenzene sulfonate|p-chloromercuribenzene sulphonate|Y
International Society of Hypertension|International Society of Hematology|N
dimethylaniline|dimethylamine|N
calf vascular resistance|coronary vascular resistance|N
computed tomographic scanning|computerized tomographic scanning|Y
inter-maxillary fixation|intermaxillary fixation|Y
hereditary non-polyposis colon cancer syndrome|hereditary nonpolyposis colorectal cancer syndrome|Y
cardiac intensive care unit|cardiovascular intensive care unit|Y
multidrug resistance related protein 1|multidrug-resistance-associated protein 1|Y
botulinum neurotoxin C|botulinum neurotoxin serotype C|Y
diffuse cutaneous leishmaniasis|disseminated cutaneous leishmaniasis|Y
quantum-dot cellular automaton|quantum cellular automaton|Y
para-nitroaniline|paranitroanilide|Y
Bcl-2 homology 3|BCL2 homology 3|Y
normal rat serum|normal rabbit serum|N
human adenovirus 35|human adenovirus type 35|Y
Canadian Dental Association|California Dental Association|N
Short Musculoskeletal Functional Assessment|Short Musculoskeletal Function Assessment|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists status 1|Y
cancer specific mortality|cause specific mortality|N
polyethylene glycol adenosine deaminase|polyethylene glycol-conjugated adenosine deaminase|Y
IL-13 receptor α 1|IL-13 receptor α1 chain|Y
insulin like material|inhibin-like material|N
insecticide treated bed net|insecticide-treated nets|Y
American Society of Anaesthesiologists physical status II|American Society of Anaesthesiologists Grade II|Y
proteinase activated receptor-1|protease activated receptor 1|Y
Escherichia coli restriction enzyme I|Escherichia coli restriction endonuclease I|Y
special AT-rich binding protein 1|special AT rich sequence binding protein 1|Y
bullous pemphigoid antigen 1|bullous pemphigoid antigen|Y
copy number aberration|copy number alteration|Y
photoplethysmogram|photo-plethysmographic|Y
human adenovirus 45|human adenovirus type 45|Y
premature atrial contracture|premature atrial contraction|Y
complex regional pain syndrome 1|complex regional pain syndrome type 1|Y
Eating Attitudes Test|Eating Attitudes Test-26|Y
interleukine-7 receptor α subunit|interleukin-7 receptor-α|Y
American Pharmaceutical Association|American Pancreatic Association|N
relative adduct level|relative adduct labeling|N
BoNT type B|BoNT serotype B|Y
stromal interaction molecule 2|stromal interacting molecule 2|Y
American Society of Anaesthesiologists status 5|American Society of Anesthesiology physical status 5|Y
urothelial bladder cancer|urinary bladder cancer|N
transient receptor potential vanilloid 4|transient receptor potential vanilloid receptor 4|Y
computed abdominal tomography|computerized axial tomography|N
granulovacuolar degeneration|granulo-vacuolar degeneration|Y
left ventricular disfunction|left ventricular dimension|N
quantitative coronary analysis|quantitative coronary angiography|Y
sodium-taurocholate cotransporting polypeptide|Na+/taurocholate cotransporting polypeptide|Y
retinoic acid receptor-γ|retinoic acid receptor gamma|Y
hydroxymethylglutaryl coenzyme A|hydroxymethylglutaryl CoA|Y
femoral blood pressure|fetal blood pressure|N
calf vascular resistance|cerebral vascular resistance|N
American Society of Anesthesiologists status IV|American Society of Anesthesiologists Class 4|Y
antigen-induced arthritis|adjuvant-induced arthritis|Y
non weight bearing|nonweightbearing|Y
phosphorylated glycogen synthase kinase 3 β|phospho-glycogen synthase kinase 3β|Y
intraarterial chemotherapy|intra-arterial catheter|N
metabotropic glutamate receptor subtype 4|metabotropic glutamate receptor 4|Y
post transplantation lymphoproliferative disorders|post-transplant lymphoproliferative disorder|Y
sub-orbicularis oculi fat lift|sub-orbicularis oculi fat pad lift|Y
transactivation response DNA-binding protein 43|transactive response DNA-binding protein 43|Y
transforming growth factor-beta receptor type II|type II transforming growth factor-beta receptor|Y
flame atomic absorption spectrophotometry|flame atomic absorption spectroscopy|N
latent membrane protein 1|latent infection membrane protein 1|Y
murine erythroleukemic|mouse erythroleukemia|Y
rheumatoid arthritis synovial fibroblast|rheumatoid arthritis synovial fluid|N
renal vascular hypertension|renovascular hypertension|Y
manganese superoxide dismutase|manganous superoxide dismutase|Y
Trait Anxiety Inventory|Test Anxiety Inventory|N
hand assisted laparoscopic surgery|hand-assisted laparoscopic splenectomy|N
sudden unexpected infant death|sudden unexplained infant death|Y
thromboelastography|thrombelastography|Y
protease-activated receptor-1|Protease-activated receptor 1|Y
upstream activation sequence 2|upstream activation site 2|Y
post-percutaneous transluminal coronary angioplasty|post-percutaneous transluminal coronary angiogram|N
transglutaminase|trans-glutaminase|Y
Job syndrome|Joubert syndrome|N
secretory phospholipase A2 IIA|secretory phospholipase A2 group IIA|Y
S-phenyl mercapturic acid|S-phenylmercapturic acid|Y
reovirus strain type 3 Dearing|reovirus type 3 Dearing|Y
American Society of Anesthesiology physical status 2|American Society of Anaesthesiologists Class 2|Y
rostral ventro-medial medulla|rostral ventromedial medulla|Y
Toronto Alexithymia Scale-20|20-item Toronto Alexithymia Scale|Y
A disintegrin and metalloproteinase-28|a disintegrin and metalloprotease 28|Y
fluid restriction|fluid retention|N
malic acid|mandelic acid|N
trimethylaminodiphenylhexatriene|trimethylammoniumdiphenylhexatriene|N
American Society of Anesthesiology grade 2|American Society of Anaesthesiologists Grade II|Y
dithiobiuret|2,4-dithiobiuret|Y
American Society of Anaesthesiologists Grade II|American Society of Anaesthesiology status II|Y
scanning laser ophthalmoscopy|scanning laser ophthalmoscope|Y
pinealectomy|pinealectomise|Y
transmembrane domain 3|third transmembrane domain|Y
intergenic transcribed spacer region|internal transcribed spacer region|Y
Kelvin force microscopy|Kelvin probe force microscopy|Y
dimethylether|dimethyl diester|N
plasminogen activator inhibition|plasminogen activator inhibitor|N
tumor necrosis factor-α|tumor necrosis factor alpha|Y
American Society of Anesthesiology physical status 1|American Society of Anesthesiologists Status I|Y
interleukin 11 receptor alpha|interleukin-11 receptor α chain|Y
serum alkaline phosphatase|skeletal alkaline phosphatase|N
Clinical Global Impression of Change|clinical global impression of change|Y
tomato aspermy virus|tomato aspermy cucumovirus|Y
adenovirus type 5|adenovirus serotype 5|Y
interphase fluorescence in situ hybridization|interphase fluorescence in-situ hybridization|Y
Schirmer 1 test|Schirmer test 1|Y
p21-activated kinase-1|P21-activated kinase 1|Y
small ubiquitin-related modifier-1|small ubiquitin-like modifier 1|Y
vulvar intraepithelial neoplasia grade 2|vulvar intraepithelial neoplasia 2|Y
volume computed tomographic dose index|computed tomographic dose index volume|Y
insulin-like growth factor-I|insulin-like growth factor 1|Y
angiotensin II receptor 1|angiotensin II type 1 receptor|Y
anti-IL-12p70 monoclonal antibody|anti-interleukin-12p70 monoclonal antibody|Y
insulin-like growth factor-2 receptor|insulinlike growth factor receptor 2|Y
vectorcardiography|vectorcardiogram|Y
peroxisome targeting signal type 2|peroxisome targeting signal 2|Y
beta-phenylethylamine|phenylethylamine|Y
vanilloid receptor|vanilloid receptor 1|Y
total anterior circulation infarction|total anterior circulation infarct|Y
classical anti-neutrophil cytoplasmic antibody|cytoplasmic antineutrophil cytoplasmic antibody|Y
pharmacy benefit manager|pharmacy benefit management|Y
auditory evoked brainstem response|auditory brainstem response|Y
lymphatic vessel invasion|lymphatic vascular invasion|Y
rexinoid receptor beta|retinoid X receptor beta|Y
adjusted rate ratio|adjusted risk ratio|N
phospho-choline|phosphocholine|Y
Schedule for Affective Disorders and Schizophrenia|Kiddie-Schedule for Affective Disorders and Schizophrenia|N
anodic aluminum oxide|anodised aluminium oxide|Y
Opiate Withdrawal Scale|Subjective Opiate Withdrawal Scale|Y
metabotropic glutamate receptor type 5|metabotropic glutamate receptor subtype 5|Y
interstitial pneumonitis|interstitial pneumonia|N
99mTc mercaptoacetyltriglycine|technetium 99m mercaptoacetyltriglycine|Y
Reiter syndrome|Rett syndrome|N
fatty acid ethylester|fatty acid ethyl ester synthase|N
high mobility group protein|high mobility group|Y
body temperature monitor|blood temperature monitor|N
air temperature|ambient temperature|Y
thoracic vertebra 4|4th thoracic vertebra|Y
xanthosine 5'-monophosphate|xanthosine monophosphate|Y
point|pint|N
medial basal hypothalamus|medial basal hypothalamic|Y
anterodorsal thalamic nucleus|anterodorsal thalami nucleus|Y
histone 3 lysine 4|histone H3 lysine 4|Y
type 1 anti-neuronal nuclear antibody|anti-neuronal nuclear antibody-type 1|Y
proximal tubule cell|proximal tubular cell|Y
folylpoly-gamma-glutamate synthetase|folylpolyglutamate synthase|Y
metabotropic glutamate receptor type 1|metabotropic glutamate 1 receptor|Y
abbreviated injury score|aggregate injury score|N
exercise induced wheeze|exercise induced wheezing|Y
malonic acid|maslinic acid|N
thromboelastography|thromboelastogram|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiology class V|Y
Kellgren-Lawrence|Kellgren/Lawrence|Y
quantification limit|quantitation limit|Y
transforming growth factor-β type II receptor|type II transforming growth factor-β receptor|Y
complement C4b binding protein|complement 4b binding protein|Y
granulocyte macrophage progenitor|granulocyte macrophage progenitor cell|Y
anti-human T-cell lymphotrophic virus type-I antibody|anti-human T cell lymphotropic virus 1 antibody|Y
rifampin|rifampicin|Y
stromal interaction molecule 1|stromal interacting molecule-1|Y
sarcoplasmic reticulum|sarcoplasmatic reticulum|Y
idiopathic portal hypertension|idiopathic pulmonary hypertension|N
intent-to-treat analysis|intention-to-treat analysis|Y
electrothermal atomic absorption spectrometric|electrothermal atomic absorption spectroscopy|Y
Migraine Disability Assessment Scale|Migraine Disability Assessment|Y
transforming growth factor beta-activated kinase-1|transforming growth factor-beta-activated kinase 1|Y
intima media thickness|intima medial thickness|Y
organophosphate-induced delayed neurotoxicity|organophosphorus compound-induced delayed neurotoxicity|Y
thiobarbituric reactive substance|thiobarbituric acid reacting substance|Y
A disintegrin and metalloprotease 8|a disintegrin and metalloproteinase-8|Y
thymic stroma-derived T cell growth factor|thymic stroma-derived T-cell growth factor|Y
left ventricular diastolic dimension|left ventricular diastolic dysfunction|N
epidural hematoma|extradural hematoma|Y
American Society of Anaesthesiology class V|American Society of Anesthesiologists Grade V|Y
American Society of Anaesthesiology physical status II|American Society of Anaesthesiology class II|Y
31phosphorus nuclear magnetic resonance|phosphorus 31 nuclear magnetic resonance|Y
immunoelectronmicroscopy|immunogold electron microscopy|Y
luteinizing-hormone|lutenising hormone|Y
paranitroanilide|p-nitroanilide|Y
Growth hormone-releasing peptide|growth hormone releasing peptide|Y
Phaseolus vulgaris leuko-agglutinin|Phaseolus vulgaris leucoagglutinin|Y
substance P immunoreactive nerve fiber|SP immunoreactive nerve fiber|Y
muscle specific actin|male specific antigen|N
fluid attenuation inversion recovery|fluid attenuated inversion recovery|Y
matrix metallopeptidase 7|matrix metalloproteinase 7|Y
azaguanine|8-azaguanine|Y
extracorporeal membrane oxygenation|extracorporeal membrane oxygenator|N
x-ray cross-complementing gene 1|x-ray repair cross-complementing protein 1|Y
a disintegrin and metalloprotease-15|A disintegrin and metalloproteinase 15|Y
maximum voluntary isometric torque|maximal voluntary isometric torque|Y
Child Turcotte Pugh score|Child Turcotte Pugh|Y
Pain Disability Index|Psoriasis Disability Index|N
avian pathogenic Escherichia coli|avian pathogenic E. coli|Y
anti-matrix metallopeptidase 13 antibody|anti-matrix metalloproteinase 13 antibody|Y
vasopressin|vasopressin 1A|N
acute inflammatory demyelinating polyneuropathy|acute inflammatory demyelinating polyradiculoneuropathy|Y
cyclic guanosinemonophosphate|cyclic guanidine monophosphate|N
insulin receptor|insulin receptor gene|N
restriction|restrict|Y
a disintegrin and metalloprotease-10|A disintegrin and metalloproteinase 10|Y
American Society of Anaesthesiologists class I|American Society of Anesthesiology Class 1|Y
IL-13 receptor alpha2-chain|IL-13 receptor alpha 2|Y
transient-evoked otoacoustic emission|transiently evoked otoacoustic emission|Y
rotavirus-associated|rhinovirus-associated|N
multiorgan failure|multiple organ failure|Y
benzoylbenzoic ATP|benzoylbenzoyl ATP|Y
flavin-containing monooxygenases|flavin-containing mono-oxygenase|Y
computer tomography scanning|computerised tomographic scanning|Y
acute lymphoblastic leucemia|B-cell acute lymphoblastic leukaemia|N
State Trait Anxiety Inventory|State Trait Anxiety Index|Y
functional spine unit|functional spinal unit|Y
transforming growth factor|transforming growth factor alpha|N
American Academy of Optometry|American Academy of Osteopathy|N
pig aortic endothelial cell|porcine aortic endothelial cell|Y
American Society of Anaesthesiology grade V|American Society of Anaesthesiologists grade 5|Y
x-ray reflectometry|x-ray reflectivity|Y
multiple endocrine neoplasia 2B syndrome|multiple endocrine neoplasia type 2B syndrome|Y
limb girdle muscular dystrophy 2I|limb girdle muscular dystrophy type 2I|Y
excision repair cross-complementing 5|excision repair cross complementation group 5|Y
American Society of Anesthesiology Grade III|American Society of Anaesthesiology status III|Y
adeno associated virus type 2|adeno-associated virus type 2|Y
Microtubule-associated protein 1A|microtubule associated protein-1a|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate 1 receptor|Y
Functional Disability Index|Facial Disability Index|N
peptide nucleic acid|polyamide nucleic acid|Y
aldehyde dehydrogenase class 1|aldehyde dehydrogenase 1|Y
regional oxygen extraction fraction|oxygen extraction fraction|N
whole body irradiation|whole breast irradiation|N
complement receptor 2|complement receptor type 2|Y
human leucocyte antigen B27|human lymphocyte antigen B-27|Y
standard drink unit|standard deviation unit|N
deoxyuridine|2'-deoxyuridine|Y
difluoromethylarginine|alpha-difluoromethylarginine|Y
p-hydroxymercuribenzoic acid|p-hydroxy-mercuribenzoate|N
myofibrillar adenosinetriphosphatase|myosin adenosinetriphosphatase|Y
dengue virus 3|dengue virus type 3|Y
maximal expiratory pressure|maximum expiratory pressure|Y
toll-like receptor-2|Toll-like receptor 2|Y
type 2 corticotrophin-releasing hormone receptor|corticotropin-releasing hormone receptor type 2|Y
damage-associated molecular pattern|danger-associated molecular pattern|Y
murine granulocyte macrophage colony stimulating factor|granulocyte-macrophage colony-stimulating factor|N
maximal Hoffmann reflex|maximum Hoffmann reflex|Y
Sphaeromyxa argentinensis|Spartina argentinensis|N
American Society of Anaesthesiologists grade III|American Society of Anesthesiologists Status 3|Y
hepatic artery embolisation|hepatic arterial embolisation|Y
cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance|Y
human parainfluenza virus 2|human parainfluenza virus type 2|Y
gamma aminobutyric acidA|gamma-aminobutyric acid type-A|Y
knob associated histidine rich protein|knob-associated histidine-rich protein|Y
Fourier transform ion cyclotron resonance mass spectrometry|Fourier transform ion cyclotron resonance mass spectrometer|Y
quantitative structure mobility relationship|quantitative structure metabolism relationship|N
adipose-derived stem cell|adipose-derived stromal cell|Y
transforming growth factor type beta|transforming growth factor beta|Y
Anatomical Therapeutic Chemical Classification System|Anatomic Therapeutic Chemical Classification System|Y
aminoterminal pro-brain-type natriuretic peptide|N-terminal pro brain-type natriuretic peptide|Y
transforming growth factor beta 1|transforming growth factor-β(1)|Y
polyphosphate-accumulating organism|phosphate accumulating organism|Y
ischæmic heart disease|ischemic heart disease|Y
chronic restraint stress|cold restraint stress|N
femoral-popliteal|femoral popliteal|Y
maximal Hoffmann reflex|maximal H reflex|Y
acute myeloid leukemia|acute myeloid leukemic|Y
B lymphocyte kinase|B lymphoid kinase|Y
hyper-immunoglobulin D syndrome|hyperimmunoglobulinemia D syndrome|Y
muscarinic2 receptor|muscarinic M2 receptor|Y
TATA box binding protein|TATA binding protein|Y
leukocyte elastase|leucocyte esterase|N
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists physical status 5|Y
flat panel volumetric computed tomography|flat-panel volume computed tomography|Y
pitt rogers danks syndrome|Pitt-Rogers-Danks syndrome|Y
heat shock protein 70|heat shock cognate 70|N
parainfluenza type 2 virus|parainfluenza virus 2|Y
colonic epithelial cell|ciliated epithelial cell|N
ectodysplasin A|ectodysplasin|Y
coded harmonic angiography|coded harmonic angio|Y
human adenovirus 30|human adenovirus type 30|Y
biphasic positive airway pressure|bilevel positive airway pressure|Y
pulse volume recording|pulse volume recorder|N
intra-arterial digital subtraction angiography|digital subtraction angiography|Y
auto-antibody|autoantibody|Y
early growth response-1 gene|early growth response 1|N
mouse tumor necrosis factor alpha|murine tumor necrosis factor alpha|Y
calcium adenosinetriphosphatase|calcium-activated adenosine triphosphatase|Y
converting enzyme inhibition|converting-enzyme inhibitor|N
venous thromboembolic disease|venous thrombo-embolic disease|Y
human immunodeficiency virus type I|human immunodeficiency virus 1|Y
nonlipodystrophic patient|nonlipodystrophic|Y
hematological malignancy|hematologic malignancy|Y
relapsing experimental autoimmune encephalomyelitis|relapsing experimental allergic encephalomyelitis|Y
near infrared fluorescent imaging|near-infra-red fluorescence imaging|Y
tropomyosin receptor kinase B|tyrosine receptor kinase B|Y
complementary determining region 3|third complementarity-determining region|Y
dopamine D2 receptor|dopamine type 2 receptor|Y
tissue culture infectious dose 50|50% tissue culture infectious dose|Y
fibroblast growth factor receptor 3 gene|fibroblast growth factor receptor 3|N
transforming growth factor beta type II receptor|type II transforming growth factor beta receptor|Y
subzonal sperm insertion|subzonal sperm injection|Y
cyclodextringlycosyltransferase|cyclodextrin glucanotransferase|Y
transforming growth factor beta receptor 1|transforming growth factor-beta receptor type I|Y
American Society of Anaesthesiologists physical status 3|American Society of Anesthesiologists Class III|Y
nonsmall cell lung cancer|nonsmall cell lung carcinoma|Y
magnetisation prepared rapid gradient echo|magnetisation prepared rapid gradient echo imaging|Y
enhanced green fluorescence protein|enhanced green fluorescent protein gene|N
cognitive failures questionnaire|Cognitive Failures Questionnaire|Y
acute infective endocarditis|active infective endocarditis|Y
carbamoylphosphate synthetase|carbamoylphosphate synthase|Y
rat proximal tubular cell|renal proximal tubular cell|N
Hospital Infection Control Practices Advisory Committee|Healthcare Infection Control Practices Advisory Committee|Y
nonoperative|non-operatively|Y
supravalvular aortic stenosis|supravalvar aortic stenosis|Y
left lower lobe|left lower lid|N
3-phosphoinositide-dependent protein kinase-1|phosphoinositide-dependent protein kinase-1|Y
scanning electron micrograph|scanning electron microscope|Y
complementary alternative medicine|complementary and alternative medical|Y
arginine insulin tolerance test|augmented insulin tolerance test|N
grade 2 cervical intraepithelial neoplasia|cervical intraepithelial neoplasia grade 2|Y
vesicoureteral reflux|vesico-ureteric reflux|Y
retinol binding protein|riboflavin binding protein|N
quantitative reverse transcriptase polymerase chain reaction|quantitative real time polymerase chain reaction|N
small ubiquitin-related modifier 2|small ubiquitin-like modifier 2|Y
tibial|tibia|Y
erythroid colony-forming cells|erythroid colony-forming cell|Y
human adenovirus 17|human adenovirus type 17|Y
common gamma chain|common γ chain|Y
proliferative rate index|proliferation rate index|Y
major breakpoint cluster region|major break-point cluster region|Y
aluminium oxide|aluminum oxide|Y
volume-weighted CT dose index|volume CT dose index|Y
mean corpuscular hemoglobin count|mean corpuscular hemoglobin concentration|Y
intraepithelial leucocyte|intraepithelial lymphocyte|N
sterol regulatory element-binding protein-1-a|sterol regulatory element binding protein 1a|Y
standardised incidence ratio|Standardized incidence ratios|Y
peak flow velocity|flow velocity|N
early growth response gene 1|early growth response 1|N
regeneration and tolerance factor|Regeneration and tolerance factor|Y
human adenovirus type 40|human adenovirus 40|Y
methyl-tert-butyl-ether|methyltertiarybutylether|Y
contrast enhancement|contrast enhanced|Y
auto-immune inner ear disease|autoimmune inner ear disease|Y
bone alkaline phosphatase|bone specific alkaline phosphatase|Y
epidermal-derived thymocyte-activating factor|Epidermal cell-derived thymocyte activating factor|Y
percutaneous mitral balloon valvotomy|percutaneous mitral valvotomy|Y
bovine adenovirus 3|bovine adenovirus type 3|Y
probability|probably|N
6-methoxybenzoxazolinone|methoxybenzoxazolinone|Y
human adenovirus 9|human adenovirus type 9|Y
bromovinyldeoxyuridine|bromovinyldesoxyuridine|Y
minimal bactericidal concentration|minimum bactericidal concentration|Y
cystic fibrosis transmembrane conductance regulator protein|CF transmembrane conductance regulator protein|Y
interleukin 7 receptor alpha|interleukin 7 receptor alpha chain|Y
5-bromo-2'-deoxyuridine triphosphate|bromo-deoxyuridine triphosphate|Y
lymphovascular space involvement|lympho-vascular space invasion|Y
transient receptor potential vanilloid receptor subtype 1|transient receptor potential vanilloid type 1 receptor|Y
ristocetin-induced platelet aggregation|ristocetin induced platelet aggregation|Y
rotation|rotational|Y
dichlorodiphenyldichloroethylene|dichlorodiphenyldichloroethene|Y
bromodomain containing protein 7|bromodomain-containing 7|Y
receiver operating characteristic curve|receiver operator characteristic|Y
A disintegrin and metalloproteinase 6|A disintegrin and metalloprotease-6|Y
auditory brainstem response|acoustic brainstem response|Y
activator protein 1 binding|activation protein 1 binding|Y
glucagonlike peptide 1|Glucagon-like peptide|Y
extracellular regulated kinase|Extracellular signal-regulated kinases|Y
interleukin 1|interleukin|Y
vitelline membrane outer layer protein I|vitelline membrane outer I protein|Y
hyper-eosinophilic syndrome|hyper-eosinophilia syndrome|Y
Kupperman Menopausal Index|Kupperman Menopause Index|Y
pattern reversal electroretinogram|pattern electroretinogram|Y
transactivation response DNA-binding protein 43|transactive response DNA-binding protein of 43 kDa|Y
RAS association domain family 1A|RAS association domain family protein 1A|Y
maximum H reflex|maximum Hoffmann reflex|Y
p-nitroanisole|p-nitroanilide|N
interleukin-1beta converting enzyme|interleukin converting enzyme|Y
reverse transcription polymerase chain reaction based assay|reverse transcriptase polymerase chain reaction based assay|Y
cholesteryl ester|cholesterol ester|Y
red man syndrome|rigid man syndrome|N
selective lymphnode dissection|sentinel lymphnode dissection|Y
factor-VIII pro-coagulant activity|factor VIII procoagulant activity|Y
premature chromatid separation|premature centromere separation|Y
receptor-like protein-tyrosine phosphatase-α|receptor protein tyrosine phosphatase alpha|Y
organophosphorus ester-induced delayed neurotoxicity|organophosphorus-induced delayed neurotoxicity|Y
polymyxin B immobilised fibre|polymyxin B-immobilized fiber|Y
corticosteroid|corticosterone|Y
sub-epicardial|epicardial|N
scoring atopic dermatitis index|scoring of atopic dermatitis|Y
micro-particle enzyme immunoassay|microparticle enzyme immunoassay|Y
single vessel disease|small vessel disease|N
modified Rankin scale|modified Rankin Scale score|Y
methylmercaptoimidazol|1-methyl-2-mercaptoimidazole|Y
Ran binding protein|RanGTP binding protein|Y
transcorneal electrical stimulation|trans-cutaneous electrical stimulation|N
Trail Making Test A|Trail Making Test-Part A|Y
myotonic dystrophy 1|myotonic dystrophy type 1|Y
computerized tomography|computed-tomography|Y
simian virus 40 virus|simian virus 40|Y
myocyte enhancer factor 2C|myocyte specific enhancer factor 2C|Y
American Society of Anaesthesiology grade II|American Society of Anaesthesiology physical status II|Y
outer membrane protein|outer membrane porin|N
metabotropic glutamate receptor subtype 3|metabotropic glutamate receptor 3|Y
live oral poliovirus vaccine|oral poliovirus vaccine|Y
antibody-dependent cell-mediated cytotoxicity|antibody dependent cellular cytotoxicity|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology status 5|Y
rostroventromedial medulla|rostral ventromedial medulla|Y
dipalmitylphosphatidylcholine|dipalmitoylphosphatidylcholine|Y
activation protein 1|activated protein 1|Y
total hydrocarbon|total hydrocarbon content|Y
immunoglobulin G4-related systemic disease|immunoglobulin G4-related sclerosing disease|Y
superior venacaval obstruction|superior vena cava obstruction|Y
interleukine-13 receptor alpha1 subunit|interleukin-13 receptor alpha-1 chain|Y
antituberculous treatment|anti-tuberculosis treatment|Y
Response Evaluation Criteria in Solid Tumours|Response evaluation criteria in solid tumors|Y
pre-B cell receptor|preB cell receptor|Y
lysosome associated membrane protein-1|lysosomal associated membrane protein-1|Y
cytosine-phosphate-guanine island|cytosine-phosphate-guanosine island|Y
ortho-succinylbenzoate synthase|o-succinylbenzoate synthase|Y
magnetic resonance enterography|magnetic resonance elastography|N
loco-regional recurrence rate|locoregional recurrence|N
columnar epithelium|ciliary epithelium|N
organophosphorus ester-induced delayed neuropathy|organophosphate-induced delayed neurotoxicity|Y
carbon dioxide excretion|carbon dioxide production|N
polycystic ovarian syndrome|polycystic ovary syndrome|Y
extracranial-intracranial arterial bypass|extra-intracranial artery bypass|Y
short heterodimer partner|small heterodimer partner|Y
non-convulsive status epilepticus|nonconvulsive status epilepticus|Y
anterodorsal thalamic nucleus|anterodorsal thalami nuclei|Y
a disintegrin and metalloprotease 22|a disintegrin and metalloproteinase-22|Y
x-ray powder diffractometry|X-ray powder diffractometry|Y
American Society of Anaesthesiology physical status II|American Society of Anesthesiology class 2|Y
cochlear implantation|cochlear implant|Y
recombinant human erythropoietin|recombinant erythropoietin|Y
nonketotic hyperglycinemia|nonketotic hyperglycemia|N
glial derived neurotrophic factor|glial cell-line-derived neurotrophic factor|Y
cholesterol ester storage disease|cholesteryl ester storage disease|Y
Quality of Life in Reflux and Dyspepsia|Quality of Life in Reflux and Dyspepsia questionnaire|Y
sporadic olivopontocerebellar atrophy|sporadic olivo-ponto-cerebellar atrophy|Y
voltage dependent anion channel 1|voltage dependent anion selective channel 1|Y
measles immunoglobulin|malaria immunoglobulin|N
proliferation cell nuclear antigen|proliferative cell nuclear antigen|Y
intensity modulation radiotherapy|intensity-modulated radiotherapy|Y
American Society of Anaesthesiology class III|American Society of Anesthesiology status III|Y
aortic systolic pressure|area systolic pressure|N
intra-thoracic blood volume|intrathoracic blood volume|Y
hepatitis delta antigen|hepatitis D antigen|Y
neuropsychological|neuropsychologic|Y
electro-myographic|electro-myography|Y
monoglucosyldiglyceride|monogalactosyldiglyceride|N
maximal oxygen uptake|maximum oxygen uptake|Y
community health center|community health council|N
glycophosphatidylinositol|glycosylphosphatidylinositol|Y
tosylphenylalanine chloromethylketone|N-tosyl-l-phenylalanine-chloromethyl ketone|Y
receptor-linked protein-tyrosine-phosphatase alpha|receptor-like protein tyrosine phosphatase α|Y
a disintegrin and metalloprotease 12-S|a disintegrin and metalloproteinase 12s|Y
renovascular hypertensive rat|renal hypertensive rat|Y
tissue plasminogen activator antigen|tissue-type plasminogen activator antigen|Y
loss of righting reflex|loss of the righting reflex|Y
scavenger receptor A|scavenger receptor class A|Y
low frequency|very low frequency|N
monoamine oxidase A|monoamineoxidase|N
American Society of Anesthesiology grade 4|American Society of Anaesthesiologists grade IV|N
vascular endothelial growth factor|vascular endothelial growth factor165|N
non-transgenic|nontransgenic|Y
American Society of Anesthesiology Class III|American Society of Anaesthesiology status III|Y
quantitative computed tomography scan|quantitative computerised tomography scan|Y
recessive X-linked ichthyosis|recessive X-linked icthyosis|Y
varicella zoster immune globulin|varicella-zoster immuno-globulin|Y
interleukine-6 receptor α subunit|interleukin-6 receptor α chain|Y
assisted mechanical ventilation|assisted mandatory ventilation|N
proton transfer reaction mass spectrometry|proton transfer reaction mass spectrometer|Y
human papillomavirus 16E7|human papillomavirus type 16 E7|Y
maximum oxygen consumption|oxygen consumption|N
electron-probe micro-analysis|electron probe micro-analyser|N
linear IgA bullous dermatosis|linear IgA bullous disease|Y
acquired immunodeficiency syndrome|acquired immune deficiency syndrome|Y
5th cervical vertebra|cervical vertebra 5|Y
endoscopic retrograde choledochopancreatography|endoscopic retrograde pancreatography|N
surface electromyogram|surface electromyographic|Y
human adenovirus serotype 13|human adenovirus type 13|Y
insulin-like growth factor II mRNA binding protein 3|insulin-like growth factor-II messenger RNA-binding protein-3|Y
small ubiquitin-related modifier-2|small ubiquitin-like modifier-2|Y
indirect immunofluorescent antibody test|indirect fluorescent antibody test|Y
human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta|Y
metatarso-phalangeal joint|metatarsal phalangeal joint|Y
melanoma chondroitin sulfate proteoglycan|melanoma-associated chondroitin sulphate proteoglycan|Y
triethylammonium phosphate|triethylamine phosphate|N
magnetisation prepared rapid gradient echo|magnetisation prepared rapid gradient echo sequence|Y
upper body obesity|upper body obese|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor II mRNA binding protein-2|Y
matrix metalloproteinase 13|matrix metallopeptidase 13|Y
cancer stem cell|cancer stemlike cell|Y
medial basal hypothalamus|medio-basal hypothalamus|Y
antiinterleukin 1alpha monoclonal antibody|anti-IL 1alpha monoclonal antibody|Y
phytohaemagglutinin-P|phytohemagglutinin P|Y
American Prosthodontic Society|American Psychosomatic Society|N
microbiology|microbiological|Y
X-linked hypophosphatemia|X-linked hypophosphatemic rickets|Y
polyacrylate|polyacrylamide|N
familial juvenile nephronophthisis|familial juvenile nephrophthisis|Y
αthalassemia|thalassemia|N
CpG island methylation phenotype|CpG island methylator phenotype|Y
calcium activated neutral protease|calcium activated neutral proteinase|Y
coenzyme Q10|co-enzyme Q-10|Y
human adenovirus type 14|human adenovirus serotype 14|Y
extracellular water|extracellular|N
p-cresol methylhydroxylase|para-cresol methylhydroxylase|Y
multidrug resistance-associated protein|multidrug resistance protein 1|N
luteinizing hormone releasing hormone|luteinising hormone releasing hormone|Y
Dobrava virus|Dobrava hantavirus|Y
anti-idiotypic antibody|antiidiotypic antibody|Y
slipped capital femoral epiphysis|Slipped capital femoral epiphyses|Y
marmoset chorionic gonadotropin|monkey chorionic gonadotropin|N
angiotensin II receptor subtype 1|angiotensin II receptor type 1|Y
venous thromboembolic event|venous thromboembolism|Y
arylhydrocarbon receptor|aromatic hydrocarbon receptor|Y
growth arrest specific 7|growth arrest specific gene 7|N
subdural hæmatoma|subdural hematoma|Y
left main stenosis|left main stem|N
primed lymphocyte typing|primed lymphocyte testing|Y
citrate synthase|citrate synthetase|Y
nonprotein sulfhydryl|non-protein sulfhydryls|Y
histamine H(1)-receptor|histamine1 receptor|Y
non-tuberculous mycobacterium|nontuberculous mycobacteriosis|N
murine erythroleukemia cell|mouse erythroleukemia cell|Y
Fourier transform|Fourier transformation|Y
paroxysmal depolarising shift|paroxysmal depolarisation shift|Y
peritoneal dialysis effluent|peritoneal dialysate effluent|Y
human adenovirus type 32|human adenovirus serotype 32|Y
nipple areola complex|nipple areolar complex|Y
magnetic resonance angiography|magnetic resonance arthrography|Y
Solid-phase micro-extraction|solid phase micro-extraction|Y
proteinase activated receptor-1|protease-activated receptor-1|Y
postural hypotension|portal hypertension|N
steroid sensitive|steroid sensitivity|Y
human immunodeficiency virus type 1|human immunodeficiency virus 1|Y
musculoskeletal|musculo-skeletal|Y
human adenovirus type 5|human adenovirus 5|Y
chlorine|chloride|Y
arterio-sclerotic heart disease|athero-sclerotic heart disease|Y
recovery ratio|recovery room|N
Salmonella enterica serotype Paratyphi C|Salmonella enterica serovar Paratyphi C|Y
plasma amine oxidase|polyamine oxidase|N
St Louis encephalitis virus|Saint Louis encephalitis virus|Y
pigment-epithelium-derived factor|Pigment epithelium-derived factor|Y
American Society of Anesthesiology Class 2|American Society of Anaesthesiology status II|Y
cytochrome P450IID6|cytochrome P4502D6|Y
cholesterol crystal embolisation|cholesterol crystal embolism|Y
parathyroid hormone-like peptide|parathyroid hormone-like protein|Y
high mobility group box 1 protein|high mobility group box 1|Y
human cord serum|human fetal cord serum|Y
transmission electronmicrograph|transmission electron microscopy|N
adherent invasive E. coli|adherent invasive Escherichia coli|Y
American Society of Anesthesiology status V|American Society of Anesthesiologists class V|Y
paired box gene 2|paired box 2|N
macrophage activation factor|macrophage-activating factor|Y
galactosylceramidase|galactosylceramide|N
triple quadrupole mass spectrometry|triple quadrupole mass spectrometer|Y
IL2 receptor alpha chain|IL-2 receptor alpha|Y
luteinizing hormone releasing factor|luteinizing hormone-releasing factor|Y
human adenovirus B|human adenovirus type B|Y
near infrared fluorescent imaging|near infrared fluorescent|N
crypt cell production rate|crypt cell proliferation rate|Y
mandibular pain dysfunction syndrome|myofascial pain dysfunction syndrome|N
asialoorosomucoid|asialo-orosomucoid|Y
spinocerebellar ataxia|spinocerebellar ataxia 2|N
multigated acquisition|multi gated acquisition scan|Y
internal transcribed spacer|internal transcribed spacer region 1|N
glutamic acid diethylester|glutamatediethylester|N
small-for-date|small for dates|Y
interleukine-18 receptor-α|interleukin-18 receptor α chain|Y
fluoro-deoxyglucose positron emission tomography|fluorine-18 fluorodeoxyglucose positron emission tomography|Y
conserved helix-loop-helix ubiquitous kinase|conserved helix loop helix ubiquitous kinase|Y
anion exchange|anion exchanger|N
transient receptor potential vanilloid receptor type 2|transient receptor potential vanilloid receptor 2|Y
ataxia-telangiectasia mutated kinase|ataxia-telangiectasia-mutated protein|Y
doublesex and male abnormal-3 related transcription factor-1|doublesex and mab-3 related transcription factor 1|Y
sternocleidomastoid|sternocleidomastoid muscle|Y
Wistar Kyoto|Wistar Kyoto rat|Y
angiotensin receptor type 1|angiotensin II receptor 1|Y
intra-vesical pressure|intraventricular pressure|Y
vivo neutron activation analysis|in-vivo neutron activation analysis|Y
bile salt export protein|bile salt excretory protein|Y
portal venous pressure|portal vein pressure|Y
macrophage activation factor|macrophage agglutinating factor|N
HIV-associated neurocognitive disorder|HIV-1 associated neurocognitive disorder|Y
polysomnographic|polysomnography|Y
polymorphous light eruption|polymorphic light eruption|Y
uronic acid|uric acid|N
human adenovirus G|human adenovirus type G|Y
indirect fluorescent antibody test|immunofluorescent antibody test|N
nucleotide-binding site-leucine-rich repeat|nucleotide binding site-leucine rich repeat|Y
sick sinus syndrome|silent sinus syndrome|N
long interspersed nuclear element-1|long interspersed nucleotide element-1|Y
acyl-acyl carrier protein|acyl carrier protein|Y
N-terminal-pro-brain-type natriuretic peptide|N terminal probrain natriuretic peptide|Y
Cercis occidentalis|Culicoides occidentalis|N
thoracic vertebra 8|8th thoracic vertebra|Y
ouabain resistance|ouabain-resistant|Y
organophosphorus ester-induced delayed neurotoxicity|organophosphorus compound-induced delayed neurotoxicity|Y
ethylenediamine tetramethylene phosphonic acid|ethylenediaminetetramethylene phosphonate|Y
maximal breathing capacity|maximum breathing capacity|Y
atrial fibrillation|auricular fibrillation|Y
macromolecular creatine kinase type 2|macrocreatine kinase type 2|Y
glutamate receptor 1|glutamate receptor subunit 1|Y
American Society of Anesthesiologists Status 3|American Society of Anesthesiologists Class III|Y
chest radiography|chest radiograph|Y
pattern reversal visual evoked potential|pattern-reversal visual evoked potential|Y
organophosphate hydrolase|organophosphorus hydrolase|Y
galactofuranose|galactofuranosyl|N
dynamic susceptibility contrast magnetic resonance imaging|dynamic susceptibility contrast enhanced magnetic resonance imaging|Y
p-chloromercuriphenylsulfonate|p-chloromercuriphenylsulfonic acid|N
calcium activated adenosine triphosphatase|calcium adenosinetriphosphatase|Y
ubiquitin fusion degradation 1|ubiquitin fusion degradation protein 1|Y
American Society of Anesthesiologists grade IV|American Society of Anesthesiologists status IV|Y
grazing incidence X-ray diffraction|grazing-incidence X-ray diffraction|Y
Fourier transform mass spectrometry|Fourier transform mass spectrometer|Y
recombinant human tumor necrosis factor alpha|recombinant human tumour necrosis factor-α|Y
uroporphyrinogen synthetase|uroporphyrinogen I synthetase|N
capacitative Ca2+ entry|capacitative calcium entry|Y
computed tomographic angiography|computed tomography angiography|Y
arterio-venous|arteriovenous|Y
periodontic|periodontics|Y
oxoprolinase|5-oxo-L-prolinase|Y
dentadorubropallidoluysian atrophy|dentatorubro-pallidoluysian atrophy|Y
type II interleukin 1 receptor|interleukin 1 receptor 2|Y
osteopetrosis|osteoporosis|N
left ventricular weight|left ventricular wall|N
juvenile chronic myeloid leukemia|juvenile chronic myelogenous leukemia|Y
folylpolyglutamate synthase|folylpolyglutamate synthetase|Y
X linked agammaglobulinemia|x linked agammaglobulinemia|Y
hydroxyapatite ceramics|hydroxyapatite cement|N
wrist extension|wrist extensor|N
endobronchial ultrasonography|endo-bronchial ultrasound|Y
small nuclear ribonucleoprotein|small nuclear ribonucleoprotein particle|Y
precursor B acute lymphoblastic leukemia|pre B acute lymphoblastic leukemia|Y
reversal potential|current reversal potential|Y
alkyladenine DNA glycosylase|alkyladenine glycosylase|Y
gamma-amino-butyric acid type-A|gamma aminobutyric acidA|Y
Musculoskeletal Tumor Society|Musculoskeletal Tumor Society Score|N
fatty acyl ethyl ester synthase|fatty acid ethyl ester synthase|Y
insulinlike growth factor receptor type 1|insulin-like growth factor receptor-I|Y
symbol digit modalities test|Symbol Digit Modalities Test|Y
chromosomal region maintenance 1|chromosome region maintenance 1|Y
type 2 NADH dehydrogenase|type II NAD(P)H dehydrogenase|Y
Continuous positive airway pressure breathing|continuous positive airway pressure|Y
diffusion kurtosis imaging|diffusional kurtosis imaging|Y
hyper-branched polyester|hyper-branched polyglycerol|N
transforming growth factor beta receptor type 2|type II transforming growth factor-beta receptor|Y
functional spine unit|functional subunit|N
American Society of Anaesthesiologists status III|American Society of Anesthesiology Class 3|Y
plasminogen activator inhibitor type 1|plasminogen activator inhibitor 1|Y
liver esterase|pig liver esterase|N
net primary productivity|net primary production|Y
cerebrovascular resistance|coronary vascular resistance|N
postoperative|postoperatively|Y
telomere repeat binding factor|telomeric repeat binding factor|Y
neomycin resistance|neomycin resistance gene|Y
limb girdle muscular dystrophy 2A|limb girdle muscular dystrophy type 2A|Y
primary pulmonary hypertension|persistent pulmonary hypertension|N
human chorionic gonadotrophin β|human chorionic gonadotropin β-subunit|Y
parasitised red blood cell|packed red blood cell|N
ribulose-1,5-bisphosphate|ribulosebisphosphate|Y
post-transplantation lymphoproliferative disease|posttransplant lymphoproliferative disorder|Y
peroxyacetic acid|peracetic acid|Y
metabotropic glutamate receptor type 3 gene|metabotropic glutamate receptor 3|N
minimal lumen diameter|minimal luminal diameter|Y
idiopathic pneumonia syndrome|idiopathic postprandial syndrome|N
graft versus host|graft versus host disease|Y
neural cell adhesion molecule|neuronal cell adhesion molecule|Y
indirect immunofluorescence antibody test|immunofluorescent antibody test|N
intra-vaginal ejaculatory latency time|intravaginal ejaculation latency time|Y
antineutrophil cytoplasmic antibody|classic anti-neutrophil cytoplasmic antibody|N
paraventricular hypothalamic nucleus|paraventricular hypothalamus|Y
Raf kinase inhibitor protein|Raf kinase inhibitory protein|Y
interleucin 6|interleukin 6|Y
cysteine proteinase inhibitor|cysteine protease inhibitor|Y
phosphatidyl-N-monomethylaminoethanol|phosphatidyl-N-monomethylethanolamine|Y
metabotropic glutamate receptor type 4|metabotropic glutamate receptor 4|Y
complement|complement 3a|N
lateral cerebral ventricle|lateral cerebroventricle|Y
proliferating cell nuclear antigen labeling index|proliferating cell nuclear antigen-labeling index|Y
internal transcribed spacer region 1|internal transcribed spacer-1|Y
anti-lymphocyte globulin|antilymphocytic globulin|Y
short interval intracortical inhibition|short-interval intra-cortical inhibition|Y
nonmelanoma skin carcinoma|nonmelanoma skin cancer|Y
bromosulphthalein|bromsulfophthalein|Y
indirect immunofluorescence antibody test|indirect fluorescent antibody test|Y
ventricular ectopic|ventricular ectopy|Y
upstream activation sequence|upstream activation site|Y
laser Doppler velocimetry|laser Doppler velocimeter|Y
cerium trichloride|cerium chloride|Y
upper respiratory tract infection|upper respiratory infection|Y
Torpedo acetylcholine receptor|acetylcholine receptor|N
prepulse inhibition|paired pulse inhibition|N
enoyl coenzyme A hydratase short chain 1|enoyl-CoA hydratase short chain 1|Y
excision repair cross-complementing-group 4|excision repair cross complementation group 4|Y
DNA double strand break|double strand DNA break|Y
peroxidase-antiperoxidase|peroxidase-antiperoxidase complex|Y
high exposure|high explosive|N
human adenovirus type 50|human adenovirus 50|Y
mechanical ventilation|nocturnal mechanical ventilation|N
maximum motor response|maximal motor response|Y
somatostatin type 2 receptor|somatostatin receptor 2|Y
anti-human T cell lymphotropic virus-I antibody|anti-human T cell lymphotropic virus type-I antibody|Y
regional oxygen saturation|regional cerebral oxygen saturation|N
anti-IL-7 monoclonal antibody|anti-interleukin-7 monoclonal antibody|Y
cannabinoid 2 receptor|cannabinoid receptor 2|Y
selenoprotein P1|selenoprotein P|Y
propofol infusion syndrome|propofol-related infusion syndrome|Y
posterior interosseous artery|posterior intercostal artery|N
P21 activated kinase 1|p21-activated kinase|Y
cone-beam computerized tomography|cone-beam computed tomography|Y
peracetic acid|phenylacetic acid|N
guanylate cyclase|guanylyl cyclase|Y
oral facial digital syndrome type V|oro-facio-digital syndrome type V|Y
δ aminolevulinic acid dehydratase|aminolevulinic acid dehydratase|Y
equid herpesvirus type 5|equine herpesvirus 5|Y
recombinant murine gamma interferon|recombinant murine interferon gamma|Y
α-glycerophosphate dehydrogenase|alpha glycerol-3-phosphate dehydrogenase|Y
fluorescent imaging plate reader|fluorescence imaging plate reader|Y
American Spinal Injury Association grade D|American Spinal Injury Association Impairment Scale grade D|Y
Standard Pseudoisochromatic Plates Part 2|Standard Pseudoisochromatic Plates 2|Y
p-nitrophenyl phosphatase|para-nitrophenyl-phosphatase|Y
helicopter emergency medical service|helicopter emergency medical system|Y
T independent type 2 antigen|thymus independent type 2 antigen|Y
phosphatidylinositol 4,5-biphosphate|phosphatidyl-inositol bis-phosphate|Y
Apolipoprotein B-48|apolipoprotein B-48|Y
poly(2-hydroxyethylmethacrylate)|poly-hydroxyethylmethacrylate|Y
DNAX-activating protein 12|DNAX activation protein of 12 kDa|Y
trace|trachea|N
portal pressure|paw pressure|N
biochemical recurrence free survival|biochemical relapse-free survival|Y
thoracic vertebra 6|6th thoracic vertebra|Y
tetracycline trans-activator|tetracycline controlled trans-activator|Y
interleukine-6 receptor α subunit|interleukine-6 receptor α|Y
American Society of Anaesthesiology status IV|American Society of Anesthesiology Class 4|Y
metabotropic glutamate receptor type 1|metabotropic glutamate receptor 1|Y
National Medical Association|National Malaria Association|N
left pulmonary vascular resistance|pulmonary vascular resistance|N
p-amino-hippurate clearance|paraaminohippurate clearance|Y
American Society of Anesthesiologists physical status 2|American Society of Anesthesiology physical status 2|Y
16-slice multidetector computed tomography|sixteen-slice multidetector-row computed tomography|Y
Basso-Beattie-Bresnahan Locomotor Rating Scale|Basso, Beattie, and Bresnahan locomotor rating scale|Y
growth factor receptor binding protein 2|factor receptor binding protein-2|N
prostaglandin I(2) synthase|prostaglandin I synthase|Y
oral-facial-digital syndrome type 1|orofaciodigital syndrome type 1|Y
low calorie diet|low calcium diet|N
mu opioid receptor|mu opioid receptor gene|N
young male|young man|Y
scavenger receptor|scavenger receptor class A|N
leukemia-inhibiting factor|leucemia inhibitory factor|Y
intensive medicine unit|internal medicine unit|N
array comparative genomic hybridisation|array based comparative genomic hybridisation|Y
5-bromo-2'-deoxyuridine|bromodeoxy-uridine|Y
isopropylacrylamide|N-isopropylacrylamide|Y
logarithm phase|logarithmic phase|Y
orthoaminoazotoluene|o-aminoazotoluene|Y
isopenicillin N synthase|isopenicillin N synthetase|Y
cDNA-amplified fragment length polymorphism|complementary DNA-amplified fragment length polymorphism|Y
American Society of Anesthesiology Grade 3|American Society of Anesthesiology physical status 3|Y
autoimmune hemolytic anemia|acquired hemolytic anemia|N
assisted-reproduction treatment|assisted-reproduction technique|Y
Gaucher disease|Gauchers disease|Y
group A beta hemolytic streptococcal|group A beta hemolytic streptococcus|Y
resting electroencephalogram|routine electroencephalogram|N
dinitrophenyl bovine gamma globulin|dinitrophenylated bovine γ-globulin|Y
non-cytopathic|noncytopathic|Y
Cockayne syndrome group B protein|Cockayne syndrome B protein|Y
electrothermal atomic absorption spectrophotometry|electrothermal atomisation atomic absorption spectrometry|Y
nucleus|nucleolus|N
16-slice multidetector-row computed tomography|16-slice multi-detector computed tomography|Y
thoracic aortic injury|traumatic aortic injury|N
American Society of Anesthesiologists status 5|American Society of Anesthesiology physical status 5|Y
Elastica van Gieson stain|Elastic van Gieson stain|Y
progesterone binding protein|pheromone binding protein|N
human adenovirus type 4|human adenovirus 4|Y
lipolysis-stimulated receptor|lipolysis stimulated receptor|Y
colony-forming-unit|colony-forming units|Y
acute ischemic syndrome|acute ischemic stroke|N
dideoxyinosine|2',3'-dideoxyinosine|Y
cyclic AMP responsive element|cAMP response element|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology Grade 1|Y
American Psychiatric Association|American Psychopathological Association|N
micelle electrokinetic capillary chromatography|micellar electrokinetic chromatography|Y
embryonal carcinoma cell|embryonic carcinoma cell|Y
cyclic voltammogram|cyclic voltammetry|N
Global Assessment of Functioning Scale|Global Assessment of Function scale|Y
anti-phenolic glycolipid-I antibody|anti-phenolic glycolipid-I|Y
dual isotope single acquisition|dual isotope simultaneous acquisition|N
light harvesting chlorophyll a/b-binding protein-I|light-harvesting chlorophyll a/b protein-I|Y
minimal fungicidal concentration|minimum fungicidal concentration|Y
quarter|quart|N
latent membrane protein 1|latent membrane protein|Y
coronary artery stenosis|carotid artery stenosis|N
iron-sulphur cluster assembly 1 homologue|iron-sulphur cluster assembly 1|N
recurrent oral ulcer|recurrent oral ulceration|Y
human B lymphotropic virus|human B-cell lymphotropic virus|Y
primary graft nonfunction|primary nonfunction|Y
vasoactive intestinal peptide immunoreactivity|vasoactive intestinal peptide immunoreactive|Y
phorbol diacetate|phorbol 12,13-diacetate|Y
middle T antigen|middle tumor antigen|Y
small-for-gestational-age|small for gestational age|Y
soluble inhibitory factor|serum inhibitory factor|Y
American Society of Anesthesiologists Status 3|American Society of Anaesthesiology status III|Y
International Filariasis Association|International Fertility Association|N
glassy carbon electrode|glass carbon electrode|Y
guanine nucleotide dissociation inhibitor 1|guanine dinucleotide phosphate dissociation inhibitor 1|Y
computerized tomography angiogram|computed tomographic angiogram|Y
poly(2-hydroxyethyl methacrylate)|polyhydroxyethylmethacrylate|Y
cannabinoid receptor 1|cannabinoid 1 receptor|Y
human adenovirus 13|human adenovirus type 13|Y
nitrogen phosphorus detector|nitrogen phosphorus detection|Y
systemic inflammatory response|systemic inflammatory reaction|Y
transient receptor potential vanilloid receptor type 1|transient receptor potential vanilloid type 1 receptor|Y
serotonin–norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor|Y
promyelocytic leukemia protein|pro-myelocytic leukaemia|N
hexosamine biosynthetic pathway|hexosamine biosynthesis pathway|Y
negative affectivity|negative affect|Y
one dimension|one-dimensional|Y
bone morphogenetic protein receptor 1|bone morphogenetic protein receptor type 1|Y
multiunit activity|motor unit activity|N
high performance liquid chromatograph|high pressure liquid chromatography|Y
hexamethylenebisacetamide|N,N'-hexamethylene-bis-acetamide|Y
type 3 familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis type 3|Y
transmyocardial laser revascularisation|trans-myocardial laser revascularization|Y
microtubule organizing center|microtubule organizing centre|Y
stress fracture|stent fracture|N
complete metabolic response|complete molecular response|N
healthy weight|heart weight|N
botulinum neurotoxin type E|botulinum neurotoxin E|Y
cerebrovascular reserve capacity|cerebrovascular reserve|Y
interleukine-13 receptor α1-chain|interleukin-13 receptor α1|Y
Rho-guanine dinucleotide phosphate dissociation inhibitor 1|Rho-guanine nucleotide dissociation inhibitor 1|Y
common variable immunodeficiency syndrome|common variable immunodeficiency|Y
xylose lysine deoxycholate agar|xylose lysine desoxycholate agar|Y
sodium tauro-24,25-dihydrofusidate|sodium taurodihydrofusidate|Y
multiple endocrine neoplasia syndrome|multiple endocrine neoplasia|Y
intracisternal A-type particle|intra-cisternal A-particle|Y
poly(ether-urethane)|polyetherurethane|Y
iduronate-2-sulphatase|iduronate sulfatase|Y
gynecologic|gynecologist|N
polyarthritis|polyarteritis|N
computer-assisted diagnosis|computer aided diagnostic|Y
human adenovirus C|human adenovirus type C|Y
peroxisome proliferator-activated receptor gamma1|peroxisome proliferator-activated receptor γ 1|Y
American Society of Anesthesiologists grade 2|American Society of Anaesthesiology status II|Y
A disintegrin and metalloprotease-23|A disintegrin and metalloproteinase 23|Y
sterol regulatory element-binding protein-1-a|sterol response element-binding protein-1-a|Y
spinocerebellar ataxia type 2|spino-cerebellar ataxia type 2|Y
organophosphorus-induced delayed neurotoxicity|organophosphorus compound-induced delayed neurotoxicity|Y
allogeneic blood transfusion|allogenic blood tranfusion|Y
adipose-derived stromal cell|adipose stromal cell|Y
interleukin 1|interleucin 1|Y
secoisolariciresinol diglucoside|secoisolariciresinol diglycoside|Y
apoptotic protease activating factor 1|apoptotic protease-activating factor-1|Y
Apolipoprotein CIII|apolipoprotein C-III|Y
intradermally|intradermal|Y
receiver operating characteristic|receiver operator characteristic|Y
average molecular weight|apparent molecular weight|N
left atrium|left arm|N
Alagille-Watson syndrome|alagille watson syndrome|Y
late positive complex|late positive component|Y
fluorescent in situ hybridisation|fluorescence in situ hybridization|Y
transient receptor potential vanilloid type 1|transient receptor potential vanilloid receptor 1|Y
phorbolmyristyl acetate|phorbol myristic acetate|Y
American Medical Women's Association|American Medical Writers' Association|N
interleukin 11 receptor alpha|interleukine-11 receptor alpha subunit|Y
cholera toxin beta subunit|cholera toxin subunit B|Y
Schonlein Henoch purpura|Schönlein-Henoch purpura|Y
human adenovirus 7|human adenovirus type 7|Y
maximal electroshock seizure|maximal electroshock|Y
Global Assessment of Functioning|global assessment of functioning|Y
human adenovirus serotype 16|human adenovirus 16|Y
macrocreatine kinase 1|macromolecular creatine kinase 1|Y
frozen embryo transfer|frozen-thawed embryo transfer|Y
Veterans Affairs Medical Center|Veterans' Affairs medical center|Y
gonadotrophin releasing factor|gastrin-releasing factor|N
nuclear factor kappa beta|nuclear factor kappaB|Y
expression sequence tag|expressed sequenced tag|Y
apolipoprotein A-IV|apolipoprotein AIV|Y
matrix-assisted laser desorption ionisation-mass spectrometry|Matrix-assisted laser desorption ionization mass spectrometry|Y
upflow sludge blanket|upflow sludge bed|Y
arginine-glycine-aspartic acid-serine|arginine-glycine-aspartate-serine|N
colony-forming unit-culture|colony-forming units in culture|Y
anti-human immunodeficiency virus type-1|anti-human immunodeficiency virus-1|Y
decidual cell response|decidual cell reaction|Y
antineutrophilic cytoplasmic antibody|antinuclear cytoplasmic antibody|Y
intramammary|intra-mammary|Y
corticotrophin-releasing-hormone receptor-2|type-2 corticotropin-releasing-hormone receptor|Y
malignant hyperthermia|malignant hyperpyrexia|Y
dermal epidermal junction|dermo-epidermal junction|Y
simple reaction time|simple reaction time task|Y
osmolality|osmolarity|N
myogenic regulatory factor 5|muscle regulatory factor 5|Y
transforming growth factor-β type II receptor|transforming growth factor-β receptor type II|Y
aγglobulinemia|agammaglobulinemia|Y
type 1 Chiari malformation|Chiari malformation I|Y
subjectively|subjective|Y
hydroxyflutamide|hydroxy-flutamide|Y
micellar electrokinetic chromatography|micellar electrokinetic capillary chromatography|Y
artificial cerebral spinal fluid|artificial cerebro-spinal fluid|Y
mesangial cell|marginal cell|N
human anti-mouse antibody|human anti-mouse antibodies|Y
alpha-difluoromethyl-arginine|difluoromethylarginine|Y
multidetector row computed tomography scan|multi-detector computed tomography scan|Y
guanidinium hydrochloride|guanidine hydrochloride|Y
American Otological Society|American Ophthalmological Society|N
bladder smooth muscle cell|smooth muscle cell|N
cisplatin|cisplatinum|Y
anodic aluminium oxide|anodised aluminium oxide|Y
T suppressor cell|suppressor T cell|Y
immunodeficiency|immune deficiency|Y
human adenovirus 19|human adenovirus serotype 19|Y
subfoveal choroidal neovascularisation|choroidal neovascularization|N
skeletal alkaline phosphatase|soluble alkaline phosphatase|N
X-linked lymphoproliferative disorder|X-linked lymphoproliferative syndrome|Y
hemopoietic stem cell transplant|hemopoietic stem cell transplantation|Y
equid herpesvirus type 5|equid herpesvirus 5|Y
Interocular transfer|intra-ocular transfer|N
visual evoked potential|visual-evoked potential|Y
long acting reversible contraceptive|long acting reversible contraception|Y
mixed lymphocyte tumor culture|mixed lymphocyte tumor cell cultures|Y
glucocorticoid receptor alpha|glucocorticoid receptor-α|Y
intra-cavernous pressure|intracavernosal pressure|Y
thermo-luminescence dosimeter|thermoluminescent dosimeter|Y
computerised tomography scanning|computed tomographic scanning|Y
Patient Health Questionnaire 2|2-item Patient Health Questionnaire|Y
perfluoro-n-decanoic acid|perfluorodecanoic acid|Y
comparative risk assessment|caries risk assessment|N
intravenous γ-globulin|intravenous gammaglobulin|Y
mean graft survival time|mean survival time|N
endothelial cell nitric oxide synthase|endothelial nitric oxide synthase|Y
malic acid|malonic acid|N
trichloroethane|trichloroethene|N
sodium polyethylene sulfonate|sodium polyanetholesulfonate|N
uroporphyrinogen I synthetase|uroporphyrinogen III synthase|N
end diastolic pressure volume relationship|end diastolic pressure volume relation|Y
intracellular Na+ activity|intracellular sodium activity|Y
photo-electric plethysmography|photo-plethysmography|Y
succinic dehydrogenase|succino-dehydrogenase|Y
minimum inhibitory concentration|minimal inhibition concentration|Y
multi-channel surface electromyography|multichannel surface electromyogram|Y
inositol hexakisphosphate|inositol hexaphosphate|Y
neuropeptide Y1 receptor|neuropeptide Y Y1 receptor|Y
oral-facial-digital syndrome type 1|oro-facio-digital syndrome type 1|Y
fluorescence imaging plate reader|fluorimetric imaging plate reader|Y
bryostatin|bryostatin 1|Y
T helper cell type 2|T helper type 2|Y
poly(ethylene-imine)|polyethylenimine|Y
Charcot-Marie-Tooth type X|Charcot-Marie-Tooth type X disease|Y
American Society of Anesthesiologists Status II|American Society of Anaesthesiology status II|Y
Clinical Global Impressions-Severity scale|Clinical Global Impressions Severity of Illness|Y
thoraco-lumbosacral orthosis|thoracolumbarsacral orthosis|Y
brain-specific angiogenesis inhibitor-3|brain angiogenesis inhibitor 3|Y
diethylaminoethanol|diethylaminoethyl|N
signal-averaged electrocardiography|signal-averaged electrocardiograms|Y
β-amyloid-1-42|amyloid β1-42|Y
metabotropic glutamate receptor type 7|metabotropic glutamate 7 receptor|Y
aluminum oxy-hydroxide|aluminum oxide hydroxide|Y
laterodorsal tegmentum|laterodorsal tegmental|Y
thyroid-stimulating-hormone|thyreo-stimulating hormone|Y
dorsal lateral prefrontal cortex|dorso-lateral prefrontal cortex|Y
parvalbumin|pre-albumin|N
cannabinoid 2 receptor|cannabinoid type 2 receptor|Y
large tumor antigen|tumor antigen|N
mean fluorescence intensity|mean fluorescent intensity|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor type 1|Y
histology activity index|histological activity index|Y
interleukin-13 receptor α1-chain|interleukin-13 receptor alpha 1|Y
antihuman lymphocyte globulin|anti-lymphocyte globulin|Y
human umbilical vein endothelium|human umbilical vein endothelial cell|Y
chondromyxoid fibroma|chondro-myxoid fibroma|Y
electron paramagnetic resonance spectroscopy|electron paramagnetic resonance|Y
primary hepatic cancer|primary hepatic carcinoma|Y
American Society of Anesthesiology status 5|American Society of Anesthesiology class V|Y
arteriolar smooth muscle cell|aortic smooth muscle cell|N
para-chloromercuriphenylsulphonic acid|parachloromercuriphenylsulfonate|N
triphenylethylene|tetraphenylethylene|N
Rho-guanine dinucleotide phosphate dissociation inhibitor 1|ρ-guanine nucleotide dissociation inhibitor 1|Y
leucylaminopeptidase|leucine aminopeptidase|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor-II mRNA binding protein 3|Y
cyclic guanosinemonophosphate|cyclic guanosylmonophosphate|Y
central vein stenosis|central venous stenosis|Y
mouse T-cell-associated serine proteinase 1|murine T-cell associated serine proteinase-1|Y
tri-iodo benzoic acid|triiodobenzoic acid|Y
recombinant follicle-stimulating hormone|follicle-stimulating hormone|N
computed tomographic arteriography|computed tomography angiography|Y
4-item Patient Health Questionnaire|Patient Health Questionnaire 4|Y
postvoid residual urine volume|postvoid residual bladder volume|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiologists status IV|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor II mRNA-binding protein 1|Y
epithelial mesenchymal transition|epithelial mesenchymal transformation|Y
telomere repeat binding factor 1|telomeric repeat binding factor 1|Y
transient receptor potential vanilloid receptor 1|transient receptor potential vanilloid type 1 receptor|Y
recombination activating gene-1|recombination-activating gene-1|Y
American Society of Anaesthesiology status IV|American Society of Anaesthesiologists status IV|Y
recombinant tissue-type plasminogen activator|recombinant tissue plasminogen activator|Y
digoxinlike immunoreactive factor|Digoxin-like immunoreactive factor|Y
receptor protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-α|Y
native|negative|N
electroencephalogram|electro-encephalogram|Y
maximum velocity value|maximal velocity value|Y
randomly amplified polymorphic DNA|random amplified polymorphic DNA analysis|Y
gonad-inhibiting hormone|growth inhibiting hormone|N
four-and-a-half LIM domain protein-2|four-and-a-half-LIM-only protein 2|Y
volume-regulated anion channels|volume regulated anion channel|Y
Insulin-like growth factor-II|insulin-like growth factor 2|Y
α-1 protease inhibitor|α 1 proteinase inhibitor|Y
phosphorylated cAMP-response element binding protein|phosphorylated cyclic AMP responsive element binding protein|Y
ambulatory surgery center|ambulatory surgical center|Y
magnetic resonance spectroscopic imaging|magnetic resonance spectroscopy imaging|Y
post-transplant|posttransplantation|Y
dimethyl-aminostyryl-methylpyridinium iodine|2-(4-dimethylaminostyryl)-1-methylpyridinium iodide|Y
American Society of Anesthesiologists Status II|American Society of Anaesthesiologists class II|Y
structure|structural|Y
fragile X mental retardation gene 1|fragile X mental retardation 1|N
relative operating characteristic|receiver operator characteristic|Y
vanilloid receptor|vanilloid receptor type 1|Y
Choristoneura fumiferana nuclear polyhedrosis virus|Choristoneura fumiferana multicapsid nucleopolyhedrovirus|Y
glycerol 3 phosphate acyltransferase|glycerophosphate acyltransferase|Y
sterol response element binding protein 1|sterol regulatory element binding protein 1|Y
metabotropic glutamate receptor 5|metabotropic glutamate receptor subtype 5|Y
α1 foetoprotein|α-feto protein|Y
medical intensive care unit|intensive care unit|Y
metabotropic glutamate receptor type 1|group 1 metabotropic glutamate receptor|Y
lymphocyte function-associated antigen 3|lymphocyte function-associated antigen-3|Y
iodine deficiency|iron deficiency|N
pea seed-borne mosaic potyvirus|pea seedborne mosaic virus|Y
transforming growth factor beta type II receptor|type II transforming growth factor-beta receptor|Y
immunoglobulin γ2|immunoglobulin G2|Y
inhibition constant|inhibitor constant|Y
hydroxy-propyl-β-cyclodextrin|hydroxypropylcyclodextrin|Y
tuberculosis|tuberculous|Y
metabotropic glutamate receptor subtype 5|metabotropic glutamate 5 receptor|Y
trivalent oral polio vaccine|trivalent oral poliovaccine|Y
insulin sensitivity|insulin sensitivity index|N
Epstein-Barr virus nuclear antigen 1|Epstein-Barr nuclear antigen-1|Y
focal segmental glomerulosclerosis|focal segmental glomerular sclerosis|Y
erythrosinisothiocyanate|erythrosin 5'-isothiocyanate|Y
muscle RING finger protein 1|muscle RING finger 1|Y
American Society of Anaesthesiology status IV|American Society of Anaesthesiologists Class IV|Y
dural arterio-venous fistula|dural arteriovenous fistula|Y
nonhistone chromosomal protein|nonhistone chromatin protein|Y
zonula occludens 2|zonula occludens protein 2|Y
metabotropic glutamate 1 receptor|metabotropic glutamate receptor 1|Y
photocatalytic oxidation|photo-catalytic oxidation|Y
mesenteric nerve stimulation|median nerve stimulation|N
outcome-based quality improvement|Outcome-Based Quality Improvement|Y
metabotropic glutamate 5 receptor|metabotropic glutamate receptor type 5|Y
human immunodeficiency virus type I|human immunodeficiency virus type 1|Y
peroxisome-targeting signal type 1|peroxisome-targeting signal-1|Y
2,3,7,8-tetrachlorodibenzo-p-dioxin|tetrachlorodibenzo-p-dioxin|Y
methemoglobin|methemoglobinemia|N
possibly|possible|Y
pathologic stage T3|pathologic tumor stage 3|Y
glutamic acid decarboxylase|glutamic acid decarboxylase antibody|N
American Society of Anesthesiology|American Society of Anesthesiologists|Y
intact parathormone|intact parathyroid hormone|Y
hyperlipoproteinemic|hyperlipoproteinemia|Y
cannabinoid type 2 receptor|cannabinoid receptor 2|Y
organophosphate nerve agent|organophosphorus nerve agent|Y
thermogravimetry-mass spectrometry|thermogravimetry-mass spectroscopy|Y
adenovirus 12 E1B|adenovirus type 12 E1B|Y
glucopyranoside|glucopyranosyl|N
antineutrophil cytoplasm antibody|antineutrophil cytoplasmic antibody|Y
random amplified polymorphic DNA method|randomly amplified polymorphic DNA method|Y
united states public health service|United States Public Health Service|Y
human platelet antigen 1|human platelet alloantigen 1|Y
murine γ-herpesvirus-68|murine gammaherpesvirus 68|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiologists status IV|Y
risperidone long acting injection|risperidone long acting injectable|Y
Estimated annual percent change|estimated annual percent change|Y
previous|previously|Y
cranial computed tomography scan|chest computed tomography scan|N
arteriosclerotic vascular disease|arteriosclerotic cardiovascular disease|Y
acute respiratory insufficiency|acute renal insufficiency|N
left ventricular diastolic dysfunction|left ventricular enddiastolic dimension|N
Proteinase-activated receptor-2|protease-activated receptor 2|Y
methyltetrahydrofuran|methyltetrahydrofolate|N
Pneumocystis carinii pneumonia|Pneumocystis carinii pneumonitis|Y
open state probability|open probability|Y
hypoxic response element|hypoxia response element|Y
trans-hiatal oesophagectomy|transhiatal esophagectomy|Y
xenotropic murine leukemia virus|xenotropic murine leukaemia virus-related virus|Y
10th thoracic vertebra|thoracic vertebra 10|Y
Pathogen-associated molecular patterns|pathogen associated molecular pattern|Y
intra-membrane particle|intramembranous particle|Y
Cockayne syndrome group B protein|Cockayne syndrome group B|N
anti-galactocerebroside|galactocerebroside|N
electrospray ionisation mass spectrometry|electrospray mass spectrometry|Y
anti-matrix metalloprotease 3 antibody|anti-matrix metallopeptidase 3 antibody|Y
interleukin 4 receptor alpha|interleukin 4 receptor alpha subunit|Y
percutaneous nephrolitholapaxy|percutaneous nephrolithotomy|Y
second transmembrane segment|transmembrane segment 2|Y
retinoid X receptor gamma|rexinoid receptor gamma|Y
GTP binding protein beta subunit|G protein beta subunit|Y
neuropeptide Y2 receptor|neuropeptide Y Y2 receptor|Y
oto-acoustic emission|oto acoustic emission test|N
precipitate|precipitation|N
epithelial membrane protein|external membrane protein|N
xenotropic murine leukemia virus|xenotropic murine leukaemia-related virus|Y
small ubiquitin-like modifier|small ubiquitin-related modifier|Y
medical|medial|N
multi-drug-resistance 1|multidrug resistance gene 1|N
American Society of Anesthesiologists physical status 2|American Society of Anaesthesiologists status II|Y
human adenovirus 49|human adenovirus type 49|Y
human adenovirus 18|human adenovirus type 18|Y
left anterior descending coronary artery|left descending coronary artery|N
organophosphorus ester-induced delayed neuropathy|organophosphorus-induced delayed neurotoxicity|Y
high threshold|hearing threshold|N
American Society of Anaesthesiologists grade 4|American Society of Anaesthesiologists Class IV|Y
high temperature requirement factor A|high temperature requirement A|Y
anti-beta 2-glycoprotein-I antibody|anti-beta2-glycoprotein I antibodies|Y
maximal urine osmolality|maximum urine osmolality|Y
basic multi-cellular unit|basic multicellular unit|Y
minimum effective concentration|median effective concentration|N
human adenovirus 21|human adenovirus serotype 21|Y
blast crisis|blastic crisis|Y
triphenyltetrazolium chloride|2,3,5-triphenyltetrazolium chloride|Y
neurofibromatosis type 2|neurofibromatosis 2|Y
apolipoprotein AI|apolipoprotein A1|Y
xanthin|xanthosine|N
lateralisation index|laterality index|Y
Venezuelan equine encephalomyelitis|Venezuelan equine encephalitis virus|N
X-ray photoelectron spectrum|xray photoelectron spectroscopy|N
Streptococcus salivarius strain K12|Streptococcus salivarius K12|Y
ischemia reperfusion|ischemic reperfusion|Y
secreted aspartic proteinase|secreted aspartyl proteinase|Y
human adenovirus serotype 7|human adenovirus type 7|Y
Stern-Volmer quenching constant|Stern-Volmer constant|Y
American Society of Anaesthesiology physical status 4|American Society of Anesthesiologists physical status IV|Y
Trait Anxiety Inventory|Anxiety Inventory|N
branched-chain α-ketoacid dehydrogenase|branched-chain α-keto acid dehydrogenase complex|Y
dichlorotriazinylaminofluorescein|dichlortriazinyl aminofluorescein|Y
adaptive optics scanning laser ophthalmoscopy|adaptive optics scanning laser ophthalmoscope|Y
macrocreatine kinase type 1|macromolecular creatine kinase type 1|Y
B cell lymphocyte kinase|B lymphocyte kinase|Y
Lentinus edodes|Lentinula edodes|Y
hexamethylphosphoramide|hexamethylphosphoric triamide|Y
x-ray repair cross-complementing gene 1|x-ray cross-complementing gene 1|Y
gold sodium thiomalate|gold sodium aurothiomalate|Y
prostaglandin type E|prostaglandin E|Y
supplement|supplementary|N
spontaneous fibrillation|spontaneous fluctuation|N
pulmonary arterial systolic pressure|pulmonary artery systolic pressure|Y
human T-cell lymphotropic virus-I antibody|human T-cell lymphotropic virus type-I antibody|Y
computer assisted sperm analysis|computer-aided sperm analysis|Y
National Health Insurance|National Health Index|N
glyceryltrierucate|glyceroyl trierucate|Y
combination oral contraceptive|combined oral contraceptive|Y
frontal midline theta activity|frontal midline theta|Y
gammaglutamyltranspeptidase|gammaglutamyltransferase|Y
Equid herpesvirus 1|equine herpesvirus 1|Y
quantitative reverse transcriptase polymerase chain reaction assay|quantitative reverse transcription polymerase chain reaction assay|Y
metabotropic glutamate receptor 7|metabotropic glutamate receptor type 7|Y
sustained virologic responder|sustained virologic response|Y
American Society of Anesthesiologists physical status II|American Society of Anaesthesiology class II|Y
giant cell interstitial pneumonitis|giant cell interstitial pneumonia|Y
receptor protein tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase κ|Y
guanylate cyclase-activating protein-1|guanylyl cyclase activating protein 1|Y
log reduction factor|logarithmic reduction factor|Y
aminopeptidase M|amino-peptidase M|Y
T cell receptor CD3 complex|T cell antigen receptor-CD3 complex|Y
human adenovirus type 41|human adenovirus 41|Y
beta-N-Methylamino-L-alanine|beta-methylamino-alanine|Y
keratoderma hereditarium mutilans|keratoderma hereditaria mutilans|Y
International Commission on Radiological Units and Measurements|International Commission on Radiation Units and Measurements|Y
ubiquitin carboxyterminal hydrolase L1|ubiquitin carboxy-terminal hydrolase L-1|Y
paradoxical sleep deprivation|partial sleep deprivation|N
B cell chronic lymphoid leukemia|B cell chronic lymphocytic leukemia|Y
Schedule for Affective Disorders and Schizophrenia Lifetime Version|Schedule of Affective Disorders and Schizophrenia-Lifetime Version|Y
hypothyroidism|hyperthyroidism|N
pseudo-exfoliation syndrome|pseudoexfoliation syndrome|Y
three dimensional ultrasound|three dimensional ultrasonography|Y
post transplantation lymphoproliferative disorders|post-transplantation lymphoproliferative disorder|Y
high voltage-activated|high-voltage-activated|Y
small intestine|small intestinal|Y
anti-tuberculosis|antituberculosis|Y
apolipoprotein E|apolipoprotein E4|N
peripheral artery tonometry|peripheral arterial tone|N
pancreatogastrostomy|pancreaticogastrostomy|Y
sitting diastolic blood pressure|supine diastolic blood pressure|N
killer cell immunoglobulinlike receptor|killer immunoglobulin receptor|Y
activating transcription factor 4|activating transcription factor-4|Y
matrix metalloproteinase 9|matrix metalloprotease 9|Y
phosphorylated cyclic AMP response element binding protein|phospho-cAMP response element binding protein|Y
Gibbs free energy|Gibbs energy|Y
microphthalmia transcription factor|microphthalmia-associated transcription factor|Y
bacterial complex|bacterial antigen complex|N
human adenovirus type 26|human adenovirus serotype 26|Y
telomerase-associated protein|telomerase-associated protein-1|Y
Wechsler Memory Scale-3rd Edition|Wechsler Memory Scale-Third Edition|Y
accelerated solvent extractor|accelerated solvent extraction|N
A disintegrin and metalloproteinase 13|A disintegrin and metalloprotease 13|Y
nephrocalcinosis|nephrocalcin|N
octadecylrhodamine B|octadecylrhodamine B chloride|Y
proliferating cellular nuclear antigen|proliferative cell nuclear antigen|Y
vanilloid receptor subtype 1|vanilloid receptor 1|Y
squamous carcinoma|sebaceous carcinoma|N
organophosphorus-induced delayed neuropathy|organophosphorus ester-induced delayed neurotoxicity|Y
prostate acid phosphatase|prostate specific acid phosphatase|Y
pulsed dye laser|pulsed-dye laser|Y
pulmonary artery-occluded pressure|pulmonary artery occlusion pressure|Y
randomly amplified polymorphic DNA analysis|random amplified polymorphic DNA analysis|Y
dideazatetrahydrofolic acid|dideazatetrahydrofolate|N
polyadenylate binding protein 2|polyA binding protein 2|Y
type 2 T helper cell|type 2 helper T cell|Y
American Society of Anaesthesiology grade I|American Society of Anesthesiologists Status I|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metallopeptidase 3 antibody|Y
staging laparotomy|staging laparoscopy|N
jugular venous plasma|jugular venous pulsation|N
fine needle aspiration cytology|fineneedle aspiration|Y
hypophysectomy|hypophysectomise|Y
normal rat kidney cell|normal rat kidney|N
jugular venous plasma|jugular venous pulse|N
electrothermal atomic absorption spectrometric|electro-thermal atomization atomic absorption spectrometry|Y
adenosine triphosphate sensitive potassium channel|adenosine triphosphate dependent potassium channel|Y
fractional shortening|functional shortening|N
ventilator acquired pneumonia|ventilator-associated pneumonia|Y
anti-cyclic citrullinated peptide antibody|anti-cyclic citrullinated peptide|Y
standardized ileal digestible|standardised ileal digestibility|Y
human adenovirus serotype B|human adenovirus type B|Y
computed tomographic coronary angiography|computed tomography coronary angiography|Y
surface enhanced Raman spectrometry|surface enhanced Raman scattering|Y
computer tomographic scan|computed tomographic scanning|Y
cannabinoid receptor 1|cannabinoid receptor type 1|Y
American Society of Anesthesiology Class III|American Society of Anesthesiologists Status 3|Y
esophageal squamous cell cancer|esophageal squamous cell carcinoma|Y
type II bone morphogenetic protein receptor|bone morphogenetic protein receptor type 2|Y
laser-induced interstitial thermo-therapy|laser interstitial thermal therapy|Y
nicotinamide adeninedinucleotide|oxidized nicotinamide adenine dinucleotide|N
vesicular stomatitis virus G|vesicular stomatitis virus glycoprotein G|Y
neurokinin1 receptor|neurokinin type 1 receptor|Y
respiratory related unit|respiration related unit|Y
fluid percussion brain injury|fluid percussion injury|Y
simian T lymphotropic virus type 3|simian T-cell lymphotropic virus type III|Y
cell adhesion molecule L1|L1 cell adhesion molecule|Y
classic anti-neutrophil cytoplasmic antibody|cytoplasmic antineutrophil cytoplasmic antibody|Y
glycosylphosphatidyl inositol linked|glycophosphatidyl inositol linked|Y
vibrating-sample magnetometer|vibrating-sample magnetometry|Y
American Society of Anesthesiology grade 2|American Society of Anaesthesiology status II|Y
mouse Leydig tumor cell|mouse Leydig tumor cell line 1|N
beta-melanocyte stimulating hormone|beta melanocyte-stimulating hormone|Y
cAMP dependent protein kinase|cyclic AMP dependent protein kinase|Y
leri weill dyschondrosteosis|Leri-Weill dyschondrosteosis|Y
Acinetobacter anitratus|Achromobacter anitratus|Y
random-amplified polymorphic DNA analysis|random-amplified polymorphic DNA|Y
frequency doubling technology perimetry|frequency doubling technology|Y
in-situ hybridization histochemistry|situ hybridization histochemistry|Y
Clinical Laboratory Standards Institute guideline|Clinical and Laboratory Standards Institute guideline|Y
tumor control dose|tumor control dose 50%|Y
DNA fragmentation factor|DNA fragmentation factor 45|N
fragile X mental retardation protein 1|fragile X mental retardation 1 protein|Y
proportional mortality ratios|proportionate morbidity ratio|N
intra-tracheal tube|intratracheal|N
GTP binding protein gamma subunit|G protein gamma subunit|Y
human adenovirus type 28|human adenovirus 28|Y
iron deficiency|immune deficiency|N
proton-induced X-ray emission|proton induced X-ray emission analysis|Y
bone morphogenetic protein|bone morphogenic protein|Y
transverse rectus abdominis musculocutaneous flap|transverse rectus abdominis muscle flap|Y
alanine-specific transfer RNA|alanine-specific tRNA|Y
micro-vascular endothelial cell|microvascular endothelial cell|Y
activating protein-1 binding|activation protein 1 binding|Y
energy dispersive spectrometer|energy dispersive spectrometry|Y
ventral intermediate nucleus|ventral intermediate|Y
rapid viral response|rapid virological response|Y
signal transducer and activator of transcription 3|signal transducer and activator of transcription-3|Y
28 item General Health Questionnaire|General Health Questionnaire 28|Y
non-ST elevation acute coronary syndrome|non-ST segment elevation acute coronary syndrome|Y
human T-cell lymphoma/leukemia virus type 1|human T cell leukemia virus type 1|Y
American Society of Anaesthesiology physical status II|American Society of Anaesthesiologists class II|Y
Wechsler Intelligence Scale for Children-Revised|Wechsler Intelligence Scale for Children Revised|Y
liquid chromatographic|liquidchromatography|Y
embryonic carcinoma cell line|embryonal carcinoma cell line|Y
uridinetriphosphate|uridine-5'-triphosphate|Y
human adenovirus serotype 38|human adenovirus type 38|Y
ubiquitin carboxyterminal hydrolase L1|ubiquitin carboxyl-terminal hydrolase-L1|Y
magnetic resonance spectroscopy|phosphorus 31 magnetic resonance spectroscopy|N
tracheoinnominate fistula|tracheoinnominate artery fistula|Y
intra-cytoplasmic sperm injection|intracytoplasmic sperm injection|Y
American Society of Anaesthesiology status IV|American Society of Anesthesiologists Status IV|Y
intrauterine transfusion|intra-uterine transfusion|Y
rat basophilic leukemia 2H3 cell line|rat basophilic leukemia cell|N
mean blood velocity|mean velocity|N
chromodomain helicase DNA binding protein 1-like|chromodomain helicase/ATPase DNA binding protein 1-like|Y
pulmonary intersticial emphysema|perinatal pulmonary interstitial emphysema|N
American Society of Anaesthesiologists Class IV|American Society of Anesthesiology grade 4|Y
interpregnancy interval|interpeak interval|N
eukaryotic translation elongation factor 1alpha|eucaryotic elongation factor 1alpha|Y
asparaginylendopeptidase|asparagine endopeptidase|Y
American Society of Anesthesiology Grade 1|American Society of Anesthesiologists Grade 1|Y
nordihydroguaiaretic acid|nor-dihydroguaiaretic acid|Y
video-assisted thoracoscopic surgery|video-assisted thoracic surgical|Y
transient receptor potential vanilloid 3|transient receptor potential vanilloid type 3|Y
phosphatidylinositol specific phospholipase C|phosphoinositide specific phospholipase C|Y
phospholipase A1|phospholipase A|N
orexin type 2 receptor|orexin2 receptor|Y
periarterial nerve stimulation|peripheral nerve stimulation|N
botulinum neurotoxin A|botulinum neurotoxin type A|Y
Epstein-Barr nuclear antigen|Epstein-Barr virus nuclear antigen|Y
cyclic guanosinemonophosphate|cyclic guanosine 3',5'-monophosphate|Y
cytopathogenic|cytopathic|Y
phosphatidylinositide|phosphatidylinositol|Y
instalment|instant|N
light harvesting chlorophyll a/b binding protein II|light harvesting chlorophyll protein II|Y
human adenovirus type 39|human adenovirus serotype 39|Y
anti-oestrogen binding site|antiestrogen binding site|Y
white man|white male|Y
electrothermal atomic absorption spectrometry|electrothermal atomic absorption spectroscopy|Y
nitrate reductase assay|nitrate reductase activity|N
computed tomography dose index volume|computed tomographic dose index volume|Y
radioactive iodinated serum albumin|radio-iodinated serum albumin|Y
aminoterminal pro-brain-type natriuretic peptide|amino-terminal pro-B-type natriuretic peptide|Y
pulmonary artery catheterisation|pulmonary artery catheter|N
thyroid hormone response element|thyroid response element|Y
high-resolution computed tomography|high resolution computerized tomography|Y
ventrolateral medullary surface|ventral medullary surface|N
perfluoro-octanoic acid|perfluorooctanoic acid|Y
radiation induced fibrosarcoma|radiation-induced fibrosarcoma|Y
tubulointerstitial fibrosis|tubulo-interstitial fibrosis|Y
American Society of Anaesthesiology status IV|American Society of Anesthesiologists physical status IV|Y
acidic sphingomyelinase|acid sphingomyelinase|Y
liver cell membrane autoantibody|liver membrane autoantibody|Y
widow|widower|N
special care nursery|special care nursing|N
uroporphyrinogen synthase|uroporphyrinogen I synthetase|Y
Golgi endoplasmic reticulum lysosome|Golgi-associated endoplasmic-reticulum-lysosome|Y
Newly Independent States|New Independent States|Y
interleukin-6 receptor α chain|interleukin-6 receptor alpha|Y
eukaryotic elongation factor 1A|eukaryotic translation elongation factor 1A|Y
matrix metalloproteinase 3|matrix metalloprotease 3|Y
occlusion derived virus|occlusion-derived virion|Y
dopamine responsive dystonia|dopa responsive dystonia|Y
citrated platelet-rich plasma|concentrated platelet rich plasma|N
obstetric brachial plexus palsy|brachial plexus palsy|N
transmission electron microscope|transmission electron microscopic|Y
non-contact tonometry|non-contact tonometer|Y
Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
computerized axial tomography scan|computed tomography scan|Y
procollagen III peptide|procollagen type III peptide|Y
killer immunoglobulin-like receptor|killer cell immunoglobulinlike receptor|Y
pulmonary artery|pulmonary arterial|Y
relapsing-remitting experimental autoimmune encephalomyelitis|relapsing remitting experimental allergic encephalomyelitis|Y
Choristoneura fumiferana nuclear polyhedrosis virus|Choristoneura fumiferana nucleopolyhedrovirus|Y
immuneglobulin|immunoglobulin|Y
nuclear spin lattice relaxation rate|nuclear spin lattice relaxation|N
single cell gel electrophoresis|single cell gel electrophoresis assay|Y
pulmonary arterial pressure|pulmonary artery pressure|Y
tissue culture infective dose|50% tissue culture infectious dose|Y
thymidine monophosphate|thiamine monophosphate|N
B cell precursor acute lymphoblastic leukemia|precursor B acute lymphoblastic leukemia|Y
gamma-amino butyric acid type B receptor|gamma-amino butyric acidB receptor|Y
human papillomavirus type 16 E5|human papillomavirus type 16 E5 protein|Y
transient receptor potential vanilloid type 1|transient receptor potential vanilloid 1|Y
emergency medical technician|emergency medical team|N
auto-immune polyendocrinopathy-candidiasis-ectodermal dystrophy|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome|Y
angiotensin-converting enzyme 2|angiotensin-converting enzyme type 2|Y
anti-CTLA-4 Ab|anti-CTLA-4 mAb|Y
total internal reflection fluorescence microscopy|total internal reflection fluorescence microscope|Y
type-β transforming growth factor|transforming growth factor-beta|Y
quantitative electroencephalography|quantitative electroencephalographic|Y
Anatomical Therapeutic Chemical Classification|Anatomical Therapeutic Chemical Classification System|Y
volume computed tomographic dose index|volume weighted computed tomography dose index|Y
dengue virus 1|dengue 1 virus|Y
cardiovascular|cardio-vascular|Y
metabotropic glutamate receptor subtype 4|metabotropic glutamate receptor type 4|Y
histidine-proline-rich glycoprotein|Histidine-proline-rich glycoprotein|Y
x linked severe combined immunodeficiency|X-linked severe combined immunodeficiency disease|Y
murine Leydig tumor cell|murine Leydig tumor cell line 1|N
N terminal probrain natriuretic peptide|N-terminal pro-brain type natriuretic peptide|Y
cyclin dependent kinase inhibitor 1B|cyclin dependent kinase inhibitor p27|Y
rexinoid receptor|retinoic acid receptor|N
Ebola virus subtype Reston|Ebola virus Reston|Y
American Society of Anaesthesiologists Class IV|American Society of Anesthesiologists Status IV|Y
total oxyradical scavenging capacity|Total Oxyradical Scavenging Capacity|Y
Canavalia ensiformis|Concanavalia ensiformis|Y
continuously stirred tank reactor|continuous stirred-tank reactor|Y
systemic artery pressure|systemic arterial pressure|Y
tetrachlorodibenzofuran|2,3,7,8-tetrachlorodibenzofuran|Y
multi-drug resistance protein 1|multidrug resistance-associated protein 1|Y
toluene-o-xylene monooxygenase|toluene/ortho-xylene monooxygenase|Y
cytochrome oxidase 1|cytochrome c oxidase 1|Y
guanylatecyclase C|guanylylcyclase C|Y
ryanodine receptor type 2|ryanodine receptor 2|Y
reverse transcription polymerase chain reaction analysis|reverse transcriptase polymerase chain reaction analysis|Y
medullary thyroid carcinoma|medullary thyroid cancer|Y
upper motoneuron|upper motor neuron|Y
apoptosis signal regulating kinase 1|Apoptosis signal-regulating kinase 1|Y
human diploid cell rabies vaccine|human diploid cell vaccine|Y
multi-drug resistant|multi-drug resistance|Y
Brief Michigan Alcohol Screening Test|brief michigan alcoholism screening test|Y
vasopressin V2 receptor agonist|vasopressin 2 receptor agonist|Y
dihexanoylphosphatidylcholine|dihexadecylphosphatidylcholine|N
porcine pancreas lipase|porcine pancreatic lipase|Y
Mini Mental State Evaluation|Mini Mental Status Examination|Y
feminiser|feminine|N
adenylyl-imido diphosphate|5'-adenylylimido-diphosphate|Y
prostaglandin endoperoxide synthase|prostaglandin endoperoxide synthetase|Y
endothelial constitutive nitric oxide synthase|endothelial cell nitric oxide synthase|Y
tertbutylhydroperoxide|tertiary butylhydroperoxide|Y
adenylate cyclase 8|adenylylcyclase 8|Y
computed tomographic pulmonary angiography|computed tomography pulmonary angiography|Y
Fellow of the Royal College of Physicians of Ireland|Fellow of the Royal College of Physicians in Ireland|Y
dopamine D2 receptor|dopamine 2 receptor|Y
anti-human immunodeficiency virus 1 activity|anti-human immunodeficiency virus type 1 activity|Y
endothelial nitric oxide synthase|endothelial cell nitric oxide synthase|Y
excision repair cross complementing-4|excision repair cross complementation group 4|Y
lympho-vascular invasion|lymphatic vascular invasion|Y
globus pallidus internus|globus pallidus internalis|Y
proportional mortality ratios|proportionate mortality ratio|Y
electrothermal atomic absorption spectrophotometry|electrothermal atomic absorption spectroscopy|Y
transcriptional enhancer factor 1|transcription enhancer factor 1|Y
Na+/H+ exchanger|Na+/H+ exchangers|Y
oxidized frying oil|oxidised frying oil|Y
proprotein convertase subtilisin kexin 9|proprotein convertase subtilisin kexin type 9|Y
hexamethylpropyleneamineoxime|99mTc-hexamethylpropyleneamineoxime|N
anti-tuberculous therapy|anti-tuberculosis therapy|Y
rapid plasmin reagin|rapid plasma reagin test|Y
computed tomographic arteriography|computed tomographic angiography|Y
forkhead box class O2|forkhead box O2|Y
pro-collagen type III peptide|procollagen III peptide|Y
translesion DNA synthesis|translesion synthesis|Y
paraminohippuric acid|para aminohippuric acid|Y
fragile X mental retardation 1 gene|fragile X mental retardation 1|N
supraomohyoid neck dissection|supra-omohyoid neck dissection|Y
insulin-like growth factor receptor type II|insulinlike growth factor 2 receptor|Y
50% tumor control dose|tumor control dose 50%|Y
American Society of Anaesthesiology class V|American Society of Anesthesiologists status 5|Y
hereditary angioneurotic edema|hereditary angio-neurotic œdema|Y
high resolution transmission electron microscopic|high-resolution transmission electron microscope|Y
Australian Medical Association|American Medical Association|N
protein phosphatase 1|protein phosphatase type 1|Y
gamma aminobutyric acidA|gamma-aminobutyric acidA|Y
desoxypyridoxine|deoxypyridinoline|N
maximal M wave|maximum M wave|Y
N-terminal-proB-type natriuretic peptide|N-terminal pro-brain-type natriuretic peptide|Y
Janus kinase|Janus kinase 2|N
carbapenem resistant Acinetobacter baumannii|carbapenem-resistant A. baumannii|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists Status I|Y
complement component C4b binding protein|complement C4b binding protein|Y
erythroblast transformation specific transcription factor|E26 transformation specific transcription factor|Y
human chorionic gonadotropin β-subunit|human chorionic gonadotropin beta|Y
grade 2 cervical intraepithelial neoplasia|cervical intraepithelial neoplasia 2|Y
ultrasound biomicroscope|ultrasound biomicroscopy|Y
Beck Depression Inventory 2|Beck Depression Inventory 2nd edition|Y
pulmonary artery occlusion|pulmonary arterial occlusion|Y
mean blood velocity|mean flow velocity|N
Sesbania mosaic virus|soybean mosaic virus|N
human adenovirus type 44|human adenovirus serotype 44|Y
cyclic guanosine 3',5'-monophosphate|cyclic guanosylmonophosphate|Y
attenuated total reflection-Fourier transform infrared spectroscopy|attenuated total reflectance-Fourier transform infra red spectroscopy|Y
a disintegrin and metalloprotease-33|a disintegrin and metalloproteinase 33|Y
standard dose|standard diet|N
Disease Activity Score in 28 joints|Disease Activity Score 28|Y
gastro-duodenal ulcer|gastroduodenal ulcer|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor-II mRNA-binding protein-2|Y
monoamino oxidase A|monoamineoxidase|N
American Society of Anaesthesiology Grade V|American Society of Anesthesiologists status 5|Y
rostral ventral medulla|rostral ventromedial medulla|N
gonadotrophin surge attenuating factor|gonadotrophin surge-attenuating factor|Y
interferon producing cell|interferon-α producing cell|N
Psychotria hawaiiensis|Pichia hawaiiensis|N
N-acetylserotonin O-methyl transferase|acetylserotonin methyltransferase|Y
vasoactive intestinal polypeptide immunoreactivity|vasoactive intestinal polypeptide immunoreactive|Y
General Health Questionnaire|30 item General Health Questionnaire|Y
Milled wood lignin|milled wood lignin|Y
interleukin 1 receptor type II|interleukin 1 receptor 2|Y
cyclobutyl pyrimidine dimer|cyclobutane pyrimidine dimer|Y
obstructive airway disease|obliterative airway disease|N
clinical target volume|clinical tumor volume|Y
estrogen receptor α knockout|oestrogen receptor-α knockout mouse|Y
American Society of Anesthesiologists Status 1|American Society of Anesthesiologists physical status I|Y
upstream repression sequence 1|upstream repression sequence|Y
IL-13 receptor alpha 1 chain|IL-13 receptor alpha 1|Y
American Optometric Association|American Orthopedic Association|N
major histocompatibility complex class I protein|major histocompatability complex class 1|Y
6-keto-prostaglandin F1 alpha|prostaglandin F1alpha|N
isolated perfused rat livers|isolated perfused rat liver|Y
optical density|optic density|Y
p-nitroanisole|p-nitroaniline|N
transient receptor potential channel 1|transient receptor potential channel-related protein 1|N
planning target volume|planning treatment volume|Y
Nociceptin/orphanin FQ|nociceptin/orphanin FQ|Y
ventral posteromedial thalamic nucleus|ventral posterior medial nucleus|Y
respiratory disturbance index|respiratory distress index|Y
individual participant data|individual patient data|Y
transient receptor potential channel 3|transient receptor potential canonical type 3|Y
computed tomography colonography|computed-tomographic colonography|Y
A disintegrin and metalloproteinase-13|a disintegrin and metalloprotease-13|Y
external beam radiation therapy|external beam radiotherapy|Y
end stage liver disease|endstage lung disease|N
sine oculis homeobox homolog 3|sine oculis homeobox 3|Y
transmembrane domain 6|sixth transmembrane domain|Y
interleukin 3 receptor α-chain|interleukin 3 receptor alpha|Y
p-chloromercuriphenylsulfonic acid|para-chloromercuriphenylsulphonic acid|Y
dengue 1 virus|dengue virus 1|Y
hereditary breast/ovarian cancer syndrome|hereditary breast and ovarian cancer syndrome|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists Class III|Y
orthoiodohippurate|131I-orthoiodohippurate|N
unfolded protein response pathway|unfolded protein response|Y
facioscapulohumeral muscular dystrophy|facio-scapulo-humeral dystrophy|Y
glutamic acid decarboxylase|glutamate decarboxylase|Y
aortic valve regurgitation|aortic regurgitation|Y
human umbilical vein endothelial|human umbilical vein endothelium|Y
Zygowilliopsis californica|Zygowillopsis californica|Y
dengue hemorrhagic fever|dengue hæmorrhagic fever|Y
internal transcribed spacer region|internally transcribed spacer|Y
American Society of Anesthesiologists Class 1|American Society of Anaesthesiologists status I|Y
urinary output|urine output|Y
survival fraction|surviving fraction|Y
upstream activator sequence 2|upstream activating sequence 2|Y
autoimmune polyendocrine syndrome type 2|autoimmune polyglandular syndrome type 2|Y
maximal power output|maximum power output|Y
class II-associated invariant chain-derived peptide|class II-associated invariant chain peptide|Y
total frequency|temporal frequency|N
Recommended Nutrient Intake|recommended nutrient intake|Y
L-phenylalanine mustard|l-phenylalanine mustard|Y
chronic aggressive hepatitis|chronic active hepatitis|Y
tetratricopeptide repeat|tetratricopeptide|Y
genetic diversity|gene diversity|Y
platelet-derived growth factor B|platelet-derived growth factor B-chain|Y
human growth hormone receptor|human growth hormone recombinant|N
instrument|instrumental|N
insulin-like growth factor II messenger RNA binding protein 2|insulin-like growth factor-II mRNA-binding protein-2|Y
lower respiratory illness|lower respiratory tract illness|Y
jugular venous pulse|jugular vein pulse|Y
peroxyacetic acid|phenylacetic acid|N
guanylate cyclase-activating protein 1|Guanylate cyclase-activating protein 1|Y
tissue plasminogen activator antigen|tissue-type plasminogen activator-antigen|Y
urinary stress incontinence|urodynamic stress incontinence|N
myosin II heavy chain kinase B|myosin heavy chain kinase B|Y
glucuronic acid|glucaric acid|N
pro-brain natriuretic peptide level|pro-B-type natriuretic peptide level|Y
umbilical cord blood transplantation|unrelated cord blood transplantation|N
plasmin inhibitor plasmin complex|α2 plasmin inhibitor/plasmin complex|Y
tryptophan|L-tryptophan|Y
chromophoric dissolved organic matter|colorued dissolved organic matter|Y
infrared multiple photon dissociation spectroscopy|infrared multiphoton dissociation spectroscopy|Y
pattern electroretinogram|pattern electroretinography|Y
liquid crystal polymer|liquid crystalline polymer|Y
A disintegrin and metalloproteinase-3|A disintegrin and metalloprotease 3|Y
fluorescent-activated cell-sorting|fluorescence-activated cell scanning|Y
American Endodontic Society|American Endocrine Society|N
corneal epithelial cell|colonic epithelial cell|N
betaglycerophosphate|beta-glycerophosphatase|N
electrical field stimulation|electric field stimulation|Y
airway pressure|mean airway pressure|N
continuous veno-venous haemodialysis|continuous venovenous hemodiafiltration|N
radium|radius|N
Assisted reproductive technologies|assisted reproductive technology|Y
lymphocyte function-associated antigen-3|leukocyte-function-associated antigen-3|Y
stimulatory G protein alpha subunit|stimulatory G protein alpha|Y
longissimus thoracis muscle|longissimus thoracis|Y
mitogen-activated protein kinase kinase-3|mitogen-activated protein kinase kinase 3|Y
alpha-methyl-p-tyrosine|alpha-methyl-paratyrosine|Y
broncho-alveolar lavage fluid|bronchoalveolar lavage fluid|Y
hyperacute xenograft rejection|hyperacute xenogeneic rejection|Y
electro-thermal atomic absorption spectrometry|electrothermal atomic absorption spectroscopy|Y
oestrogen receptor α knockout mouse|estrogen receptor alpha knockout|Y
positive slow wave|positive sharp wave|N
heavy chain joining gene|heavy chain joining|N
dog unit|dose unit|N
lipovitellin|lecithovitellin|Y
physio-therapist|physiotherapy|N
human adenovirus serotype 22|human adenovirus type 22|Y
receptor-like protein tyrosine phosphatase α|receptor protein-tyrosine phosphatase-α|Y
limb girdle muscular dystrophy type 2B|muscular dystrophy type 2B|Y
receptor protein tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase-ψ|Y
indirect immunofluorescent antibody test|indirect fluorescence antibody test|Y
Reye's disease|Reiters disease|N
Drawida japonica|Draba japonica|N
routine electroencephalogram|resting electroencephalogram|N
American Society of Anaesthesiology Grade V|American Society of Anesthesiologists Grade V|Y
radiocontrast medium|radiographic contrast medium|Y
objective structured teaching evaluation|objective structured teaching examination|Y
a disintegrin and metalloproteinase 12s|a disintegrin and metalloprotease 12s|Y
Philadelphia chromosome negative|Philadelphia chromosome positive|N
Anatomic Therapeutic Chemical Classification|Anatomic Therapeutic Chemical Classification System|Y
randomly amplified polymorphic DNA|random-amplified polymorphic DNA analysis|Y
chorionic gonadotropin|monkey chorionic gonadotropin|N
beta 1,4-galactosyltransferase|galactosyltransferase|Y
American Society of Health-System Pharmacists|American Society of Hospital Pharmacists|Y
complement C4b binding protein|complement component C4b binding protein|Y
intergenic transcribed spacer|internally transcribed spacer|Y
UDP glucuronosyltransferase|UDP glucuronyltransferase|Y
invitro|in vitro|Y
magnetoencephalographic|magnetoencephalography|Y
computed tomographic arterial portography|computed tomography arterial portography|Y
first transmembrane segment|first transmembrane domain|Y
angiotensin receptor type 1|angiotensin II receptor type 1|Y
ventricular extrastimulus|ventricular extrasystole|N
cytotoxic necrotising factor type 1|cytotoxic necrotising factor 1|Y
inductively coupled plasma source mass spectrometry|inductively coupled plasma mass spectrometer|Y
cardiac microvascular endothelial cell|coronary microvascular endothelial cell|Y
response element|responsive element|Y
vitamin D receptor|vitamin D receptor gene|N
multiple organ dysfunction syndrome|multiple organ dysfunction score|N
cholecystokinin type A receptor|cholecystokinin A receptor|Y
transmembrane domain 2|second transmembrane domain|Y
transmembrane domain 1|first transmembrane domain|Y
posttransplantation|posttransplant|Y
severe combined immunodeficiency disease|severe combined immune deficiency|Y
peptide tyrosine tyrosine|polypeptide tyrosine tyrosine|Y
Man Rogosa Sharpe agar|deMan Rogosa Sharpe agar|Y
transient receptor potential vanilloid receptor type 1|transient receptor potential vanilloid receptor subtype 1|Y
insulin degrading enzyme|insulin-degrading enzyme|Y
branched chain α-ketoacid dehydrogenase complex|branched-chain alpha-keto acid dehydrogenase complex|Y
prolyl hydroxylase domain protein 2|prolyl hydroxylase domain-containing protein 2|Y
phorbol myristic acetate|phorbol myristic acid|Y
microbacterium avium-intercellulare complex|Mycobacterium avium intracellulare complex|Y
hyaluronic acid binding protein|hyaluronan binding protein|Y
trans-oesophageal atrial pacing|transesophageal atrial pacing|Y
human adenovirus 6|human adenovirus type 6|Y
immune thrombocytopenic purpura|immune thrombo-cytopenia|Y
electroarteriography|electroantennography|N
vetricular ectopic beat|ventricular ectopic beat|Y
idiopathic pulmonary arterial hypertension|idiopathic pulmonary artery hypertension|Y
breast-conserving therapy|breast conserving therapy|Y
specific protein 1|specificity protein 1|Y
human parainfluenza virus type 1|human parainfluenza virus 1|Y
randomly amplified polymorphic DNA profile|random amplified polymorphic DNA profile|Y
enterotoxigenic E coli|enterotoxigenic Escherichia coli|Y
human beta defensin 3|human β-defensin 3|Y
concurrent chemoradiotherapy|concomitant chemoradiotherapy|Y
lateral occipital cortex|lateral occipital complex|Y
adaptor protein complex 2|adaptor protein 2|Y
protein phosphatase|phosphoprotein phosphatase|Y
isolated perfused kidney|isolated and perfused rat kidney|N
tonometric blood pressure|toe blood pressure|N
intavenous infusion|intravenous infusion|Y
water/trifluoroethanol|trifluorethanol|N
β-glycerophosphate|betaglycerophosphate|Y
anti-matrix metalloprotease 3 antibody|anti-matrix metalloproteinase-3 antibody|Y
vulvar intraepithelial neoplasia 1|vulvar intraepithelial neoplasia grade 1|Y
trehalose-6,6'-dimycolate|trehalose dimycolate|Y
phosphoinositide dependent kinase 1|phosphatidylinositol-dependent kinase 1|Y
recombination|recombinant|Y
Mitogen-activated protein kinase kinase 1|mitogen activated protein kinase kinase 1|Y
alpha, beta-methylene adenosine triphosphate|methylene adenosine triphosphate|Y
peroxisomal membrane protein|peroxisome membrane protein|Y
matrix metallopeptidase 9|matrix metalloprotease 9|Y
maturation phase promoting factor|metaphase promoting factor|N
injection drug user|injecting drug use|Y
American Society of Anaesthesiologists physical status IV|American Society of Anesthesiology physical status IV|Y
energy dispersive spectroscopy|energy dispersive spectrometry|Y
tissue-type transglutaminase|tissue trans-glutaminase|Y
ultrasound biomicroscopic|ultrasound biomicroscopy|Y
American Society of Anesthesiologists Grade I|American Society of Anaesthesiology status I|Y
variable heavy|variable heavy chain|Y
cytochrome oxidase subunit 1|cytochrome c oxidase subunit 1|Y
magnetocardiogram|magnetocardiography|Y
tumor-associated antigens|tumor-associated antigen|Y
cardiovascular disease risk|cerebrovascular disease risk|Y
Ran binding domain|RNA binding domain|N
necrosis factor receptor type I|soluble tumor necrosis factor receptor type I|Y
adenine nucleotide transporter|adenine nucleotide translocator|Y
X-ray cross complementing group 1|x-ray repair cross complementing group 1|Y
rat microvascular endothelial cell|retinal microvascular endothelial cell|N
ganglioside M1|ganglioside GM1|N
multiple endocrine neoplasia 2B|multiple endocrine neoplasia type 2B|Y
plethysmographic|plethysmography|Y
International Index of Erectile Function|international index of Erectile Function|Y
sodium polyethylene sulfonate|sodium polystyrene sulfonate|N
dimethylphenylisocyanide|dimethylphenylisonitrile|N
laterodorsal tegmentum|laterodorsal tegmental nucleus|Y
per anum|per annum|Y
Family Impact Scale|Fatigue Impact Scale|N
CTL precursor cell|precursor cell|N
acquired immunodeficiency syndrome|acquired immunodeficiency disease syndrome|Y
mitochondrial membrane potential|mitochondria membrane potential|Y
soluble intercellular adhesion molecule|soluble intercellular adhesion molecule 1|Y
adeno-associated virus|adenovirus-associated virus|Y
peristimulus time|poststimulus time|N
glutaryl coenzyme A dehydrogenase|glutaryl CoA dehydrogenase|Y
sustained virologic responder|sustained virological response|Y
cymbidium mosaic potexvirus|Cymbidium mosaic virus|Y
guanine nucleotide binding protein|nucleotide binding protein|N
ultrasound biomicroscope|ultrasound biomicroscopic|Y
anti-hepatitis B surface antigen|antihepatitis B surface antibody|N
benzo(a)pyrene|benzo[a]pyrene|Y
angiotensin type 1|angiotensin 2 type 1|Y
electronmicroscope|electronmicroscopy|Y
intraventricular septum|interventricular system|N
technetium-99m methoxyisobutylisonitrile|technetium-99m methoxy-isobutyl-isonitrile|Y
cranial computed tomography scan|cranial computerised tomography scan|Y
oxygen free radical|oxygen derived free radical|Y
computer tomography scanning|computed tomographic scanning|Y
pyrenylalanine|pyridylalanine|N
turnip mosaic potyvirus|Turnip mosaic virus|Y
transmural electrical stimulation|transcranial electrical stimulation|Y
soluble alkaline phosphatase|alkalinephosphatase|N
short interfering RNA|small interfering RNA|Y
forced swimming test|forced-swim test|Y
cytoplasmic phospholipase A2|cytosolic phospholipase A2|Y
methyl CpG binding domain|methyl CpG binding domain protein|Y
serum aspartate aminotransferase|soluble aspartate aminotransferase|Y
guanylate cyclase activating protein-2|guanylyl cyclase-activating protein II|Y
aminoterminal pro-brain-type natriuretic peptide|amino-terminal pro B-type natriuretic peptide|Y
temporal arteritis|temporal artery|N
flame atomic absorption spectrometric|flame atomic absorption spectrophotometry|Y
ventricular septal defect|ventricular septum defect|Y
fibroblast growth factor receptor 2|fibroblast growth factor receptor|N
acutely decompensated heart failure|acute decompensated heart failure|Y
individual participant data|individual patient datum|Y
DNA packaging site|DNA packaging|N
cementum attachment protein|cell attachment protein|N
x-ray repair cross complementing 1|x-ray repair cross-complementing protein 1|Y
retinoic acid receptor|retinoic acid receptor alpha|N
peritoneal mast cell|peritoneal mesothelial cell|N
toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Y
human adenovirus type 24|human adenovirus serotype 24|Y
American Society of Anaesthesiology status IV|American Society of Anesthesiology grade 4|Y
American Society of Anesthesiology status V|American Society of Anaesthesiology class V|Y
recombinant murine β interferon|recombinant murine interferon β|Y
X-linked severe combined immunodeficiency|x linked severe combined immunodeficiency|Y
CCAAT enhancer binding protein alpha|CCAAT enhancer binding protein-α|Y
neural|neuronal|Y
phenylethylisothiocyanate|phenethylisothiocyanate|Y
a disintegrin and metalloprotease 3|a disintegrin and metalloproteinase 3|Y
artificial cerebral spinal fluid|artificial cerebrospinal fluid|Y
fluorescent|fluorescein|N
p-hydroxymercuribenzoic acid|p-hydroxymercuribenzoate|N
Mini Mental Status Exam|Mini Mental Status Examination|Y
secretory phospholipase A(2)-IIa|secretory phospholipase A2 group IIA|Y
large cell carcinoma|liver cell carcinoma|N
magnetisation prepared rapid gradient echo imaging|magnetisation prepared rapid gradient echo sequence|Y
lateral superior olive|lateral superior olivary nucleus|Y
glutamic oxalacetic transaminase|glutamine oxaloacetic transaminase|Y
S-adenosyl-L-methionine|adenosylmethionine|Y
factor VIII coagulant activity|factor VIII procoagulant activity|Y
a disintegrin and metalloprotease 17|A disintegrin and metalloproteinase 17|Y
phosphatidylinositol glycan class A|phosphatidyl inositol glycan A|Y
vibro-arthrographic|vibroarthrography|Y
Electrically evoked compound action potential|evoked compound-action potential|Y
Norwalk-like viruses|Norwalk-like virus|Y
malignant fibrous histiocytoma|malignant fibrous histocytoma|Y
post transplantation lymphoproliferative disorders|post-transplantation lymphoproliferative disease|Y
caloric restriction|calorie restriction|Y
receptor protein tyrosine phosphatase alpha|receptor-like protein tyrosine phosphatase alpha|Y
cord blood transplantation|cord blood transplant|Y
estrogen receptor alpha knockout|estrogen receptor alpha knockout mouse|Y
cytidinediphosphocholine|cytidine diphosphate choline|Y
N,N-diethylphenylacetamide|diethylphenylacetamide|Y
phosphoinositide dependent kinase 1|3-phosphoinositide-dependent protein kinase-1|Y
aspirin exacerbated respiratory disease|aspirin-exacerbated respiratory disease|Y
Bariatric analysis and reporting outcome system|Bariatric Analysis and Reporting Outcome System|Y
multirow detector computed tomography|multidetector row computerized tomography|Y
hypoxicischemic|hypoxia ischemia|Y
aminolevulinate synthase 2|5-aminolevulinate synthase|N
classical anti-neutrophil cytoplasmic antibody|classic anti-neutrophil cytoplasmic antibody|Y
glycyrrhizic acid|glycyrrhetinic acid|N
neutralisation test|neutralisation|N
non-rapid-eye-momement sleep|non-rapid eye movement sleep|Y
nucleic acid amplification technology|nucleic acid amplification test|Y
acetyl coenzyme A carboxylase 1|acetyl CoA carboxylase 1|Y
tetramethylphenylenediamine oxidase|N,N,N',N'-tetramethyl-p-phenylene diamine oxidase|Y
fast oxidative glycolytic fiber|fast twitch oxidative glycolytic fiber|Y
oral facial digital syndrome|oro-facio-digital syndrome|Y
laevonorgestrel intra-uterine system|levonorgestrel releasing intra-uterine system|Y
stromal cell derived factor 1|Stromal cell-derived factor|Y
gas chromatograph-mass spectrometer|gas chromatography mass spectrometry|Y
bronchial alveolar lavage fluid|bronchoalveolar lavage fluid|Y
coccygeal vertebra 1|1st coccygeal vertebra|Y
infantile polyarteritis nodosa|infantile periarteritis nodosa|Y
oxophytodienoic acid|12-oxo-phytodienoic acid|Y
experimental allergic encephalitis|experimental allergic encephalomyelitis|Y
antineutrophil cytoplasmic antibody|cytoplasmic antineutrophil cytoplasmic antibody|Y
dinitrophenylhydrazine|2,4-dinitrophenylhydrazine|Y
programmed death-1|Programmed Death-1|Y
computed tomographic colography|computed tomographic cisternography|N
differential interference contrast|differential interference contrast microscopy|Y
collagen VI α 2|collagen type VI α 2|Y
metabotropic glutamate receptor 2|metabotropic glutamate 2 receptor|Y
lymphoreticular system|lympho-reticular system|Y
human adenovirus 45|human adenovirus serotype 45|Y
pituitary adenylate cyclase-activating polypeptide type 1 receptor|pituitary adenylate cyclase-activating peptide type 1 receptor|Y
color Doppler ultrasonography|color Doppler ultrasound|Y
endothelial cell|epithelial cell|N
peak airway pressure|positive airway pressure|N
cytidine triphosphatase|cytosine triphosphatase|Y
American Society of Anesthesiology physical status 1|American Society of Anaesthesiology status 1|Y
meat-and-bone meal|meat and bone meal|Y
experimental auto-immune encephalomyelitis|experimental autoimmune encephalitis|Y
Highest Occupied Molecular Orbital|highest occupied molecular orbital|Y
iridocorneal endothelial syndrome|irido-corneo-endothelial syndrome|Y
pyroglutamyl peptidase II|pyroglutamyl aminopeptidase II|Y
anti-human T-cell lymphotrophic virus type-1 antibody|anti-human T cell lymphotropic virus-I antibody|Y
choriocarcinoma|cholangio-carcinoma|N
SPARC related modular calcium binding protein 1|SPARC related modular calcium binding 1|Y
inter-burst interval|interbreath interval|N
human T cell lymphotrophic virus-1|human T cell lymphotropic virus type 1|Y
ureterovesicular junction|urethrovesical junction|Y
suppressor of cytokine signaling 3|suppressor of cytokine signaling-3|Y
mixed lymphocyte reaction|mixed lymphocyte response|Y
alkyl hydroperoxide reductase C|alkylhydroperoxide reductase subunit C|Y
MAPK phosphatase 1|MAP kinase phosphatase 1|Y
chronic lymphoid leukemia|chronic lymphocytic leucemia|Y
American Society of Anaesthesiologists status III|American Society of Anaesthesiologists physical status III|Y
tumour colony-forming unit|tumor colony-forming units|Y
extracellular signal related kinase|Extracellular signal-regulated kinases|Y
acute lymphatic leukemia|acute lymphoblastic leucemia|Y
American Society of Anaesthesiologists Status 1|American Society of Anaesthesiology status I|Y
2 dimensional gel electrophoresis|twodimensional electrophoresis|Y
transforming growth factor type-β|transforming growth factor beta|Y
American Society of Anaesthesiologists Class IV|American Society of Anesthesiology class IV|Y
American Society of Anesthesiologists Status 1|American Society of Anesthesiology Grade 1|Y
oocyte cumulus complex|oocyte-cumulus cell complex|Y
bilateral limb deficit|bilateral deficit|Y
iodobenzamide|[123I]iodobenzamide|N
alpha-phenyl-n-tert-butyl nitrone|phenyl-tert-butylnitrone|Y
dual anti-platelet therapy|dual antiplatelet therapy|Y
human adenovirus serotype 16|human adenovirus type 16|Y
myeloid leukemia factor 1|leukemia factor 1|Y
unfavorable non-Hodgkin lymphoma|untreated non-Hodgkin lymphoma|N
7th cervical vertebra|cervical vertebra 7|Y
p-chloromercuribenzene sulfonate|p-chloromercuribenzene sulfonic acid|N
Picea glauca|Prionace glauca|N
alanine aminotransferase|alanine transferase|Y
human adenovirus serotype 41|human adenovirus 41|Y
multiple gated acquisition scan|multi gated acquisition scan|Y
genomic ribonucleic acid|guide ribonucleic acid|N
American Society of Anesthesiology status 4|American Society of Anesthesiologists grade IV|Y
recommended daily intake|recommended dietary intake|Y
guanylate cyclase-activating protein-1|Guanylate cyclase-activating protein 1|Y
azoxymethane|azoxy-methanol|Y
eosinophilic chemotactic factor|eosinophil chemotactic factor|Y
fluoro-deoxy-glucose|fluoro-2-deoxy-D-glucose|Y
hypertensive|hypertension|Y
Clostridium difficile associated disease|Clostridium difficile–associated diarrhea|Y
growth hormone releasing hormone|growth hormone-releasing hormone|Y
borderline hypertension|borderline hypertensive|Y
subacute thrombosis|sub-acute stent thrombosis|N
lectin-dependent cellular cytotoxicity|lectin-dependent cell-mediated cytotoxicity|Y
anti-interleukin-10|anti-interleukin-10 antibody|Y
interleukine-13 receptor alpha1-chain|interleukin-13 receptor alpha1|Y
insulin-like growth factor I receptor|insulinlike growth factor receptor 1|Y
nonphytate phosphorus|nonphytin phosphorus|Y
a disintegrin and metalloprotease 9|A disintegrin and metalloproteinase 9|Y
hairy enhancer of split 1|hairy and enhancer of split-1|Y
receiver operating characteristic|receiver operating characteristic curve|Y
amyotropic lateral sclerosis|anterolateral sclerosis|N
American Society of Anaesthesiology physical status 1|American Society of Anesthesiologists Class 1|Y
IL-2 receptor alpha-chain|IL2 receptor alpha|Y
ventromedial hypothalamus|ventromedial hypothalamic nucleus|Y
dichlorobenzene|1,4-Dichlorobenzene|Y
American Society of Anesthesiology grade 5|American Society of Anesthesiology class V|Y
beta-amyloid precursor protein-cleaving enzyme-2|beta-site amyloid precursor protein cleaving enzyme 2|Y
p-chloromercuriphenylsulfonate|parachloromercuriphenylsulfonate|Y
polyhydroxyvalerate|poly-β-hydroxyvalerate|Y
cardiac computed tomographic angiography|coronary computed tomography angiography|Y
antiinterleukin 4 receptor monoclonal antibody|anti-IL 4 receptor monoclonal antibody|Y
mitral annulus|mitral annular|Y
amino-terminal proB-type natriuretic peptide|aminoterminal pro-brain-type natriuretic peptide|Y
sustained virologic responder|sustained virological responder|Y
multiplanar reconstruction image|multiplanar reformation image|Y
water immersion restraint stress|water restraint stress|Y
pentoxyresorufin O-dealkylase|7-pentoxyresorufin O-depentylase|N
neuromuscular block|neuro-muscular blocking|Y
electrocochleography|electrocochleogram|Y
aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 1|Y
metabotropic glutamate receptor type 7|metabotropic glutamate receptor subtype 7|Y
methyl beta-cyclodextrin|methyl-beta-cyclodextrin|Y
hematology|hematologist|Y
cell mediated immune response|cell-mediated immune response|Y
anti-human T-cell lymphotrophic virus type-I antibody|anti-human T-cell lymphotropic virus-1 antibody|Y
5-day biochemical oxygen demand|biochemical oxygen demand|Y
ubiquitin-like domain|ubiquitinlike protein|Y
GTP binding protein alpha(i1) subunit|G protein alpha(i1) subunit|Y
synchronous intermittent mandatory ventilation|synchronised intermittent mandatory ventilation|Y
melanoma-inhibiting activity|melanoma inhibitory activity|Y
histology activity index|histologic activity index|Y
murine tumour necrosis factor α|mouse tumor necrosis factor alpha|Y
median reaction time|mean retention time|N
human adenovirus type 43|human adenovirus serotype 43|Y
catechol orthomethyltransferase|catechol o methyltransferase|Y
interleukin-18 receptor alpha chain|interleukin-18 receptor alpha|Y
multiple choice questionnaire|multiple choice question|Y
γ-aminobutyric acid-C receptor|gamma-aminobutyric acid type-C receptor|Y
angiotensin type 1 receptor|angiotensin II type 1 receptor|Y
bone morphogenetic protein receptor 1A|bone morphogenetic protein receptor type 1A|Y
external beam radiotherapy|external beam radiation therapy|Y
interleukine 7 receptor α|interleukin-7 receptor α chain|Y
substance P immunoreactive|substance P like immunoreactive|Y
immunocytochemical assay|immunocytochemical analysis|Y
Chronic Respiratory Disease Questionnaire|Chronic Respiratory Questionnaire|Y
cruciform binding protein|calcium binding protein|N
technetium 99m pyrophosphate|technetium 99m stannous pyrophosphate|Y
autoimmune polyendocrine syndrome type 1|autoimmune polyendocrinopathy syndrome type 1|Y
Recommended dietary allowance|recommended dietary allowance|Y
human adenovirus 23|human adenovirus serotype 23|Y
acute myelogenous leukemia|acute myeloid leukemia|Y
procollagen type I C-terminal peptide|procollagen I C-terminal peptide|Y
interleukin 2 receptor alpha|interleukin 2 receptor alpha chain|Y
electrophile responsive element|electrophile response element|Y
matrix metalloprotease 7|matrix metalloproteinase 7|Y
recombinant murine interferon-β|recombinant murine interferon beta|Y
peptidylprolyl isomerase|peptidyl-prolyl cis-trans isomerase|Y
transforming growth factor-beta1|transforming growth factor-β(1)|Y
intramaxillary fixation|inter-maxillary fixation|Y
American Society of Anaesthesiology grade I|American Society of Anaesthesiologists grade 1|Y
lipoperoxidation|lipid peroxidation|Y
human adenovirus 23|human adenovirus type 23|Y
plasma membrane calcium ATPase|plasma membrane calcium pump|Y
human adenovirus serotype 48|human adenovirus type 48|Y
objective structured teaching exercise|objective structured teaching evaluation|Y
cytolytic T lymphocyte precursor cell|cytotoxic T lymphocyte precursor cell|Y
cytochrome c oxidase subunit II|cytochrome oxidase subunit II|Y
inverted terminal repeats|inverted terminal repeat|Y
serum amyloid A-1|serum amyloid A1|Y
insulinlike growth factor receptor type 1|insulinlike growth factor receptor 1|Y
minimum lumen area|minimal lumen area|Y
midlatency auditory evoked potential|middle latency auditory evoked potential|Y
31phosphorus magnetic resonance spectroscopy|phosphorus 31 magnetic resonance spectroscopy|Y
acute myelocytic leukemia|acute myeloid leukemia|Y
once a week|once weekly|Y
high resolution melt analysis|high resolution melt|Y
upstream activating sequence 2|upstream activation site 2|Y
human leucocyte antigen D related|human leucocyte antigen DR|Y
voltage-sensitive Ca2+-channel blocker|voltage sensitive calcium channel blocker|Y
intracellular Ca2+ concentration|intracellular free calcium concentration|Y
insulinlike growth factor receptor type 2|insulinlike growth factor 2 receptor|Y
histocompatibility locus antigen|histocompatibility leucocyte antigen|Y
cannabinoid receptor 1|cannabinoid receptor|Y
metabotropic glutamate receptor subtype 6|metabotropic glutamate receptor 6|Y
iso-nicotinamide|isonicotinate|N
perfluoro-octanoate|perfluoro-octanoic acid|N
minimal transit time|mean transit time|N
neurocalcin|nephrocalcin|N
randomized control trial|randomized-controlled trial|Y
phosphatidic acid phosphatase|prostatic acid phosphatase|Y
human adenovirus type 32|human adenovirus 32|Y
migratory-inhibiting factor|migration inhibition factor|Y
mineralocorticoid|mineralo-corticoid|Y
insulin-like growth factor-II mRNA binding protein-2|insulin-like growth factor II messenger RNA binding protein 2|Y
substance P immunoreactivity|substance P immunoreactive|Y
Lowry-Wood syndrome|lowry wood syndrome|Y
bronchodilator|broncho-dilation|Y
phosphodiesterase 5|phosphodiesterase type 5|Y
computed tomogram|computed-tomography|Y
globohexaosylceramide-keyhole limpet hemocyanin QS-21 vaccine|globo H-keyhole limpet hemocyanin QS-21 vaccine|Y
late activation antigen 4|very late activation antigen 4|Y
peripheral myelin protein 22|peripheral myelin protein|N
phenylthiocarbamyl|phenylthiocarbamide|Y
alpha 1-protease inhibitor|alpha 1 proteinase inhibitor|Y
cytokine-induced killer|cytokine induced killer|Y
thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome|thrombotic thrombocytopenic purpura/hemolytic uremic syndrome|Y
airway smooth muscle cell|arteriolar smooth muscle cell|N
terminal deoxynucleotidyltransferase|terminal deoxyribonucleotidyltransferase|Y
transforming growth factor beta receptor type 2|type II transforming growth factor beta receptor|Y
osteochondritis dissecans|osteochondrosis dissecans|Y
vertical vestibulo-ocular reflex|visual-vestibulo-ocular reflex|N
Toll interleukin 1 resistance|Toll interleukin 1 receptor|N
optic atrophy 1|optic atrophy type 1|Y
tumor-infiltrating leukocyte|tumour infiltrating lymphocyte|Y
mean fluorescence intensity|mean fluorescence index|Y
polymerase chain reaction-sequence-based typing|polymerase chain reaction-sequencing based typing|Y
intraarticular|intra-auricular|N
vectorcardiographic|vectorcardiogram|Y
red clover necrotic mosaic dianthovirus|red clover necrotic mosaic virus|Y
American Society of Anaesthesiologists physical status II|American Society of Anaesthesiology status II|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiology status I|Y
human papillomavirus type 1|human papillomavirus 1|Y
oral-facial-digital syndrome type I|oro-facio-digital syndrome type I|Y
drug hypersensitivity syndrome|dapsone hypersensitivity syndrome|N
yttrium-stabilized tetragonal zirconia polycrystal|yttria-stabilized tetragonal zirconia polycrystal|Y
posttransplant lymphoproliferative disease|post-transplant lymphoproliferative disorder|Y
human adenovirus type 8|human adenovirus 8|Y
fatty acid translocase|fatty acid transporter|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiology Grade 2|Y
angiotensin type 1 receptor|angiotensin II receptor 1|Y
doublesex and mab-3-related transcription factor 1|doublesex and male abnormal-3 related transcription factor-1|Y
hydroperoxyeicosatetraenoic acid|hydroxyeicosatetraenoic acid|N
Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Y
quantum mechanical|quantum mechanics|Y
prohormone convertase 1|proprotein convertase 1|Y
evoked compound-action potential|electrically evoked compound action potential|Y
transient receptor potential vanilloid receptor subtype 1|transient receptor potential vanilloid 1|Y
naphthalene|naphthacene|N
late onset congenital adrenal hyperplasia|congenital adrenal hyperplasia|N
receptor-linked protein-tyrosine-phosphatase alpha|receptor-like protein tyrosine phosphatase alpha|Y
mitogen-activated protein kinase kinase kinase|microtubule-associated protein kinase kinase kinase|N
angiotensin 2 type 1|angiotensin type 1|Y
peri-geniculate nucleus|pregeniculate nucleus|Y
medial hypothalamic area|medial hypothalamic ablation|N
T2-weighted image|T2 weighted imaging|Y
human T lymphotropic virus 2|human T cell lymphotropic virus type 2|Y
preejection period index|pre-ejection period index|Y
cannabinoid receptor 1|cannabinoid receptor gene|N
observed effect concentration|no observable effect concentration|N
helper T cell|T helper cell|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor 1|Y
a disintegrin and metalloprotease-12|A disintegrin and metalloproteinase 12|Y
optimum length|optimal length|Y
idiopathic hypertrophic subaortic stenosis|ideopathic hypertrophic subaortic stenosis|Y
distal inter-phalangeal joint|distal interphalangeal joint|Y
American Society of Anaesthesiology grade II|American Society of Anesthesiologists Status II|Y
American College of Clinical Pharmacology|American College of Clinical Pharmacy|Y
neural Wiskott-Aldrich syndrome protein|neuronal Wiskott-Aldrich syndrome protein|Y
diode array detection|diode array detector|Y
thyroid hormone receptor-β|thyroid hormone receptor beta|Y
N-terminal-pro-B-type natriuretic peptide|N-terminal pro-brain type natriuretic peptide|Y
Wechsler Preschool and Primary Scale of Intelligence, Revised|Wechsler Preschool and Primary Scale of Intelligence-Revised|Y
slowly adapting pulmonary stretch receptor|slowly adapting stretch receptors|Y
tetrahydro-biopterin|tetrahydrobiopterin|Y
angiotensinconverting enzyme|angiotensin I-converting enzyme|Y
tropomyosin receptor kinase C|tropomyosin-related kinase C|Y
transcranial magnetic stimulus|transcranial magnetic|Y
IL12 receptor beta2|IL12 receptor beta2 chain|Y
ultra-fast computed tomography|ultrafast computed tomography|Y
computerised provider order entry|computerised physician order entry|Y
glycolic acid|glyoxylic acid|N
formin homology domain containing protein-1|formin homology 2 domain containing 1|N
break induced replication|break-induced replication|Y
single electron transfer|single embryo transfer|N
pelvic nerve stimulation|perivascular nerve stimulation|N
leu enkephalin|enkephalin|N
peroxisome proliferator-activated receptor gamma co-activator-1|Peroxisome proliferator-activated receptor gamma coactivator-1|Y
antigen binding protein|actin binding protein|N
anterior tibia|anterior tibial|Y
cellular adhesion molecule|cell adhesion molecule|Y
Dual energy X-ray absorptiometry|dual Xray absorptiometry|Y
intracellular Ca2+ concentration|intracellular free Ca2+ concentration|Y
late gadolinium enhancement cardiac magnetic resonance|late gadolinium enhancement cardiovascular magnetic resonance|Y
equid herpesvirus type 1|Equid herpesvirus 1|Y
intraamniotic|intraaortic|N
phospho-choline|phosphorylcholine|Y
transactivation responsive element|trans-activation responsive|Y
politician|political|N
interferon stimulated response element|IFN stimulated response element|Y
sinus tachycardia segment elevation myocardial infarction|ST segment elevation myocardial infarction|N
Short Musculoskeletal Functional Assessment|Short Musculoskeletal Function Assessment Questionnaire|Y
vasopressin V2 receptor|vasopressin 2 receptor|Y
thromboglobulin|thyroglobulin|N
bone morphogenetic protein 2|bone morphogenic protein 2|Y
uroporphyrinogen I synthase|uroporphyrinogen synthase|N
signal-averaged electrocardiography|signal-averaged electrocardiogram|Y
blood oxygen level dependent|blood oxygenation level dependent|Y
low alcohol sensitivity|low alcohol sensitive|Y
flame atomic absorption spectrometry|flame atomic absorption spectroscopy|Y
internal transcribed spacer region|internal transcribed spacers|Y
IFN-α producing cell|IFN producing cell|N
x-ray magnetic circular dichroism|X-ray magnetic circular dichroism|Y
fluorescence activated cell sorter|fluorescence-activated cell sorting|Y
vascular endothelial cell growth factor receptor|vascular endothelial growth factor receptor|Y
lowest-observed-adverse-effect level|lowest-observed adverse effect level|Y
x-ray powder diffraction|x-ray powder diffractometry|Y
anti-IL 7 monoclonal antibody|anti-interleukin 7 monoclonal antibody|Y
tropical calcific pancreatitis|tropical chronic pancreatitis|Y
diastolic arterial pressure|diastolic aortic pressure|N
migrating motor complex|migrating myoelectric complex|Y
retinoic acid receptor|retinoid X receptor|N
progranulin|granulin|N
ventroposterolateral|ventro-posterior lateral|Y
zinc deficient diet|zinc deficient|Y
99mTc galactosylneoglycoalbumin|technetium-99m galactosylneoglycoalbumin|Y
inositol trisphosphate|inositol 1,4,5-trisphosphate|Y
American Society of Anaesthesiologists status V|American Society of Anesthesiology physical status 5|Y
International Classification for Nursing Practice|International Classification of Nursing Practice|Y
50% effective concentration value|median effective concentration value|Y
restriction enzyme mediated integration|restriction enzyme-mediated integration|Y
leucocyte adhesion deficiency type 1|leucocyte adhesion deficiency 1|Y
bone alkaline phosphatase|alkalinephosphatase|N
dorsal periaqueductal gray|dorsal periaqueductal gray matter|Y
superior cervical ganglionectomy|superior cervical ganglionectomized|Y
immunoreceptor tyrosine based inhibition motif|immunoreceptor tyrosine based inhibitory motif|Y
American Society of Anesthesiology Class IV|American Society of Anesthesiologists Class 4|Y
right portal vein|rabbit portal vein|N
electromyograph|electro-myographic|Y
ultraviolet C light|ultraviolet C|Y
ubiquitin carboxy terminal hydrolase|Ubiquitin C-terminal hydrolase|Y
anti-IL6 receptor monoclonal antibody|anti-interleukin-6 receptor monoclonal antibody|Y
extended spectrum β-lactamase|extended spectrum beta lactamase|Y
homozygous alpha-1 proteinase inhibitor deficiency|homozygous α-1 protease inhibitor deficiency|Y
neuroepithelioma|neuroepithelium|N
human adenovirus serotype 18|human adenovirus type 18|Y
bovine capillary endothelial cell|bovine corneal endothelial cell|N
left ventricular|left ventricle|Y
transverse rectus abdominis muscle flap|transverse rectus abdominis myocutaneous flap|Y
homologous recombination repair|homologous recombinational repair|Y
killer immunoglobulin-like receptor|killer immunoglobulin receptor|Y
electron-beam computerised tomography|electron beam computed tomography|Y
Charcot-Marie-Tooth type 4C|Charcot-Marie-Tooth disease type 4C|Y
psychiatric emergency room|pediatric emergency room|N
glycosyl-phosphatidyl-inositol-anchored protein|glycophosphatidylinositol anchored protein|Y
Trypticase soy broth|tryptic soy broth|Y
chronic heart disease|cyanotic heart disease|N
anti-interleukin-4 receptor alpha antibody|anti-IL4 receptor alpha antibody|Y
internal limiting membrane|inner limiting membrane|Y
computer tomographic scan|computed tomography scanning|Y
quinidine sulfate|quinine sulfate|N
transcription activation domain|transcriptional activation domain|Y
electrospray ionisation quadrupole ion trap mass spectrometer|electrospray ionisation quadrupole ion trap mass spectrometry|Y
percutaneous nephro-ureterolithotomy|percutaneous nephrolithotomy|Y
DNA polymerase iota|polymerase iota|Y
mouse growth hormone|growth hormone|N
respiratory control ratio|respiratory control rate|N
67 kDa laminin receptor|laminin receptor|Y
transactivation response element|transactivation responsive element|Y
auditory evoked brainstem response|auditory brain response|Y
subventricular zone|sub-ventricular zone|Y
lipid peroxidation|lipid oxidation|Y
macroenzyme creatine kinase type 2|macromolecular creatine kinase type 2|Y
unilateral salpingooophorectomy|unilateral salpingo-oophorectomy|Y
leucocyte migration inhibitory factor|leucocyte migration inhibition factor|Y
serum- and glucocorticoid-regulated kinase|serum- and glucocorticoid-inducible kinase 1|Y
malignant hyperthermia susceptible|malignant hyperthermia susceptibility|Y
preintensive care unit|pre-intensive care unit|Y
carotid artery stenting|carotid artery stenosis|N
Goldmann applanation tonometer|Goldmann applanation tonometry|Y
technetium 99m hexamethylpropylene amine oxime|99mTc hexamethylpropyleneamine oxime|Y
metabotropic glutamate 2 receptor|metabotropic glutamate receptor 2|Y
Autism Behavior Checklist|Aberrant Behavior Checklist|N
chick embryo|chicken embryo|Y
chronic lymphatic leucemia|chronic lymphoid leukemia|Y
polymorphic information content|polymorphism information content|Y
2-deoxy-D-glucose|deoxyglucose|Y
mobile intensive care unit|intensive care unit|N
norethisterone|norethindrone|Y
human coronary arterial endothelial cell|human coronary artery endothelial cell|Y
antifilaggrin antibody|anti-fibrillarin antibody|N
p-chlorophenol|pentachlorophenol|N
fluorescent activated cell sorter|fluorescent-activated cell-sorting|Y
porcine follicle-stimulating hormone|pure follicle-stimulating hormone|N
bronchoalveolar lavage|bronchoalveolar lavage fluid|Y
resource utilisation|research utilisation|N
phosphorylated glycogen synthase kinase-3 β|phospho-glycogen synthase kinase 3β|Y
randomly amplified polymorphic DNA-analysis|random-amplified polymorphic DNA analysis|Y
irido-corneo-endothelial syndrome|iridio corneo endothelial syndrome|Y
Fourier transform ion cyclotron resonance mass spectrometry|Fourier transform ion cyclotron resonance|Y
human adenovirus type 50|human adenovirus serotype 50|Y
diethylamine|diethanolamine|N
tablet|table|N
antiinterleukin 4 receptor monoclonal antibody|anti-IL-4 receptor monoclonal antibody|Y
flavin-containing monooxygenase 1|flavin containing mono-oxygenase 1|Y
early growth response protein 1|early growth response 1|Y
normoalbuminuria|normoalbuminuric|Y
American Society of Anesthesiologists class II|American Society of Anesthesiology Class 2|Y
unconditional stimulus|unconditioned stimulus|Y
forkhead box class O1|forkhead box O-1|Y
sharp wave ripple complex|sharp wave ripple|Y
quadrupole ion trap mass spectrometer|quadrupole ion trap mass spectrometry|Y
right leg|right lobe|N
American Society of Anesthesiology Class 4|American Society of Anaesthesiology physical status 4|Y
American Society of Anaesthesiologists grade 3|American Society of Anesthesiology grade 3|Y
lowest-observable-adverse-effect level|lowest-observed adverse effect level|Y
peroxisome targeting signal type 1|peroxisomal targeting signal 1|Y
external ventricular drain|external ventricular drainage|Y
activation protein 1|activated protein-1|Y
arabinofuranosyladenosine triphosphate|9-beta-D-arabinofuranosyladenine 5'-triphosphate|Y
GDP GTP exchange factor|GDP exchange factor|Y
left atrial|left atrium|Y
alloantibody|autoantibody|N
low density lipoprotein receptor related protein 1|lipoprotein receptor related protein|Y
equine herpesvirus type 5|equine herpesvirus 5|Y
insulin-like growth factor receptor type I|insulin-like growth factor receptor-I|Y
electrical conductivity|electric conductivity|Y
cannabinoid receptor 1|cannabinoid type 1 receptor|Y
γ-amino-butyric acid type B receptor|gamma-aminobutyric acidB receptor|Y
hydroxy-eicosatetraenoic acid|hydroxyeicosatetraenoic acid|Y
cytosine deaminase|cytidine deaminase|N
membrane bio-reactor|membrane biological reactor|Y
metaphalangeal|metatarsophalangeal|N
spinocerebellar ataxia type 14|spinocerebellar ataxia 14|Y
signaling lymphocytic activation molecule|signaling lymphocyte activation molecule|Y
uroporphyrinogen synthase|uroporphyrinogen synthetase|Y
Tyrode's albumin lactate pyruvate|albumin lactate pyruvate|Y
spinocerebellar ataxia 10|spinocerebellar ataxia type 10|Y
butoxycarbonyl|tert-butoxycarbonyl|Y
combined anti-retroviral treatment|combined anti-retroviral therapy|Y
Swedish krona|Swedish Crowns|Y
Aleutian disease virus|Aleutian mink disease parvovirus|Y
glucose transporter 4|glucose transporter type 4|Y
minimum alveolar concentration|minimum alveolar anesthetic concentration|Y
direct-smear fluorescent antibody|direct fluorescent antibody|Y
reverse transcriptase polymerase chain reaction|reverse transcription polymerase chain reaction|Y
skilled birth attendant|skilled birth attendance|Y
phospho-creatine|phosphocreatine|Y
phosphorus accumulating organism|phosphate accumulating organism|Y
pericardial adipose tissue|perirenal adipose tissue|N
metabotropic glutamate receptor 2|metabotropic glutamate receptor type 2|Y
American Society of Anaesthesiologists status II|American Society of Anesthesiology status II|Y
poly-morphonuclear|polymorphonucleate|Y
American Society of Anaesthesiology grade I|American Society of Anesthesiologists Class 1|Y
sub-glottal pressure|subglottic pressure|Y
angiotensin converting enzyme inhibition|angiotensin-converting-enzyme inhibition|Y
antibody-coated bacteria|antibody coated bacterium|Y
fluorine 18-fluoro-deoxy-glucose|fluorine 18-labeled fluoro-deoxy-glucose|Y
uric acid|ursolic acid|N
Edmonton Symptom Assessment Scale|Edmonton Symptom Assessment System|Y
proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation technique|Y
capillary zone electrophoresis|capillary zone electrophoretic|Y
fluorescence in situ hybridization|multi-fluor fluorescence in-situ hybridization|N
equilibrative nucleoside transporter 1|type 1 equilibrative nucleoside transporter|Y
nuclear antigen|EBV nuclear antigen|N
MMX Multi Matrix System|Multi Matrix System|Y
obstructive sleepapnea|obstructive sleep apnea syndrome|Y
multifluor FISH|multicolor FISH|Y
computed tomographic angiography scan|computed tomography angiography scan|Y
Epworth Sleepiness Scale|Epworth Sleepiness Score|Y
American Society of Anaesthesiologists status III|American Society of Anesthesiology status 3|Y
average daily gain|average daily weight gain|Y
spinocerebellar ataxia 2|spino-cerebellar ataxia type 2|Y
β-amyloid-42|amyloid β-42|Y
adipose stromal cell|adipose stem cell|N
synaptosome-associated protein 25|synaptosomal-associated protein of 25 kDa|Y
infectious bovine rhinotracheitis virus|infectious bovine rhinotracheitis|N
chlorite-oxidised oxyamylose|chlorite-oxidised amylose|Y
upstream activating sequence|upstream activation sequence|Y
obstetrics|obstetric|Y
sustained ventricular tachycardia|sinoventricular tachycardia|N
fatty-liver-and-kidney syndrome|fatty liver and kidney syndrome|Y
ubiquitin conjugating enzyme 2C|ubiquitin-conjugating enzyme E2C|Y
(123)I-metaiodobenzylguanidine|iodine 123 metaiodobenzylguanidine|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid receptor 6|Y
anterior chamber associated immune deviation|anterior chamber-associated immune deviation|Y
distal inter-phalangeal joint|distal interphalangeal|Y
SPARC related modular calcium binding protein 1|secreted modular calcium binding protein 1|Y
cornu ammonis region 1|cornu ammonis 1|Y
macrocreatine kinase 1|macrocreatine kinase type 1|Y
stimulatory G protein α-subunit|stimulatory G-protein α|Y
iron binding protein|binding protein|N
Setaria verticillata|Salvia verticillata|N
ventilator associated pneumonia|ventilator-associated pneumonia|Y
non-claret disjunctional protein|nonclaret disjunctional|Y
3,4-dihydroxyphenylpyruvic acid|dihydroxyphenylpyruvic acid|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists status 5|Y
West Los Angeles Veterans' Administration Medical Center|West Los Angeles Veterans Affairs Medical Center|Y
pertussis toxoid|pertussis toxin|Y
CF transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator|Y
recognised myocardial infarction|recurrent myocardial infarction|N
indirect fluorescence antibody test|indirect fluorescent antibody technique|Y
intensity-modulated radiotherapy|intensity modulated radiation therapy|Y
delayed graft function|Delayed graft function|Y
A disintegrin and metalloprotease-22|a disintegrin and metalloproteinase-22|Y
interleukin-1 beta converting enzyme|interleukin converting enzyme|Y
AMP-activated protein kinase alpha|AMP activated protein kinase|N
human T cell leukemia virus type 1|human T cell lymphotropic virus type 1|Y
recurrent implantation failure|repeated implantation failure|Y
electro-mobility shift assay|electrophoresis mobility shift assay|Y
open cholecystectomy|open colectomy|N
polymerase iota|DNA polymerase iota|Y
DNA crosslink repair protein 1C|DNA crosslink repair 1C|Y
retinoblastoma gene|retinoblastoma 1|N
bovine viral diarrhea|bovine virus diarrhea|Y
three dimensional quantitative structure activity relationship study|3D quantitative structure activity relationship study|Y
cerebrotendinous xanthomatosis|costotendinous xanthomatosis|N
lecithin cholesterol acyltransferase|lecithin-cholesterol acetyltransferase|Y
nitroarginine|NG-nitro-L-arginine|Y
specific red cell adherence|specific red cell adherence test|Y
median survival time|mean survival time|N
light-harvesting chlorophyll a/b-binding protein-II|light harvesting chlorophyll protein II|Y
trichloroethane|trichloroethylene|N
Glasgow Outcome Score|Glasgow Outcome Scale|Y
ortho-phthalaldehyde|o-phthaldialdehyde|Y
sodium potassium 2 chloride cotransporter|sodium potassium chloride cotransporter|N
pulsatile index|pulsatility index|Y
homozygous alpha-1 protease inhibitor deficiency|homozygous alpha-1-proteinase inhibitor deficiency|Y
polyproline type II|polyproline II|Y
field emission in-lens scanning electron microscope|field emission in-lens scanning electron microscopy|Y
trinitroglycerin|tri-nitro-glycerine|Y
human immunodeficiency virus type 1 infection|human immunodeficiency virus 1 infection|Y
sustained virological response rate|sustained virologic response|N
metabotropic glutamate receptor subtype 6|metabotropic glutamate receptor type 6|Y
ristocetin-induced platelet aggregation|ristocetin induced platelet agglutination|Y
anti-matrix metalloproteinase 7 antibody|anti-matrix metalloprotease 7 antibody|Y
butylatedhydroxytoluene|butylhydroxytoluene|Y
American Society of Anaesthesiologists Class 3|American Society of Anaesthesiologists physical status III|Y
hypothalamo-pituitary-thyroid axis|hypothalamus-pituitary-thyroid axis|Y
magnetic motor evoked potential|muscle motor evoked potential|Y
nerve stimulation|sciatic nerve stimulation|N
brain angiogenesis inhibitor 2|brain-specific angiogenesis inhibitor 2|Y
transient receptor potential vanilloid receptor 2|transient receptor potential vanilloid type 2|Y
adenovirus 5 E1A|adenovirus type 5 E1A|Y
probable|probably|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiology status II|Y
T2-weighted image|T(2)-weighted image|Y
ovarian epithelial carcinoma|ovarian epithelial cancer|Y
pulmonary arterial smooth muscle cell|pulmonary artery smooth muscle cell|Y
vagus nerve stimulation|vagus nerve stimulator|Y
nasogastric tube|naso-gastric tube|Y
interleukin 2 receptor alpha subunit|interleukin 2 receptor alpha|Y
vaginally|vaginal|Y
sublingually|sub-lingual|Y
stable graft function|slow graft function|N
human T-cell lymphoma/leukaemia virus type 1|human T cell leukemia virus type 1|Y
domestic shorthaired cat|domestic shorthair cat|Y
human adenovirus 43|human adenovirus serotype 43|Y
interleukin 2 receptor alpha subunit|interleukin 2 receptor alpha chain|Y
Indian Medical Association|Industrial Medical Association|N
endothelin B receptor|endothelin receptor B|Y
machinery|machine|Y
pneumococcal surface antigen A|pneumococcal surface adhesin A|Y
indirect immunofluorescent assay|immunofluorescent assay|N
ventilation rate|ventilation ratio|N
dihydroorotate dehydrogenase|dihydro-orotate dehydrogenase|Y
chemokine receptor 2|C-C chemokine receptor 2|Y
human adenovirus 27|human adenovirus type 27|Y
progesterone receptor B|progesterone receptor isoform B|Y
computed axial tomographic scanning|computerized axial tomography scanning|Y
external granular layer|external granule cell layer|Y
Walleye dermal sarcoma virus|wall-eye dermal sarcoma virus|Y
sulfonylurea receptor 1|sulfonylurea receptor|Y
flow mediated dilatation|flow mediated dilation|Y
parathyroid hormone related protein|parathyroid hormone related peptide|Y
numerical pain scale|numeric pain scale|Y
objective structured teaching exercise|objective structured teaching examination|Y
hyperimmunoglobulinemia E syndrome|hyperimmunoglobulin E syndrome|Y
human pancreatic growth hormone-releasing factor|human pancreatic growth-hormone-releasing factor|Y
Latin America|Latinamerican|Y
post-conception|postconception|Y
noninfective nonallergic rhinitis|non infective non allergic rhinitis|Y
iron deficient|iron deficiency|Y
human adenovirus 36|human adenovirus serotype 36|Y
glial cell-line-derived neurotrophic factor|glial cell line-derived neurotrophic factor|Y
anti-beta-2-glycoprotein-I antibody|anti-beta2-glycoprotein I antibodies|Y
coronary artery obstruction|coronary artery occlusion|Y
staphylococcal superantigen-like 5|staphylococcal superantigen-like protein 5|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiology class III|Y
no observed adverse effect level|observed adverse effect level|N
stromal cell derived factor-1|stromal cell derived factor 1|Y
soluble complement receptor 1|soluble complement receptor type 1|Y
voltage dependent anion selective channel 2|voltage dependent anion channel 2|Y
excision repair cross-complementing-group 2|excision repair cross-complementing 2|Y
leucine specific transfer RNA|leucine specific tRNA|Y
ultra-sonography|ultrasonographically|Y
premature auricular contraction|premature atrial contraction|Y
acute myeloid leukemia-associated|acute myelogenous leukemia-associated|Y
American Society of Anesthesiology physical status 1|American Society of Anaesthesiologists status 1|Y
surface electromyography|surface electromyogram|Y
renal epithelial cell|reticular epithelial cell|N
computed tomography colography|computed tomographic cisternography|N
flame atomic absorption spectrometer|flame atomic absorption spectrophotometry|Y
IL-18 receptor alpha|IL-18 receptor α-chain|Y
American Society of Anesthesiology Class IV|American Society of Anesthesiology status 4|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Status I|Y
x-ray repair cross-complementing group 1|X-ray cross complementing group 1|Y
Staphylococcus aureus Cowan strain I|Staphylococcus aureus Cowan I|Y
interleukin-13 receptor alpha1|interleukine-13 receptor α1-chain|Y
DNA gyrase B subunit|DNA gyrase subunit B|Y
nuclear factor erythroid-2-related factor 2|nuclear factor-erythroid 2 p45-related factor 2|Y
triethylene glycol|tetraethyleneglycol|N
6 min walk test|6 minute walk test|Y
short term variation|short term variability|Y
peroxisome proliferator activated receptor response element|peroxisome proliferator response element|Y
ground glass opacification|ground glass opacity|Y
cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia 3|Y
matrix metalloproteinase 9|matrix metallopeptidase 9|Y
Expanded Program of Immunization|Expanded Program on Immunization|Y
organic cation|organic carbon|N
serum alkaline phosphatase|alkalinephosphatase|N
primary hypertension|portal hypertension|N
mean power frequency|median power frequency|N
well differentiated thyroid carcinoma|well differentiated thyroid cancer|Y
positron emission tomographic|positron emission computed tomography|Y
annualized relapse rate|annual relapse rate|Y
residency|residence|N
Toll-like receptor 5|toll-like receptor 5|Y
interleukin-13 receptor alpha1|interleukine-13 receptor alpha 1-subunit|Y
simultaneous pancreas-kidney|simultaneous pancreas-kidney transplant|Y
American Society of Anesthesiology grade 3|American Society of Anesthesiology Class 3|Y
targeting signal type 2|peroxisome targeting signal type 2|Y
light harvesting chlorophyll protein|light-harvesting chlorophyll a/b protein|Y
Bacterium bifidum|Bifidobacterium bifidum|Y
NIMA-related kinase-1|NIMA-related protein kinase-1|Y
neuromuscular blocker|neuro-muscular blocking|Y
facteur thymique sérique|facteur thymique serique|Y
American Psychological Society|American Proctologic Society|N
high mobility group 1 protein|high mobility group protein 1|Y
indirect hæmagglutination antibody|indirect hæmagglutination|Y
insulin-like growth factor I receptor|insulinlike growth factor receptor type 1|Y
pustulosis palmaris et plantaris|pustulosis palmoplantaris|Y
metabotropic glutamate receptor subtype 7|metabotropic glutamate 7 receptor|Y
nitric oxide synthesis|nitric oxide synthase|Y
non-ST-elevation acute coronary syndrome|non-ST-segment-elevation acute coronary syndrome|Y
S-adenosyl-L-methionine|S adenosylmethionine|Y
metabotropic glutamate 5 receptor|metabotropic glutamate receptor subtype 5|Y
interleukin 1|interleukin-I|Y
hydrophilic interaction chromatography|hydrophilic interaction liquid chromatography|Y
zinc protoporphyrin IX|zincprotoporphyrin|Y
dehydroquinate dehydratase|3-dehydroquinate dehydratase|Y
motion after-effect|motion aftereffect|Y
auditory brain response|auditory brainstem response|Y
alkylhydroperoxide reductase|alkylhydroperoxide reductase subunit C|N
coronary artery by-pass surgery|coronary artery bypass surgery|Y
adenoviral vector|adenovirus vector|Y
umbilical arterial catheter|umbilical artery catheter|Y
receiver operating characteristic|receiver operator characteristic curve|Y
Hematopoietic Cell Transplantation Comorbidity Index|Hematopoietic Cell Transplantation-Specific Comorbidity Index|Y
coronary intensive care unit|cardiovascular intensive care unit|Y
simian T lymphotropic virus type 3|simian T-cell lymphotropic virus type 3|Y
minimum alveolar concentration|minimal alveolar concentration|Y
human adenovirus 31|human adenovirus type 31|Y
amino-terminal pro-B-type natriuretic peptide|N-terminal pro-brain type natriuretic peptide|Y
classical antineutrophil cytoplasmic antibody|cytoplasmic antineutrophil cytoplasmic antibody|Y
glial cell line-derived neurotrophic factor|glial-cell derived neurotrophic factor|Y
alpha-glucan water dikinase|glucan water dikinase|Y
cannabinoid receptor type 1|cannabinoid 1 receptor|Y
least common multiple|lowest common multiple|Y
short interfering ribonucleic acid|small interfering ribonucleic acid|Y
diphenyl dimethyl dicarboxylate|biphenyl dimethyl dicarboxylate|Y
left anterior descending artery|left anterior descending branch|Y
wingless-type MMTV integration site family member|Wingless-type MMTV integration site|Y
gynecology|gynecologist|Y
cytoskeleton|cytoskeletal|Y
regulatory protein|regulatory particle|N
vascular closure staple|vascular closure system|N
Staggered Spondaic Word|staggered spondaic word|Y
adenovirus type 5 E1A protein|adenovirus 5 E1A protein|Y
melanocortin receptor 4|melanocortin 4 receptor|Y
medial basal hypothalamus|medio-basal hypothalamic|Y
human platelet alloantigen|human platelet antigen|Y
delayed sleep phase syndrome|delayed sleep-phase syndrome|Y
recurrent laryngeal neuropathy|recurrent laryngeal nerve|Y
conventional mechanical ventilation|controlled mechanical ventilation|N
human immunodeficiency virus infection|human immunodeficiency viral infection|Y
splenic vein thrombosis|splanchnic vein thrombosis|N
coproporphyrinogen oxidase deficiency|coproporphyrinogen oxidase|N
volume weighted computed tomography dose index|volume-weighted computed tomographic dose index|Y
Global Assessment Questionnaire|Global Assessment Question|Y
polarisable continuum model|polarized continuum model|Y
cerebral amyloid angiopathy|cerebrovascular amyloid angiopathy|Y
ion chromatographic|ion chromatography|Y
ganglion cell layer|granule cell layer|N
erythrogenic toxin type A|erythrogenic toxin A|Y
human cerebral endothelial cell|human corneal epithelial cell|N
classification and regression tree analysis|classification and regression tree|Y
inferior parietal lobe|inferior parietal lobule|Y
parainfluenza virus 1|parainfluenza virus type 1|Y
central nervous system leukemia|central nervous system leukæmia|Y
vascular endothelial growth factor|vascular endothelium growth factor|Y
most comfortable loudness|most comfortable loudness level|Y
nearfield acoustic holography|near-field acoustical holography|Y
high mobility group box protein 1|high mobility group box 1|Y
voltage sensitive calcium channel|voltage sensitive Ca2+ channel|Y
recombinant human platelet derived growth factor B chain|recombinant human platelet-derived growth factor-BB|Y
mixed lymphocyte tumor cell|mixed lymphocyte tumor culture|Y
design change|dressing change|N
anti-hepatitis A virus antibody|antihepatitis A virus|Y
inorganic phosphate|inorganic phosphorus|N
γ-amino butyric acid type B receptor|γ-amino-butyric acid B receptor|Y
multislice computed tomography angiography|multislice computed tomography coronary angiography|Y
Toll-like receptor-4|toll-like receptor-4|Y
American Genetic Association|American Goiter Association|N
Attentional Network Test|Attention Network Task|Y
prostate acid phosphatase|phosphatidic acid phosphatase|N
malignant papillary mesothelioma|malignant pleural mesothelioma|N
observed effect concentration|no observed effect concentration|N
complement receptor 1|complement receptor type 1|Y
ventroposteromedial nucleus|ventral posteromedial nucleus|Y
lymphatic vessel density|lymphatic vascular density|Y
American Society of Anesthesiologists Status 1|American Society of Anesthesiologists Class 1|Y
Ski-related novel gene N|ski-related novel protein N|N
globohexaosylceramide-keyhole limpet hemocyanin QS-21 vaccine|Globo H-keyhole limpet hemocyanin QS-21 vaccine|Y
particle-induced X-ray emission analysis|proton induced X-ray emission analysis|Y
adenovirus 2|adenovirus type 2|Y
small ubiquitin-like modifier-4|small ubiquitin-related modifier-4|Y
radiation-induced fibrosarcoma|radiation-induced fibrosarcoma-1|Y
intrastromal corneal ring segment|intracorneal ring segment|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia 1|Y
transient receptor potential canonical 3|transient receptor potential canonical type 3|Y
intergenic transcribed spacer|internal transcribed spacers|Y
low molecular weight protein|low molecular weight proteinuria|N
permissible exposure limit|permissible exposure level|Y
peripherally inserted central venous catheter|peripherally inserted central catheter|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Grade I|Y
mouse immunoglobulin G|monomeric immunoglobulin G|N
mean fluorescent intensity|median fluorescent intensity|N
American Society of Anesthesiologists class II|American Society of Anaesthesiology physical status II|Y
pathologic complete response|pathological complete remission|Y
ultraviolet A|ultraviolet light A|Y
Academy of Psychosomatic Medicine|Academy of Physical Medicine|N
human immunodeficiency virus 1 antibody|human immunodeficiency virus type 1 antibody|Y
basal core promoter|basic core promoter|Y
transfer factor|transfer function|N
immunofluorescence antibody test|immunofluorescent antibody test|Y
solid organ transplantation|solid organ transplant|Y
laparoscopic appendicectomy|laparoscopic appendectomy|Y
thromboelastogram|thrombelastography|Y
relative error|refractive error|N
Behavioral Assessment System for Children, second edition|Behavior Assessment System for Children, second edition|Y
capillary electrochromatography|capillary electrochromatographic|Y
bone mineral density|bone mineral densitometry|N
American Society of Anesthesiologists physical status 5|American Society of Anesthesiologists status 5|Y
sex determining region Y gene|sex determining region Y|N
N-acetylneuraminic acid|N-acetyl neuraminic acid|Y
tropomyosin receptor kinase B|tropomyosin related kinase B|Y
receptor-type protein tyrosine phosphatase beta|receptor protein tyrosine phosphatase beta|Y
mixed leucocyte culture test|mixed lymphocyte culture test|Y
acute myeloid leukemia cell|acute myelogenous leukemia cell|Y
Patient Health Questionnaire 9|9-item Patient Health Questionnaire|Y
norleucinal|norleucine|Y
mean pulmonary arterial pressure|mean pulmonary artery pressure|Y
headout immersion|head-out water immersion|Y
Mini Mental Status Exam|Mini Mental State Exam|Y
lipoprotein-depleted serum|lipoprotein-deprived serum|Y
hæmagglutinin neuraminidase|hemagglutinin-neuraminidase protein|Y
near infrared fluorescent|near-infra-red fluorescent|Y
entero-haemorrhagic Escherichia coli|enterohemorrhagic Escherichia coli|Y
nitric oxide synthase|nitric oxide synthase 1|Y
chronic lymphatic leucemia|chronic lymphocytic leucemia|Y
quantitative structure activity relationship study|quantitative structure-affinity relationship study|Y
systemic arterial blood pressure|systolic arterial pressure|N
hyperparathyroidism|hypoparathyroidism|N
breast conservation therapy|breast conserving therapy|Y
lymphocyte function-associated antigen|lymphocyte-function-associated antigen|Y
cyclin dependent kinase inhibitor|cyclin kinase inhibitor|Y
atherosclerotic occlusive disease|aortic occlusive disease|N
adrenalectomy|adrenalectomise|Y
maximal mouth opening|maximum mouth opening|Y
second generation|second filial generation|Y
consumer driven health plan|consumer-directed health plan|Y
human papillomavirus|human papillomavirus 16|N
volume weighted computed tomographic dose index|volume-weighted computed tomography dose index|Y
speech and language therapy|speech and language therapist|Y
random-amplified polymorphic DNA analysis|random amplified polymorphic DNA analysis|Y
Cortical somatosensory evoked potential|cortical somatosensory-evoked potential|Y
organophosphorus pesticide|organophosphate pesticide|Y
delta-aminolevulinic acid dehydratase activity|aminolevulinic acid dehydratase|N
N(2)-(4-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate|butyl-phenyl-deoxyguanosine triphosphate|Y
extra-intracranial bypass|extra-intracranial artery bypass|Y
left ventricular systolic|left ventricular systolic pressure|Y
collisionally induced dissociation|collisional induced dissociation|Y
unrelated cord blood transplant|umbilical cord blood transplant|N
medial|median|N
myelodystrophic syndrome|myelo-dysplastic syndrome|Y
prostate cancer|prostatic cancer|Y
magnetic resonance angiogram|magnetic resonance angiography|Y
electron capture detection|electron capture detector|Y
malignant mixed müllerian tumor|malignant mixed Mullerian tumor|Y
myocyte enhancer factor 2C|muscle enhancer factor 2C|Y
bovine rhinovirus|bovine rotavirus|N
autoimmune chronic active hepatitis|autoimmune type chronic active hepatitis|Y
anti-matrix metallopeptidase-7 antibody|anti-matrix metalloprotease-7 antibody|Y
progesterone induced blocking factor|progesterone-induced blocking factor|Y
Sint Radboud University Hospital|Saint Radboud University Hospital|Y
coatomer protein complex I|coat protein complex I|Y
atrial effective refractory period|antegrade effective refractory period|N
Salmonella typhimurium|Salmonella typhimurium mitogen|N
B cell precursor acute lymphoblastic leukemia|precursor B cell acute lymphoblastic leukemia|Y
receptor-like protein-tyrosine phosphatase ψ|receptor protein tyrosine phosphatase psi|Y
nuclear corepressor|nuclear receptor corepressor|Y
herpes simplex virus thymidine kinase gene|herpes simplex virus thymidine kinase|N
ventroposteromedial nucleus|ventral posterior medial nucleus|Y
conditioned stimulus|conditioning stimulus|Y
maximal expiratory flow|maximum expiratory flow rate|Y
x-ray repair cross-complementing gene 1|x-ray repair cross complementing 1|Y
cytotoxic lymphoid line|cytotoxic T lymphocyte line|Y
nonheart beating donor|non-heart-beating donor|Y
primed-lymphocyte test|primed lymphocyte testing|Y
controlled ecological life support system|closed ecological life support system|Y
hypercapnic ventilatory responsiveness|hypercapnic ventilatory response|Y
metastatic colorectal carcinoma|metastatic colorectal cancer|Y
interferon consensus sequence binding protein|consensus sequence binding protein|Y
untranslated region|untranslational region|Y
interleukin-12 receptor β 1|interleukin-12 receptor β 1 chain|Y
random-amplified polymorphic DNA-polymerase chain reaction|randomly amplified polymorphic DNA-polymerase chain reaction|Y
metatarsophalangeal joint|metatarso-phalangeal joint|Y
mutation frequency|mutant frequency|Y
neuromuscular blockade|neuromuscular blocker|Y
myofibril fragmentation index|myofibrillar fragmentation index|Y
Oklahoma State University|Ohio State University|N
carcinoid valvular heart disease|cardiovascular heart disease|N
N-terminal-pro-brain-type natriuretic peptide|N-terminal proB-type natriuretic peptide|Y
Cdc kinase subunit 1|cyclin kinase subunit 1|N
whole brain radiotherapy|whole breast radiotherapy|N
human adenovirus 21|human adenovirus type 21|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloprotease-3 antibody|Y
miniature inverted repeat transposable element|miniature inverted-repeat transposable element|Y
fragile X mental retardation 1|fragile X mental retardation 1 gene|N
Simplified Acute Physiology Score|simplified acute physiology score|Y
middle aortic syndrome|midaortic syndrome|Y
endomysial antibody|antiendomysium antibody|Y
interleukin-3 receptor-α|interleukine-3 receptor α chain|Y
ribonuclease inhibitor protein|ribonuclease inhibitor|Y
apoprotein A-I|apolipoprotein AI|Y
synaptosomal associated protein-25 kDa|synaptosome-associated protein 25 kDa|Y
beta-site amyloid precursor protein cleaving enzyme 1|beta-site amyloid precursor protein-cleaving enzyme|Y
juvenile laryngeal papillomatosis|juvenile laryngeal papilloma|Y
peptide histidine isoleucinamide|peptide histidine isoleucine|Y
Conus striatus|Colius striatus|N
pleural mesothelial cell|peritoneal mesothelial cell|N
state-dependent learning|State-Dependent Learning|Y
envelope protein|envelope glycoprotein|N
rostroventromedial medulla|rostral ventro-medial medulla|Y
fumonisin B(1)|fumonisin B1|Y
endothelial protein C receptor|endothelial cell protein C receptor|Y
acute myelocytic leukemia|acute myeloid leukemic|Y
atrioventricular reciprocating tachycardia|atrioventricular re-entry tachycardia|Y
osteoporotic|osteoporosis|Y
anthropomorphic test device|anthropomorphic test dummy|Y
Src homology domain 2|Src homology region 2|Y
non-tuberculous mycobacteriosis|nontuberculous mycobacterial|Y
American Society of Anaesthesiology status III|American Society of Anesthesiologists physical status III|Y
equine herpesvirus type 1|equine herpesvirus 1|Y
macrocreatine kinase 2|macrocreatine kinase type 2|Y
postinhibition rebound|postinhibitory rebound|Y
troponin|troponin T|N
acute lateral sclerosis|anterolateral sclerosis|N
guanylnucleotide exchange factor|guanine nucleotide exchange factor|Y
endo-bronchial ultrasonography|endobronchial ultrasonography|Y
anti-tissue transglutaminase|antitissue transglutaminase antibody|Y
splenic vein thrombosis|superficial vein thrombosis|N
inositol trisphosphate receptor|inositol 1,4,5-trisphosphate receptor|Y
trinitro-toluene|trinitrotoluene|Y
time of flight mass spectrometry|time-of-flight mass spectrometer|Y
2-methoxyacetic acid|methoxyacetic acid|Y
ultrasonic cardiography|ultrasound cardiography|Y
Frasier syndrome|Fisher syndrome|N
paired box 8|paired box gene 8|Y
hypoxia inducible transcription factor|hypoxia inducible transcription factor 1|Y
ventrolateral nucleus|ventral lateral nucleus|Y
left costal margin|lower costal margin|N
giant axon neuropathy|giant axonal neuropathy|Y
hemolymph stimulatory factor|hemolymph stimulatory factor (Manduca)|Y
posttransplant lymphoproliferative disease|posttransplantation lympho-proliferative disorder|Y
X-ray cross complementing group 1|x-ray cross-complementing 1|Y
persistent müllerian duct syndrome|persistent Mullerian duct syndrome|Y
polypyrimidine tract|polypurine tract|N
beta adrenergic receptor kinase 1|β adrenergic receptor kinase-1|Y
multiplex ligation dependent probe amplification|multiple ligation-dependent probe amplification|Y
high field asymmetric waveform ion mobility spectrometry|field asymmetric ion mobility spectrometry|Y
antigalactose|anti-galactosyl|N
tracheobronchomalacia|tracheobronchomegaly|N
corticotropin releasing hormone receptor type 2|corticotrophin-releasing-hormone receptor-2|Y
ischæmia-reperfusion|ischemia reperfusion|Y
static magnetic field|main magnetic field|N
second transmembrane domain|transmembrane domain 2|Y
Physical Component Score|Physical Composite Score|Y
chromosomal replication origin|chromosomal DNA replication origin|Y
Salmonella enterica serotype Paratyphi A|Salmonella enterica serovar Paratyphi A|Y
hormone binding domain|heparin binding domain|N
Von Willebrand disorder|Von Willebrand disease|Y
unilateral ovariectomy|unilaterally ovariectomized|Y
glucose-regulated protein-78|glucose-regulated protein|N
blastic phase|blast phase|Y
vesicular monoamine transporter 1|vesicular monoamine transporter type 1|Y
electrical stimulation|electrical stimulus|Y
variant antigenic type|variant antigen type|Y
light harvesting complex 2|major light-harvesting complex|Y
sub-mucous|submucosa|Y
very low frequency power|very low frequency|N
tricuspid regurgitation velocity|tricuspid regurgitant jet velocity|Y
lumbar vertebra 3|3rd lumbar vertebra|Y
prostaglandin G2|prostaglandin G(2)|Y
enterochromaffinlike|enterochromaffin like|Y
counterflow centrifugal elutriation|counterflow centrifugation elutriation|Y
D-Pen2,D-Pen5 enkephalin|[D-Pen2, D-Pen5]enkephalin|Y
cardiotocogram|cardiotocographic|Y
programmed temperature vapourization|programmed-temperature vapouriser|Y
American College of Physicians|American College of Pharmacists|N
parainfluenza virus 3|parainfluenza virus type 3|Y
operational psychodynamic diagnosis|Operationalised Psychodynamic Diagnosis|Y
dynamic lung compliance|dynamic compliance|Y
upper respiratory infection|upper respiratory illness|Y
β-aminopropionitrile|beta aminopropionitrile|Y
para-chloromercuribenzenesulfonate|p-chloromercuribenzene sulfonate|Y
equid herpesvirus type 3|Equid herpesvirus 3|Y
C-C motif chemokine receptor-2|C-C chemokine receptor 2|Y
environmental|environment|Y
laparoscopic-assisted distal gastrectomy|laparoscopy-assisted distal gastrectomy|Y
intermediate care facility|intensive care facility|N
American Society of Anesthesiology status 4|American Society of Anesthesiologists Class 4|Y
hydrophobic organic compound|hydrophobic organic contaminant|N
cyclical vomiting syndrome|cyclic vomiting syndrome|Y
cardiac fibroblast|chick fibroblast|N
progressive systemic scleroderma|progressive systemic sclerosis|Y
atrioventricular nodal re-entry tachycardia|atrioventricular nodal re-entrant tachycardia|Y
critical fusion frequency|critical flicker frequency|Y
computerised tomographic scan|computerized tomography scan|Y
vertical vestibulo-ocular reflex|vestibuloocular reflex|N
autologous mixed lymphocyte reaction|autologous mixed lymphocyte response|Y
approximate|approximately|Y
viral genome-linked protein|genome-linked protein|Y
eukaryotic translation elongation factor 1alpha|eukaryotic translation elongation factor 1A|Y
stretch activated ion channel|stretch activated channel|Y
American Society of Anaesthesiology Grade V|American Society of Anesthesiologists class V|Y
minimum infective dose|minimal infective dose|Y
tumor necrosis factor beta|tumour necrosis factor-β|Y
juvenile chronic myelocytic leukemia|juvenile chronic myelogenous leukemia|Y
left anterior descending artery|left anterior descending coronary artery|Y
corneal epithelial cell|corneal endothelial cell|Y
Center for Epidemiological Studies-Depression Scale|Centre for Epidemiologic Studies Depression Scale|Y
cobalamin binding protein|calcium binding protein|N
fluid restriction|food restriction|N
nucleolus organiser|nucleolar organizer|Y
factor-VIII pro-coagulant activity|factor VIII coagulant activity|Y
color coded duplex sonography|color-coded Duplex sonography|Y
human adenovirus type 14|human adenovirus 14|Y
tert-butylhydroperoxide|t-butylhydroperoxide|Y
2'-deoxyguanosine 5'-monophosphate|deoxyguanosine monophosphate|Y
anti-matrix metalloprotease-7 antibody|anti-matrix metallopeptidase 7 antibody|Y
deterioration index|desaturation index|N
nonspecific interstitial pneumonitis|nonspecific interstitial pneumonia|Y
locally advanced cervical carcinoma|locally advanced cervical cancer|Y
oral facial digital syndrome type VI|oro-facio-digital syndrome type VI|Y
recurrence group|reference group|N
migration inhibition test|macrophage migration inhibition test|N
uric acid|uridylic acid|N
inducible nitric oxide synthase enzyme|inducible nitric oxide synthase|Y
American Society of Anesthesiology status 5|American Society of Anesthesiologists status 5|Y
acetylcholine-induced current|acetylcholine-induced inward current|N
mouse epidermal growth factor|murine epidermal growth factor|Y
Charcot-Marie-Tooth syndrome type 1B|Charcot-Marie-Tooth disease type 1B|Y
para-chloromercuriphenylsulfonate|parachloromercuriphenylsulfonic acid|N
pentaerythrityl triacrylate|penta-erythritol triacrylate|Y
hepatic arterial flow|hepatic artery flow|Y
matrix metalloprotease 3|matrix metalloproteinase 3|Y
virologic failure|virological failure|Y
dimethylsulfide|dimethylsulfate|N
interaural time difference|inter-aural time difference|Y
International Psychoanalytical Association|International Psychogeriatric Association|N
positive cofactor 4|positive coactivator 4|Y
primary cerebral lymphoma|primary cardiac lymphoma|N
metabolic bone disease|metastatic bone disease|N
laterodorsal tegmental|laterodorsal tegmental nucleus|Y
marmoset chorionic gonadotropin|chorionic gonadotropin|N
zonula occludens 3|zonula occludens 3 protein|Y
lymphoid protein tyrosine phosphatase|lymphoid tyrosine phosphatase|Y
fronto-temporal dementia|fronto-temporal degeneration|Y
Equid herpesvirus 2|equine herpesvirus 2|Y
depressive spectrum disease|depression spectrum disease|Y
thymus-expressed chemokine|Thymus-expressed chemokine|Y
alpha glycerophosphate dehydrogenase|alpha glycerol-3-phosphate dehydrogenase|Y
thymus independent type 1 antigen|T-independent type-1 antigen|Y
m-chlorophenylbiguanide|meta-chlorophenyl-biguanide|Y
right lower lid|right lower lobe|N
olive mill wastewater|olive mill waste|Y
malnutrition, inflammation and atherosclerosis syndrome|malnutrition-inflammation-atherosclerosis syndrome|Y
differential display reverse transcriptase polymerase chain reaction|differential display reverse transcription polymerase chain reaction|Y
light-harvesting chlorophyll a/b-binding protein-II|light-harvesting chlorophyll a/b protein II|Y
N terminal probrain natriuretic peptide|N-terminal proB-type natriuretic peptide|Y
laser assisted in-situ keratomileusis|laser in situ keratomileusis|Y
IL-2 receptor alpha-chain|IL-2 receptor-alpha|Y
methanotrophic bacterium|methanogenic bacterium|N
p-nitroacetophenone|para-nitroacetophenone|Y
pro-collagen type III peptide|pro-collagen III peptide|Y
sarcoplasmic reticular|sarcoplasmatic reticulum|Y
continuous medical education|continuing medical education|Y
rifampicin|rifampin|Y
Kirsten rat sarcoma viral oncogene|Kirsten rat sarcoma viral oncogene homolog|Y
peripheral obstructive arterial disease|peripheral occlusive arterial disease|Y
resonance Raman scattering|resonance Rayleigh scattering|N
cottontail rabbit papillomavirus|cotton-tail rabbit papilloma virus|Y
N,N,N',N'-tetramethylethylenediamine|tetramethylethylenediamine|Y
trimethylamine N-oxide reductase|trimethylamine oxide reductase|Y
immune complex dissociated|immune complex dissociation|Y
B cell prolymphocytic leukemia|prolymphocytic leukemia|Y
tuberomamillary nucleus|tubero-mammillary nucleus|Y
hydroxyurea|hydroxy-urea|Y
insulin sensitive|insulin sensitivity|Y
American Society of Anesthesiologists grade 2|American Society of Anaesthesiologists Status 2|Y
crude mortality ratio|crude mortality rate|N
cortical magnetic stimulation|cervical magnetic stimulation|N
time-resolved fluorescence resonance energy transfer|time resolved fluorescence resonance energy transfer|Y
locus control region|long control region|N
glycerolphosphate acyltransferase|glycerophosphate acyltransferase|Y
blood lead concentration|blood lactate concentration|N
porcine circovirus 1|porcine circovirus type 1|N
retinal pigmented epithelium cell|retinal pigment epithelial cell|Y
radioimmunoprecipitation|radio-immune precipitation|Y
retinoid X receptor-β|retinoid X receptor beta|Y
transforming growth factor-beta type II receptor|type II transforming growth factor beta receptor|Y
brain-type natriuretic peptide|brain natriuretic peptide|Y
human adenovirus type A|human adenovirus serotype A|Y
pre B acute lymphoblastic leukemia|precursor B cell acute lymphoblastic leukemia|Y
local-regional control|loco-regional control|Y
American Society of Anesthesiology Class 4|American Society of Anaesthesiology grade IV|Y
severe combined immunodeficiency|severe combined immune deficiency|Y
biomedical engineering technician|biomedical equipment technician|N
thoracic radiotherapy|thoracic radiation therapy|Y
mitotic phase cell|mitosis phase cell|Y
octachlorodibenzo-p-dioxin|octachlorodibenzodioxin|Y
triphenylphosphate|triphenylphosphite|N
activator protein 1|activation protein 1|Y
sustained virological response rate|sustained virological responder|N
proliferative index|proliferating index|Y
slow action potential|sensory action potential|N
quantitative reverse transcription polymerase chain reaction|quantitative reverse transcriptase polymerase chain reaction|Y
inositol trisphosphate receptor|Inositol 1,4,5-trisphosphate receptors|Y
Tourette syndrome|Turner syndrome|N
systemic inflammatory response syndrome|systemic inflammatory reaction syndrome|Y
renal pelvic dilatation|renal pelvis dilatation|Y
Gadolinium diethylene triamine pentaacetic acid|gadolinium-diethylenetriamine pentaacetic acid|Y
resonance enhanced multiphoton ionisation|resonance-enhanced multi-photon ionisation|Y
large tumor antigen|large T antigen|Y
South African|South America|N
intra-vaginally|intravaginal|Y
verbal rating scale|verbal rating score|Y
postpercutaneous transluminal coronary angioplasty|post-percutaneous transluminal coronary angiogram|Y
relative biological effect|relative biological effectiveness|Y
immunohistochemical|immunohistochemically|Y
near infrared fluorescence imaging|near-infra-red fluorescent imaging|Y
antiretroviral|anti-retroviral drug|Y
single-photon emission computerised tomography|single photon emission computer tomography|Y
smooth lipo-polysaccharide|smooth lipopolysaccharide|Y
interleukine-13 receptor α 1-subunit|interleukine-13 receptor α 1|Y
hormone resistant prostate cancer|hormone refractory prostate cancer|Y
electropneumography|electro-pneumogram|Y
antimicrobial resistant organism|antibiotic resistant organism|Y
American Society of Anesthesiologists physical status III|American Society of Anesthesiology physical status III|Y
diphtheria toxin|diphtheria toxoid|Y
director|direction|N
computed tomographic enterography|computed tomography enterography|Y
angiotensin receptor blocker|angiotensin II receptor blocker|Y
living donor lobar lung transplant|living donor lobar lung transplantation|Y
tungsten oxide|tungsten trioxide|Y
Mini Mental State Evaluation|MiniMental State Examination|Y
living related donor transplant|living related donor transplantation|Y
nucleolar organising region|nucleolar organiser region|Y
dehydrotestosterone|dihydro-testosterone|N
average peak flow velocity|average peak velocity|Y
white matter|white male|N
pulmonary vein stenosis|pulmonary valve stenosis|N
malonyl CoA:acyl carrier protein transacylase|malonyl coenzyme A:acyl carrier protein transacylase|Y
American Society of Anesthesiology Class 2|American Society of Anaesthesiology physical status II|Y
percutaneous coronary intervention|percutaneous intervention|Y
Von Hippel Lindau|Von Hippel Lindau gene|N
Kunitz protease inhibitor|protease inhibitor|N
murine beta-defensin 4|mouse beta-defensin 4|Y
Choristoneura fumiferana nuclear polyhedrosis virus|Choristoneura fumiferana nucleopolyhedrosis virus|Y
autoimmune polyglandular syndrome type 1|autoimmune polyendocrine syndrome type 1|Y
glucose transporter type 1 deficiency syndrome|glucose transporter 1 deficiency syndrome|Y
T cell intracellular antigen 1|intracellular antigen|N
ponto-geniculo-occipital|pontogeniculo-occipital|Y
stress related mucosal damage|stress related mucosal disease|Y
von Hippel-Lindau tumor suppressor protein|von Hippel-Lindau tumour-suppressor protein|Y
Bournemouth Disability Questionnaire|Brief Disability Questionnaire|N
apnea and hypopnoea index|apnea hypopnea index|Y
non-rapid eye movement|non-rapid-eye-movement|Y
δ-sleep-inducing peptide|delta sleep inducing peptide|Y
post-mortem computed tomography|postmortem computed tomographic|Y
Inductively coupled plasma-mass spectroscopy|inductively coupled plasma mass spectrometry|Y
dopamine 3 receptor|dopamine D3 receptor|Y
intact parathyroid hormone|intact parathormone|Y
coronary artery calcification score|coronary artery calcium score|Y
GTP binding protein alpha(i1) subunit|G-protein alpha(i1) subunit|Y
ethyldehydroxysparsomycin|ethyldeshydroxysparsomycin|Y
cytochrome P450 3A4|cytochrome P-450 isoform 3A4|Y
Stichodactyla helianthus neurotoxin|Stichodactyla helianthus toxin|Y
glutamine synthase|glutamine synthetase|Y
IL4 receptor alpha|IL4 receptor alpha chain|Y
human parainfluenza virus 3|human parainfluenza virus type 3|Y
dimethylglyoxime|dimethylglycine|N
volume flow rate|volumetric flow rate|Y
multirow detector computed tomography|multi-detector-row computed tomography|Y
glucosephosphate|glycerophosphate|N
American Society of Anaesthesiologists status 3|American Society of Anesthesiology physical status 3|Y
post-radiotherapy|postradiotherapy|Y
Parastrongylus costaricensis|Phaseolus costaricensis|N
PGI(2) synthase|PGI synthase|Y
type 2 corticotrophin-releasing hormone receptor|corticotrophin-releasing-hormone receptor-2|Y
cyclic AMP responsive element|cyclic AMP response element|Y
ultrasonically activated shears|ultrasonically-activated scalpel|N
inferior myocardial infarction|impending myocardial infarction|N
geranylgeranylpyrophosphate|geranylgeranyl diphosphate|Y
diethylenetriaminepentaacetate|diethylenetriaminepentacetic acid|N
plasminogen activator antigen|tissue plasminogen activator antigen|Y
human adenovirus 40|human adenovirus type 40|Y
lymphovascular space involvement|lymph vascular space involvement|Y
histamine methyltransferase|histone methyltransferase|N
interdigestive myo-electric complex|interdigestive motor complex|Y
glucocerebrosidase|glucocerebrosidase gene|N
Haloarcula marismortui|Halobacterium marismortui|Y
major cytogenetic remission|major cytogenetic response|Y
microelectromechanical system|micro electromechanical systems|Y
vanilloid receptor type 1|vanilloid receptor 1|Y
trifluoroacetylated|trifluoroacetate|Y
visually evoked cortical potential|visual evoked cortical potential|Y
simian retrovirus|simian type D retrovirus|N
routine electroencephalogram|resting electroencephalography|N
chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyneuropathy|Y
neu laxova syndrome|Neu-Laxova syndrome|Y
percutaneous nephrolitholapaxy|percutaneous nephrolithotripsy|Y
beta amyloid precursor protein cleaving enzyme|beta-site amyloid precursor protein cleaving enzyme 1|Y
mega-dalton|megadalton|Y
zona reticularis|zona reticulata|Y
reconstituted human epidermis|reconstituted human epithelium|N
meta-chlorophenyl piperazine|m-chlorophenylpiperazine|Y
alternative reading frame|alternate reading frame|Y
Fugl-Meyer assessment|Fugl-Meyer Assessment Scale|Y
real time quantitative reverse-transcription polymerase chain reaction|real time quantitative reverse transcriptase polymerase chain reaction|Y
functional electrical stimulation|field electrical stimulation|N
lactosaminated human serum albumin|lactosylated human serum albumin|N
postmeiotic segregation 1|postmeiotic segregation increased 1|Y
mucus|mucous|Y
monoamino oxidase B|monoamine oxidase B|Y
pulmonary arterial wedge pressure|pulmonary artery wedge pressure|Y
plaque forming unit|plaque-forming units|Y
copy number variant|copy number variation|Y
negative likelihood ratio|positive likelihood ratio|N
G protein alpha3 inhibitory subunit|G protein alpha i3 subunit|Y
human parathyroid hormone-related peptide|human parathyroid hormone-related protein|Y
tetracycline resistant|tetracycline resistance|Y
insulin-like growth factor I receptor|insulinlike growth factor receptor|Y
epidermal growth factor receptor|epithelial growth factor receptor|Y
essential hypertension|low renin essential hypertension|N
American Society of Anaesthesiology status IV|American Society of Anaesthesiologists grade 4|Y
valvular calcification|vascular calcification|N
maximum expiratory flow volume curve|maximal expiratory flow volume curve|Y
magnetoencephalograph|magnetoencephalogram|Y
perchloroethene|perchloroethylene|Y
computed tomography perfusion|computed tomography perfusion imaging|Y
nucleus reticularis lateralis|nucleus recessus lateralis|N
nonselective cation channel|non-selective cation|Y
interleukine-13 receptor α-1 chain|interleukin-13 receptor α 1|Y
slight|slightly|Y
adenine nucleotide translocator 2|adenine nucleotide translocase 2|Y
maximal voluntary ventilation|maximum voluntary ventilation|Y
double balloon endoscope|double balloon enteroscope|Y
very low birthweight|low birthweight|N
insulinlike growth factor 1 receptor|insulin-like growth factor receptor-I|Y
magnesium adenosinetriphosphatase|adenosinetriphosphatase|N
ubiquitin carboxyl-terminal hydrolase L5|ubiquitin carboxyterminal hydrolase L5|Y
laryngoonychocutaneous syndrome|laryngo-onychocutaneous syndrome|Y
acute lymphatic leukemia|acute lymphoid leukemia|Y
human acquired immune deficiency syndrome|human acquired immunodeficiency syndrome|Y
medial superior olivary nucleus|medial superior olive|Y
digitally reconstructed radiograph|digitally-reconstructed radiograph|Y
transient receptor potential channel 3|transient receptor potential canonical 3|Y
intrauterine growth restricted|intra-uterine-growth-retarded|Y
histamine H(3)-receptor|histamine 3 receptor|Y
tumor control dose|50% tumor control dose|Y
extracellular signal-regulated kinase|extracellular-signal-regulated kinase 2|N
heart transplantation|heart transplant|Y
membrane potential|transmembrane potential|Y
aldehyde dehydrogenase class 1|aldehyde dehydrogenase|N
reversive post-optokinetic nystagmus|reverse post-optokinetic nystagmus|Y
anti-matrix metallopeptidase 3 antibody|anti-matrix metalloproteinase-3 antibody|Y
American Health Foundation|American Hepatic Foundation|N
uroporphyrinogen|uroporphyrinogen I|N
propionic acidemia|propionic acid|N
fluorine-18-fluorodeoxyglucose positron emission tomography|fluorodeoxyglucose positron emission tomography|Y
stromal derived factor 1alpha|stromal cell-derived factor-1alpha|Y
intensity modulated radiotherapy|intensity modulated radiation therapy|Y
Saint George Respiratory Questionnaire|St George Respiratory Questionnaire|Y
knee extension|knee extensor|N
3,4-dihydroxyphenylacetic acid|dihydroxyphenylacetic acid|Y
laser scanning confocal microscopy|laser scanning confocal microscope|Y
platelet-derived growth factor receptors|platelet derived growth factor receptor|Y
protease-activated receptor-2|protease-activated receptor 2|Y
trans-oesophageal echo|trans-oesophageal echocardiogram|Y
microtubule|microtubular|Y
multi-detector-row computed tomography scan|multi-detector computed tomography scan|Y
maleic acid|maslinic acid|N
unspecified respiratory disease|upper respiratory disease|N
alpha-1,3 galactosyltransferase|alpha-glucosyltransferase|N
American Society of Anaesthesiologists status 5|American Society of Anesthesiologists physical status 5|Y
thyroid-binding globulin|thyroxin binding globulin|Y
myeloid differentiation protein 2|myeloid differentiation factor 2|Y
American Society of Anesthesiologists Class 1|American Society of Anaesthesiology class I|Y
S-adenosylhomocysteine|adenosylhomocysteine|Y
myeloid cell leukemia sequence 1 protein|myeloid cell leukemia 1 protein|Y
minimum local anesthetic concentration|minimum local analgesic concentration|Y
capillary filtration coefficient|capillary filtration capacity|N
vitellogenin binding protein|victorin binding protein|N
staphylococcal enterotoxin B|Staphylococcus aureus enterotoxin B|Y
coronary microvascular endothelial cell|microvascular endothelial cell|N
transforming growth factor-beta|type β transforming growth factor|Y
Employee Retirement Income Security Act of 1974|Employee Retirement Income Security Act|Y
entero-haemorrhagic Escherichia coli|entero-haemorrhagic E coli|Y
presenilin 1-associated protein|presenilin associated protein|Y
American Academy of Optometry|American Academy of Ophthalmology|N
autoimmune hemolytic anemia|acute hemolytic anemia|N
X-ray absorption near edge spectroscopy|X-ray absorption near edge structure spectroscopy|Y
hepatitis B viral infection|hepatitis B virus infection|Y
estrogen receptor alpha|estrogen receptor 1|N
cannabinoid type 1 receptor|cannabinoid receptor|Y
X-linked inhibitor of apoptosis protein|X-linked inhibitor-of-apoptosis protein|Y
X-linked lymphoproliferative disorder|X-linked lympho-proliferative disease|Y
multiple congenital abnormality|multiple congenital anomaly|Y
left upper lobe|left upper lobectomy|N
Csk binding protein|CREB binding protein|N
supravalvular aortic stenosis|subvalvular aortic stenosis|N
synthetic oviductal fluid|synthetic oviduct fluid|Y
transcription factor E3|transcription factor μE3|Y
laparoscopic-assisted gastrectomy|laparoscopy-assisted gastrectomy|Y
computed tomography angiogram|computed tomography angiography|Y
anti-perinuclear factor|antiperinuclear factor|Y
scavenger receptor|class A scavenger receptor|N
gravitoinertial acceleration|gravito-inertial acceleration|Y
St George Respiratory Questionnaire|George's Respiratory Questionnaire|Y
cytotoxic T lymphocyte antigen 4|cytotoxic T lymphocyte-associated antigen 4|Y
receptor-linked protein-tyrosine-phosphatase alpha|receptor-like protein tyrosine phosphatase-α|Y
computed tomography arterial portography|computed tomography during arterial portography|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor-II messenger RNA-binding protein|Y
peripheral electrical stimulation|programmed electrical stimulation|N
major-histocompatibility-complex class I-related chain A|major histocompatibility complex class I chain related gene A|Y
excision repair cross-complementing 2|excision repair cross complementation group 2|Y
phosphorylcholine|phosphatidylcholine|N
myocyte specific enhancer factor 2C|myocyte specific enhancer binding factor 2C|Y
respiratory care|respiratory chain|N
University of Washington Quality of Life Questionnaire|University of Washington quality-of-life questionnaire|Y
RNA arbitrarily primed polymerase chain reaction|arbitrarily primed polymerase chain reaction|N
bradykinin 2 receptor|bradykinin B(2) receptor|Y
fragile histidine triad|fragile histidine triad gene|N
adult thymectomy|adult thymectomized|Y
thermoluminescent detector|thermoluminescent dosimetry|Y
insulin-like growth factor-II mRNA-binding protein-3|insulin-like growth factor II messenger RNA-binding protein 3|Y
12-lead electrocardiography|12 lead electrocardiogram|Y
insulin related substrate|insulin receptor substrate|Y
maximum oxygen uptake|maximal oxygen uptake|Y
age-associated memory impairment|age associated memory impairment|Y
human adenovirus type D|human adenovirus serotype D|Y
vasodilator-stimulated phosphoprotein|vasodilator stimulated phosphoprotein|Y
liquid chromatography negative ion electrospray tandem mass spectrometry|liquid chromatography-electrospray ionization tandem mass spectrometry|Y
thermo-luminescent dosimetry|thermoluminescent dosimetry|Y
left ventricular end-diastolic volume|Left ventricular end-diastolic volume|Y
amyloid precursor-like protein 2|Amyloid precursor-like protein 2|Y
substance P immunoreactivity|substance P like immunoreactive|N
biventricular|bi-ventricular|Y
transforming growth factor beta receptor type I|transforming growth factor-β receptor 1|Y
isolated perfused rat kidney model|isolated perfused kidney model|Y
human adenovirus 17|human adenovirus serotype 17|Y
mechanism|mechanic|N
partially hepatectomized|partial hepatectomy|Y
sustained response|sustained responder|Y
angiotensin II receptor type 1|angiotensin II receptor 1|Y
acetyl-leucinyl-leucinyl-methional|acetyl-leucyl-leucyl-methional|Y
International Committee on Taxonomy of Viruses|International Committee for the Taxonomy of Viruses|Y
peak pressure|paw pressure|N
gastroesophageal reflux disease|gastro-esophageal reflux disease|Y
hypothalamopituitary adrenal axis|hypothalamic-pituitary-adrenal|Y
computer-assisted semen analysis|computer-assisted semen analyzer|Y
Secreted Frizzled-related protein 1|secreted frizzled related protein-1|Y
American Society of Anesthesiology grade 5|American Society of Anaesthesiologists Grade V|Y
American Society of Anesthesiology status 4|American Society of Anesthesiology physical status IV|Y
corneal endothelial cell|cerebral endothelial cell|N
human immunodeficiency virus 1 RNA level|human immunodeficiency virus type 1 RNA level|Y
left ventricular diastolic diameter|left ventricular enddiastolic dimension|Y
orthophenylenediamine|o-phenylenediamine|Y
group 1 metabotropic glutamate receptor|metabotropic glutamate receptor 1|Y
cranial computed tomography|cranial computerised tomography|Y
myocyte-specific enhancer binding factor 2|myocyte enhancer binding factor 2|Y
internal derangement|internal drainage|N
ventral posteromedial thalamic nucleus|ventroposteromedial thalamic nucleus|Y
p-chloromercuriphenylsulfonic acid|parachloromercuriphenylsulfonate|N
O-methylhydroxylamine|o-methylhydroxylamine|Y
serous otitis media|secretory otitis media|Y
hydroxylysylnorleucine|hydroxylysinonorleucine|Y
nitric oxide synthetase|nitric oxide synthase|Y
maximal tolerated dose|maximally-tolerated dose|Y
radiology information system|radiologic information system|Y
major histocompatability complex|major histo-compatibility complex|Y
donor lymphocyte infusion|donor leukocyte infusion|Y
transactivation domain|transcription activation domain|Y
canonical correlation analysis|canonical correspondence analysis|N
oxolinic acid|oxalic acid|N
micro-vessel density|microvessel density|Y
severe chronic neutropenia|severe congenital neutropenia|N
balloon mitral valvotomy|balloon mitral valvuloplasty|Y
poly(3-hydroxybutyrate)depolymerase|poly-beta-hydroxybutyrate depolymerase|Y
cell-mediated cytolysis|complement-mediated cytolysis|N
trefoil factor 3|trefoil factor family 3|Y
beta-APP cleaving enzyme|beta APP-cleaving enzyme 1|Y
aortic occlusive disease|arterial occlusive disease|N
soyabean trypsin inhibitor|soybean trypsin inhibitor|Y
computed tomographic arthrography|computed tomography angiography|Y
guanidinium hydrochloride|guanidinium chloride|Y
Disease Activity Score|Disease Activity Score 28|Y
T2 weighted imaging|T2-weighted images|Y
four-and-a-half LIM domain protein 3|four and a half LIM only protein 3|Y
late gadolinium enhancement cardiac magnetic resonance|late gadolinium enhanced cardiac magnetic resonance|Y
Hamilton Anxiety Rating Scale|Hamilton Anxiety Scale|Y
S-nitroso human serum albumin|S-nitrosylated human serum albumin|Y
maple sugar urine disease|maple syrup urine disease|Y
human adenovirus type 47|human adenovirus 47|Y
15-item Patient Health Questionnaire|Patient Health Questionnaire 15|Y
interleukin-5 receptor α subunit|interleukine-5 receptor-α|Y
diethyl-stilboestrol|diethylstilbesterol|Y
13carbon urea breath test|carbon 13 urea breath test|Y
supraventricular tachyarrhythmia|supraventricular tachycardia|Y
American Society of Anesthesiology status 5|American Society of Anesthesiology physical status 5|Y
individual patient data|individual patient datum|Y
self-expandable metallic stent|self-expanding metallic stent|Y
dimethylphthalate|dimethylphosphate|N
transitional zone|transition zone|Y
portal venous blood|peripheral venous blood|N
trypanosome lymphocyte triggering factor|lymphocyte triggering factor|N
American Society of Anesthesiologists Grade 3|American Society of Anaesthesiologists Class III|Y
therapeutic ultrasound|thoracic ultrasound|N
hypobaric hypoxia|hypoxic hypoxia|Y
propylthiouracil|6-n-propylthiouracil|Y
human immunodeficiency virus 1 infection|human immunodeficiency virus type 1 infection|Y
Crocidura occidentalis|Cercis occidentalis|N
Peroxisome proliferator-activated receptor gamma coactivator-1|peroxisome proliferator-activated receptor gamma coactivator-1|Y
Epstein-Barr nuclear antigen 1|Epstein-Barr virus nuclear antigen 1|Y
antihuman lymphocyte globulin|antilymphocytic globulin|Y
diffuse type gastric cancer|diffuse gastric cancer|Y
organophosphate-induced delayed neuropathy|organophosphorus ester-induced delayed neurotoxicity|Y
ventral posteromedial nucleus|ventral posterior medial nucleus|Y
physical therapy|physical therapist|N
American Society of Anaesthesiology grade V|American Society of Anesthesiologists Grade V|Y
cyclic guanidine monophosphate|cyclic guanosine 3',5'-monophosphate|N
human brain microvascular endothelial cell|human brain microvessel endothelial cell|Y
high-resolution computerized tomography|high resolution computed tomographic|Y
coccygeal vertebra 3|3rd coccygeal vertebra|Y
lipoamide dehydrogenase|dihydrolipoamide dehydrogenase|N
castration refractory prostate cancer|castration resistant prostate cancer|Y
monounsaturated fatty acid|monounsaturated fat|Y
ruminally undegradable protein|rumen undegradable protein|Y
pathologic complete remission|pathologic complete response|Y
American Society of Anaesthesiologists grade 3|American Society of Anaesthesiologists Class 3|Y
lymphocytic choriomeningitis|lymphocytic meningitis|N
magnetic resonance angiogram|magnetic resonance arthrography|N
anti-matrix metalloproteinase 13 antibody|anti-matrix metalloprotease 13 antibody|Y
antidouble stranded DNA antibody|antidouble stranded DNA|Y
cyclic nucleotide-gated|cyclic nucleotide gated channel|Y
congenital central hypoventilation syndrome|central congenital hypoventilation syndrome|Y
excision repair cross-complementing-4|excision repair cross complementation group 4|Y
p-chloromercuribenzene sulfonic acid|p-chloromercuribenzene sulfonate|N
military anti-shock trouser|medical anti-shock trouser|Y
human corneal endothelial cell|human corneal epithelial cell|N
adipose-derived stromal cell|adipose-derived stem cell|N
hydroxypropylcyclodextrin|hydroxypropyl-beta-cyclodextrin|Y
American Society for Clinical Investigation|american society for clinical investigation|Y
methyl CpG binding protein|methyl CpG binding protein 2|N
B2 receptor|receptor|N
adenovirus type 5 E3|adenovirus 5 E3|Y
ischemic leg disease|ischæmic limb disease|N
phosphopantetheinyl transferase|phosphopantetheine protein transferase|Y
middlesex elderly assessment of mental state|Middlesex Elderly Assessment of Mental State|Y
thymus humoral factor|thymic humoral factor|Y
oxygen-radical absorbing capacity|oxygen radical absorbance capacity|Y
standard uptake value ratio|standardised uptake value ratio|Y
testicular feminisation|testicular feminised|Y
thyroglobulin antibody|thyroglobulin activity|N
acetylated low-density lipoprotein|acetylated low density lipoproteins|Y
fibrin fibrinogen degradation product|fibrinogen degradation product|Y
American Society of Anesthesiology physical status 2|American Society of Anesthesiology status II|Y
recommended daily allowance|recommended dietary allowance|Y
brain endothelial cell|bovine endothelial cell|N
modified Rankin score|modified Rankin Scale score|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiology Class I|Y
nucleoside-triphosphatase|nucleoside triphosphatase|Y
anaplastic thyroid carcinoma|anaplastic thyroid cancer|Y
cerebral endothelial cell|choroidal endothelial cell|N
X-linked severe combined immunodeficiency|X-linked severe combined immunodeficiency disease|Y
cortical-basal ganglionic degeneration|corticobasal ganglionic degeneration|Y
fibrinogen degradation product|fibrinogen/fibrin degradation product|Y
botulinum neurotoxin serotype B|botulinum neurotoxin type B|Y
American Osteopathic Association|American Orthopedic Association|N
computed tomography colography|computed tomography colonography|Y
short interval intracortical inhibition|short intracortical inhibition|Y
thyrotoxin receptor antibody|thyrotropin receptor antibody|N
local regional recurrence|locoregional recurrence|Y
transforming growth factor beta type II receptor|transforming growth factor beta receptor type II|Y
Toronto Alexithymia Scale-26|26-item Toronto Alexithymia Scale|Y
nonbreastfeeding|non-breastfed|Y
American Society of Anesthesiologists grade IV|American Society of Anesthesiologists Class 4|Y
gonadotropin releasing hormone agonist|gonadotropin-releasing hormone analogs|Y
arabinosyluracil|arabinofuranosyluracil|N
interleukin 12 receptor beta2 chain|interleukin 12 receptor beta2|Y
gold thioglucose|goldthioglucose|Y
adaptor protein 1 binding|activation protein 1 binding|N
γ-glutamyl transpeptidase|gamma-glutamyltranspeptidase|Y
malic acid|maslinic acid|N
70 kDa ribosomal protein S6 kinase|p70 ribosomal protein S6 kinase|Y
D1 dopamine receptor|dopamine D(1) receptor|Y
3,4-dihydroxyphenylalanine|dihydroxyphenylalanine|Y
American Society of Anesthesiologists physical status 1|American Society of Anaesthesiology class 1|Y
U2 snRNP auxiliary factor|U2 auxiliary factor|Y
National Inpatient Sample|Nationwide In-patient Sample|Y
American Society of Anesthesiologists Class 1|American Society of Anaesthesiology status I|Y
left salpingo-oophorectomy|left salpingoophorectomy|Y
Clinical Global Impressions Severity of Illness|Clinical Global Impressions-Severity of Illness scale|Y
gastrin binding protein|glucan binding protein|N
urothelial cancer|urothelial cell|N
video-assisted thoracoscopic surgery|video assisted thoracic surgery|Y
fibrin split product|fibrinogen split product|Y
left ventriculogram|left ventriculography|Y
insulinlike growth factor receptor type 1|insulin-like growth factor-1 receptor|Y
thyroid hormone binding globulin|thyroxin binding globulin|N
mercaptoethylamine|beta mercaptoethylamine|Y
human T-cell lymphoma/leukaemia virus type 2|human T cell leukemia virus type 2|Y
American Society of Anaesthesiologists status III|American Society of Anaesthesiology physical status 3|Y
left ventricular hypertrophy|left ventricle hypertrophy|Y
computerised tomography scanning|computerised tomographic scanning|Y
dehydrocholate|dehydrocholesterol|N
rifampin resistance|rifampicin resistance|Y
rhinovirus-induced|rotavirus-induced|N
dengue virus type 1|dengue virus 1|Y
American Society of Anaesthesiologists status II|American Society of Anaesthesiologists Grade II|Y
carboxyterminal amino acid|carboxylterminal amino acid|Y
neuro-Behcet disease|neuro-Behcet's disease|Y
chromosomal aberration|chromosome aberration|Y
metabotropic glutamate receptor 2|metabotropic glutamate receptor subtype 2|Y
fatty acyl coenzyme A synthetase|fatty acyl CoA synthetase|Y
galactose oxidase|glucose oxidase|N
coherent diffraction imaging|coherent diffractive imaging|Y
systemic|system|N
intrathoracic blood volume index|intra-thoracic blood volume index|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiologists physical status I|Y
IL-11 receptor α-chain|IL-11 receptor-alpha|Y
skin sympathetic nerve activity|splanchnic sympathetic nerve activity|N
oleanolic acid|oleic acid|N
periventricular-intraventricular hemorrhage|peri-intraventricular haemorrhage|Y
binucleate cell|binucleated cell|Y
electroconvulsive therapy|electroconvulsive treatment|Y
electron diffraction|gas electron diffraction|N
respiratory inductance plethysmography|respiratory inductive plethysmograph|Y
chemohyperthermic peritoneal perfusion|continuous hyperthermic peritoneal perfusion|Y
membrane-associated RING-CH-1|membrane-associated RING-CH protein 1|Y
practical nurse|practice nurse|N
World Health Organization Quality of Life Questionnaire|World Health Organization Quality of Life|Y
multilamellar vesicle|multilaminar vesicle|Y
equine herpesvirus 2|equid herpesvirus type 2|Y
polymorphic ventricular tachycardia|polymorphous ventricular tachycardia|Y
Patient Health Questionnaire 8|eight-item Patient Health Questionnaire|Y
apoprotein A-I|apolopoprotein A-1|Y
salvage radiotherapy|salvage radiation therapy|Y
primary somatosensory|primary somatosensory cortex|Y
quadrupole mass spectrometry|quadrupole mass spectrometer|Y
trifluoroacetyl|trifluoroacetate|Y
peritoneal carcinoma|peritoneal carcinomatosis|N
insulin-like growth factor II messenger RNA binding protein 3|insulin-like growth factor-II mRNA-binding protein 3|Y
delayed traumatic intracerebral hemorrhage|delayed traumatic intracerebral hematoma|Y
multiple endocrine neoplasia type 1 syndrome|multiple endocrine neoplasia 1 syndrome|Y
soluble amyloid precursor protein alpha|secreted amyloid precursor protein alpha|Y
electron probe x-ray microanalysis|electron-probe X-ray micro-analysis|Y
rapid eye movement sleep behavior disorder|rapid eye movement behavior disorder|Y
murine beta-defensin 2|mouse beta-defensin 2|Y
acidophilic|acidophil|Y
prefrontal cortical|prefrontocortical|Y
serotonin binding protein|spermine binding protein|N
x-ray repair cross complementing 1|x-ray repair cross complementing group 1|Y
human adenovirus 39|human adenovirus type 39|Y
American Society of Anesthesiology Class I|American Society of Anaesthesiology status I|Y
sexually transmitted disease|sexually-transmitted disease|Y
electrothermal atomic absorption spectrophotometry|electrothermal atomic absorption spectrometric|Y
excision repair cross-complementing 8|excision repair cross-complementation group 8|Y
American Psychiatric Association|American Psychological Association|N
hemagglutination inhibition assay|hemagglutination inhibitory antibody|Y
computed tomography scan|computerised tomographic scan|Y
activator protein 1|adaptor protein 1|N
organophosphorus ester-induced delayed neuropathy|organophosphorus ester-induced delayed neurotoxicity|Y
neisserial heparin binding antigen|Neisseria heparin binding antigen|Y
anti-tuberculosis therapy|antitubercular therapy|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists status I|Y
interleukin 1 receptor 2|interleukin 1 receptor type II|Y
extracorporeal lung assist|extracorporeal lung assistance|Y
pancreatoduodenal resection|pancreaticoduodenal resection|Y
mini-chromosome maintenance protein-2|mini-chromosome maintenance-2|Y
transforming growth factor beta receptor type 1|transforming growth factor beta receptor I|Y
four and a half LIM only protein 2|four and a half LIM protein 2|Y
trimethylphosphate|trimetaphosphate|N
time-resolved fluorescence immunoassay|time resolved fluorometric immunoassay|Y
sacral nerve modulation|sacral neuromodulation|Y
maternal serum alpha fetoprotein|maternal serum alpha feto protein|Y
binding protein|binding potential|N
all trans retinoid acid|all transretinoic acid|Y
maximal predicted heart rate|maximum predicted heart rate|Y
a disintegrin and metalloproteinase-23|a disintegrin and metalloprotease-23|Y
minimum inhibitory concentration|minimal inhibitory concentration|Y
computer based testing|computer based training|N
activating protein-1 complex|activator protein 1 complex|Y
hepatic arterial blood flow|hepatic artery blood flow|Y
bannayan zonana syndrome|Bannayan-Zonana syndrome|Y
American Society of Parasitology|American Society of Parasitologists|N
multiple drug resistance|multiple drug resistant|Y
human immunodeficiency type 1 virus|human immunodeficiency virus 1|Y
anti-IL-6 receptor monoclonal antibody|anti-interleukin-6 receptor monoclonal antibody|Y
myocardial perfusion single-photon-emission computerised tomography|myocardial perfusion single-photon emission computed tomography|Y
immunoglobulin G4 antibody|immunoglobulin gamma-4 antibody|Y
lymphovascular space involvement|lymphvascular space invasion|Y
glycated hemoglobin|glycohemoglobin|Y
thiobarbituric acid reactive substance|thiobarbituric acid reactive species|Y
oral facial digital syndrome type V|orofaciodigital syndrome type V|Y
tropomyosin receptor kinase A|tyrosine receptor kinase A|N
single-photon emission computerised tomography|single-photon emission-computed tomography|Y
total skin electron beam radiation|total skin electron beam irradiation|Y
American Society of Anesthesiology Class 4|American Society of Anaesthesiologists Class IV|Y
trans-activation response|trans-activation responsive|Y
lower respiratory tract infection|lower respiratory tract illness|Y
handling induced convulsion|handling-induced convulsions|Y
combined anti-retroviral therapy|combination anti-retroviral therapy|Y
organophosphate-induced delayed neuropathy|organophosphorus-induced delayed neurotoxicity|Y
biventricular pacemaker-implantable cardioverter defibrillator|biventricular internal cardioverter defibrillator|Y
excision repair cross-complementing 5|excision repair cross complementing group 5|Y
idiopathic interstitial pneumonitis|idiopathic interstitial pneumonia|Y
receptor protein tyrosine phosphatase eta|receptor-like protein-tyrosine phosphatase eta|Y
antirat neutrophil serum|antineutrophilic serum|N
myofacial pain dysfunction syndrome|mandibular pain dysfunction syndrome|N
retropubic radical prostatectomy|robotic radical prostatectomy|N
benzodiazepin|benzo-diazepine|Y
extracellular acidification rate|extra-cellular acidification rate|Y
mutant frequency|median frequency|N
cystic adenomatoid malformation|congenital adenomatoid malformation|N
insulin-like growth factor-II messenger RNA-binding protein-1|insulin-like growth factor II mRNA-binding protein 1|Y
flexible bronchoscope|flexible bronchoscopy|Y
Molossus ater|Molothrus ater|N
catheterise|catheter|N
binaphthol|binaphthyl|N
corticotrophin-releasing-hormone receptor type-2|corticotrophin-releasing-hormone receptor 2|Y
acute nonlymphocytic leukemia|acute nonlymphoblastic leucemia|Y
converting enzyme inhibition|converting enzyme inhibitors|Y
intra-vascular lymphomatosis|intra-vascular lymphoma|Y
Helicobacter pylori stool antigen test|Helicobacter pylori stool antigen|Y
stromal cell derived factor-1|stromal derived factor 1|Y
betasecretase|beta secretase 1|Y
classic intrafascial supracervical hysterectomy|classic intrafascial Semm hysterectomy|Y
portal venous blood flow|portal vein blood flow|Y
in vivo neutron activation|in-vivo neutron activation|Y
indirect fluorescence antibody test|indirect fluorescent antibody test|Y
equid herpesvirus type 1|equine herpesvirus 1|Y
National Health Corporation|national healthcare corporation|Y
tuberoinfundibular dopamine|tuberoinfundibular dopaminergic|Y
American Society of Anesthesiology status 5|American Society of Anaesthesiologists grade V|Y
para-nitroaniline|p-nitroaniline|Y
naphthylacetic acid|naphthaleneacetic acid|Y
antiphenolic glycolipid 1|antiphenolic glycolipid 1 antibody|Y
carboxy-haemoglobin|carboxyhemoglobin|Y
regional cerebral blood volume|relative cerebral blood volume|N
rhinovirus positive|rotavirus-positive|N
aminophenol triacetic acid|o-aminophenol-N,N,O-triacetic acid|Y
lymphocyte predominance Hodgkin disease|lymphocyte predominant Hodgkin disease|Y
American Society of Anaesthesiologists Status 2|American Society of Anaesthesiology physical status II|Y
pulmonary perfusion pressure|portal perfusion pressure|N
ventricular brain ratio|ventricle-brain ratio|Y
cDNA-amplified fragment length polymorphism|cDNA amplified fragment length polymorphism|Y
metaphalangeal|metacarpophalangeal|N
Toll/interleukin-1 receptor domain-containing adaptor inducing IFN-beta|toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
parainfluenza type 2 virus|human parainfluenza type 2 virus|Y
pyrogen-releasing factor|prolactin-releasing factor|N
health care finance administration|Health Care Financing Administration|Y
surgical wound infection|sternal wound infection|N
severe combined immunodeficient-repopulating cell|severe combined immunodeficiency-repopulating cell|Y
first transmembrane segment|transmembrane segment 1|Y
cytosolic|cytosol|Y
transcutaneous electrical nerve stimulator|transcutaneous electric nerve stimulation|Y
triplex-forming oligonucleotide|triplex forming oligonucleotide|Y
Wingless-type MMTV integration site family|Wingless-type MMTV integration site|Y
paired box gene 5|paired box 5|Y
p-chloromercuriphenylsulphonic acid|p-chloromercuriphenylsulfonic acid|Y
Subjective Well-being under Neuroleptics|Subjective Well-being under Neuroleptics scale|Y
mouse Leydig tumor cell line 1|murine Leydig tumor cell line 1|Y
tumour to background ratio|target to background ratio|N
FK506 binding protein 12|FK506 binding protein|N
computed tomographic arteriography|computed tomographic arthrography|N
downstream regulatory region|distal regulatory region|N
reciprocating gait orthosis|reciprocating-gait orthosis|Y
sensory evoked potential|somatosensory evoked potential|Y
short intracortical inhibition|short latency intracortical inhibition|Y
equine herpesvirus 5|equid herpesvirus 5|Y
autonomous replication sequence|autonomous replicating sequence|Y
three dimensional quantitative structure activity relationship study|three-dimensional quantitative structure-affinity relationship study|Y
6-n-propyl-2-thiouracil|propylthiouracil|Y
immune-response-associated antigen|immune response gene associated antigen|Y
Staphylococcus aureus Cowan|Staphylococcus aureus Cowan I|Y
nuclear receptor co-repressor 2|nuclear corepressor 2|Y
3,4-dimethoxyphenylethylamine|dimethoxyphenylethylamine|Y
transferrin receptor|serum transferrin receptor|N
cytotoxic T-lymphocyte-associated antigen-4|cytotoxic T lymphocyte-associated antigen 4|Y
catalytic constant|catalytic rate constant|Y
matrix assisted laser desorption/ionization time of flight mass spectrometric|matrix-assisted laser desorption/ionization time-of-flight mass spectrometry|Y
heteronuclear multiple bond coherence|heteronuclear multiple bond connectivity|Y
percutaneous trans-luminal balloon angioplasty|percutaneous transluminal angioplasty|Y
tensionfree vaginal tape|tensionfree vaginal tape procedure|Y
intravenous immunoglobulin|intravenous gammaglobulin|Y
border disease virus|Borna disease virus|N
American Society of Anaesthesiologists grade III|American Society of Anesthesiology Grade III|Y
Madin Darby canine kidney cell|Madin Darby canine kidney|Y
macroenzyme creatine kinase type 2|macrocreatine kinase type 2|Y
quantitative structure retention relationship|quantitative structure reactivity relationship|N
prostaglandin A(1)|prostaglandin A1|Y
thoracoabdominal aortic aneurysm|thoracoabdominal aneurysm|Y
4-Dimethylaminopyridine|dimethylaminopyridine|Y
receptor-linked protein-tyrosine-phosphatase alpha|receptor protein-tyrosine phosphatase-α|Y
clinical global impressions of change|Clinical Global Impression of Change|Y
Ohio State University|Oregon State University|N
photo-plethysmography|photoplethysmogram|Y
platelet-derived growth factor receptor-α|Platelet-derived growth factor receptor alpha|Y
superconducting quantum interference device|super-conducting quantum-interference device|Y
tert-amyl alcohol|tertiary amyl alcohol|Y
ultraviolet A radiation|ultraviolet irradiation|N
systematized nomenclature of medicine|Systematized Nomenclature of Medicine|Y
hypoxic|hypoxia|Y
computed tomography enteroclysis|computed tomography enterography|N
Eating Attitudes Test|eating attitudes test|Y
tumor necrosis factor receptor 2|Tumor necrosis factor receptor II|Y
lower respiratory infection|lower respiratory tract infection|Y
maximum tolerated dose|maximally-tolerated dose|Y
major cardiovascular event|major adverse cardiovascular event|Y
variant surface protein|variant-specific surface protein|Y
American Society of Anesthesiologists Status I|American Society of Anesthesiology status I|Y
lactic dehydrogenase|lactate dehydrogenase|Y
butyric acid|boric acid|N
AMP-activated kinase|AMP-activated protein kinase|Y
insulin-like growth factor II mRNA-binding protein 1|insulin-like growth factor-II messenger RNA binding protein 1|Y
conditioned stimulus|conditional stimulus|Y
receptor protein tyrosine phosphatase delta|receptor-like protein tyrosine phosphatase-delta|Y
azauracil|6-azauracil|Y
Seattle Veterans' Administration Medical Center|Seattle Veterans' Affairs Medical Center|Y
enterovirus type 71|enterovirus 71|Y
median fluorescence intensity|median fluorescent intensity|Y
guanosine|guanine|N
trichloroethene|trichloroethylene|Y
receptor-type protein-tyrosine phosphatase-β|receptor protein tyrosine phosphatase beta|Y
ribosomal protein S6 kinase|p70 ribosomal protein S6 kinase|Y
type-2 corticotrophin-releasing-hormone receptor|corticotrophin-releasing-hormone receptor-2|Y
latent TGF-β binding protein 1|latent TGFbeta binding protein 1|Y
Q-T dispersion|QT dispersion|Y
insulin-like growth factor II messenger RNA-binding protein-2|insulin-like growth factor-II mRNA-binding protein-2|Y
m-chlorophenyl piperazine|1-(m-chlorophenyl)piperazine|Y
dengue 2 virus|dengue type 2 virus|Y
diffusion-weighted image|diffusion-weighted imaging|Y
trans-vaginal ultrasonography|transvaginal ultrasound|Y
real time reverse transcriptase polymerase chain reaction|realtime reverse transcription polymerase chain reaction|Y
American Association of Medical Colleges|American Association of Medical Clinics|N
administrator|administration|N
gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone agonist|N
inactivated poliomyelitis vaccine|inactivated polio vaccine|Y
ocular hypertension|ocular hypertensive|Y
illinois test of psycholinguistic ability|Illinois Test of Psycholinguistic Abilities|Y
double balloon endoscopy|double balloon enteroscopy|Y
receptor protein-tyrosine phosphatase-η|receptor-like protein tyrosine phosphatase-eta|Y
intra-uterine pressure|intrauterine pressure|Y
digestive energy|digestible energy|Y
human adenovirus type 28|human adenovirus serotype 28|Y
follicle stimulating|follicle stimulating hormone|N
nicotinamide adeninedinucleotide|nicotinamide adenine dinucleotide reduced|N
para-aminohippuric acid|p-aminohippuric acid|Y
adrenocorticotropic hormone|adreno-corticotropic hormone|Y
poliovirus receptor related protein 1|poliovirus receptor related 1|Y
density functional theory|density functional theoretical|Y
anti-retinal antibody|anti-reticulin antibody|N
total endoplasmic reticulum|tubulo-cisternal endoplasmic reticulum|N
prefrontal cortical|prefrontal cortex|Y
post-transplantation lymphoproliferative disease|posttransplantation lympho-proliferative disorder|Y
human corticotropin-releasing hormone|Human corticotropin releasing hormone|Y
T-cell colony-forming cell|T-colony-forming cell|Y
postsynaptic density-95|postsynaptic density protein 95|Y
Growth-related oncogene-alpha|growth-related oncogene alpha|Y
multidetector computed tomographic scan|multi-detector computed tomography scan|Y
late gadolinium enhanced cardiac magnetic resonance|late gadolinium enhanced cardiovascular magnetic resonance|Y
equine herpesvirus 3|equine herpesvirus type 3|Y
nonspecific urethritis|non-specific urethritis|Y
Self-Efficacy Scale|Cultural Self-Efficacy Scale|N
immunocyto-chemically|immunocytochemical|Y
randomly amplified polymorphic DNA analysis|random amplification of polymorphic DNA analysis|Y
multi-drug resistance|multiple drug resistance|Y
peroxisome proliferator-activated receptor-gamma2|peroxisome proliferator activated receptor-γ 2|Y
mixed anxiety depression disorder|mixed anxiety depressive disorder|Y
cytochrome oxidase II|cytochrome oxidase|N
stereotactic electroencephalography|stereo-electroencephalography|Y
toll-like receptor 3|Toll-like receptor-3|Y
nucleolar organising region|nucleolus organiser region|Y
iodine-123 metaiodobenzyl guanidine|iodine 123 metaiodobenzylguanidine|Y
multiple monitored electroconvulsive therapy|multiple-monitored electro-convulsive therapy|Y
antithyroid antibody|thyroid antibody|Y
gut transit time|gastric transit time|Y
military treatment facility|military medical treatment facility|Y
percentage|percent|Y
murine double minute 2|mouse double minute 2|Y
transcutaneous oxygen pressure|transcutaneous oxygen tension|N
upstream activation region|upstream activator region|Y
Peabody Developmental Motor Scale-2|Peabody Developmental Motor Scales-Second Edition|Y
pulmonary edema|pulmonary emphysema|N
pigment epithelium|pigment epithelial|Y
temporal lobectomy|temporal lobe|N
tail length|total length|N
virion protein 16|viral protein 16|Y
very preterm|very pre-term|Y
twodimensional|2-dimensional|Y
American Board of Orthodontics|American Board of Orthodontists|Y
